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Marine substrata are colonized by a variety of marine microorganisms, which are capable of 
producing novel compounds due to their diverse and often extreme environmental conditions 
as well as interactions with their associated eukaryotic host organisms. Seaweed serve as an 
important host for bacteria that synthesize bioactive natural substances. Seaweed-associated 
bacteria represent an inexhaustible reservoir of bioactives with potential application in 
pharmaceutical, medicine and food industries. The antibacterial, anti-biofilm and anti-quorum 
sensing potential of bacteria associated with ten South African seaweeds was therefore 
assessed.  
Cultivable seaweed-associated bacteria (n=96) were screened for antibacterial activity 
against five resistant clinical and six aquaculture indicator bacteria utilizing the primary cross 
streak screening assay. Following shake flask fermentations and ethyl acetate extractions 
extracts, from 30 selected isolates were screened using the agar-well diffusion assay and 
minimum inhibitory concentrations (MIC) were determined for 14 extracts. Selected bacteria 
were identified by 16S rRNA gene amplification and sequencing. Active crude extract of 
MAB24-SW1 was then analysed using nuclear magnetic resonance (NMR) and gas 
chromatography-mass spectrometry (GC-MS). Extracts capable of inhibiting initial adhesion 
and detachment of mature biofilm of clinical and aquaculture pathogens were identified using 
the crystal violet microtitre plate assay. The anti-quorum sensing inhibitory potential was 
assessed utilizing Staphylococcus aureus agr and Enterococcus faecalis fsr inhibition assays.  
Primary screening indicated that 38% (37/96) and 73% (71/96) of isolates displayed 
varying antimicrobial activity against clinical and aquaculture indicator strains, respectively. 
Isolate MAB24-SW1 was found to be active against clinical and aquaculture indicators with 
MICs as low as 0.39 mg/ml. The isolate identified as Bacillus velezensis, produced a potential 
analogue of surfactin, which was identified through NMR following partial purification of the 
crude extract. Crude extracts also demonstrated anti-biofilm potential. Inhibition of adhesion 
was most effective at 5 mg/ml for Staphylococcus aureus, Yersinia ruckeri, Vibrio 
parahaemolyticus, Pseudomonas aeruginosa and Aeromonas hydrophila. Extracts were most 
effective in the dispersal of mature biofilms of clinical and aquaculture strains, with the best 
results been observed against S. aureus, V. parahaemolyticus A. hydrophila, P. aeruginosa, 
and Edwardsiella tarda. The total range of biofilm inhibition by extracts was between 0.08% 
- 113.84%. Variation was observed in the efficacy of extracts against initial adherence of 
indicator strains, with ≥ 90% reduction potential being demonstrated by MAB10B-SW1 
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(Bacillus sp.), MAB24-SW1 (B. velezensis), AB4-SW2 and AB3-SW6 against Pseudomonas 
aeruginosa. Anti-quorum sensing inhibitory potential against Staphylococcus aureus was 
assessed  utilizing luminescence and green protein fluorescence (GFP) reduction in the 
Staphylococcus agr assay, crude extracts of MAB6-SW1 (Rhodococcus fascians), MAB10B-
SW1 (Bacillus sp.), MAB24-SW1 (B. velezensis), AB7-SW8 (Streptomyces sp.), AB1-SW9 
(Microbacterium maritypicum) and AB4-SW10 (Strepyomyces labedae) were capable of 
quorum sensing inhibition without causing cell death, with some isolates demonstrating ≥ 50% 
inhibition of GFP. When the anti- quorum sensing inhibitory potential of extracts were tested 
against Enterococcus virulence factor under the control of the fsr quorum sensing system 
(gelatinase production), isolate AB2-SW8 (Streptomyces sp.) demonstrated inhibitory potential 
against both fsr and agr systems without causing cell death.  
Decreased efficiency and resistance of pathogens to antibiotics has necessitated the 
development of new therapeutic alternatives. Based on their anti-biofilm and anti-quorum 
sensing potential, South African seaweed-associated bacteria with their secondary metabolites 
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INTRODUCTION AND LITERATURE REVIEW 
 
1.1 Introduction  
The increased incidence of infectious diseases worldwide together with the utilization of 
antimicrobial agents to treat infections has created a global epidemic, with the emergence of 
multidrug-resistant (MDR) bacteria (Aeromonas, Enterococcus, Escherichia, Klebsiella, 
Pseudomonas, Staphylococcus, and Vibrio spp.) being observed in clinical and aquaculture 
settings (Defoirdt, 2016; Tan et al., 2016). Given this global antimicrobial resistance problem, 
the discovery of novel antimicrobial agents and investigation of their mechanisms of action as 
potential therapeutic compound leads are essential issues for modern pharmaceutical research.  
The increasing prevalence of resistant bacteria is a limiting factor in the efficacy of current 
drugs, however, antimicrobial drug discovery is highly unattractive to pharmaceutical 
companies due to short antibacterial drug life cycles and the acute, rather than chronic, nature 
of antibacterial therapy (Gillings, 2013).  
Since the marine environment covers more than 70% of the world’s surface and remains 
relatively unexplored (Zozaya-Valdes et al., 2015), it is an important source for the discovery 
of novel bioactive compounds as most of the Earth’s microbial communities are located within 
this source. The oceans are an untapped resource for discovery of new compounds since only 
a fraction the biodiversity of marine microbes have been identified and the biological and 
chemical diversity of their bioactive metabolites has not been fully explored (Wahl et al., 
2012).  The marine environment is thus the focus for natural product discovery as it is a prolific 
source of not only plants and animals but the microorganisms associated with them, due to their 
adaptation to this unique environmental habitat and production of a wide variety of primary 
and secondary metabolites that have demonstrated significant biological activities (Kiuru et al., 
2014). It thus represents a source of novel chemical compounds with potential applications as 
pharmaceuticals, cosmetics, nutritional supplements, molecular probes, fine chemicals, and 
agrichemicals (de Oliveira et al., 2012; Penesyan et al., 2013a). 
Marine biodiversity exploration has included an intensive focus on marine macroalgae 
or seaweeds for the discovery of novel treatment options (Lee et al, 2014).  Marine macroalgae, 
or seaweeds, have been utilized as sea vegetables, medicines, and fertilizers for centuries.    
Seaweed surfaces are home to a variety of microorganisms, spores and invertebrate larvae that 
attempt to settle on the thallus surface in which some share a beneficial relationship with their 
host.  They employ a variety of mechanisms to protect their host which includes the synthesis 
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of bioactive compounds (anti-biofouling, antimicrobial agents, etc), which can be adapted for 
human use, with the discovery and development of useful metabolites and potentially novel 
technologies (Wahl et al., 2012; Singh et al., 2015). 
Seaweed-associated bacteria are potential sources of pharmaceutical interest due to 
their production of structurally diverse compounds exhibiting broad-spectrum biological 
activities (Subramani and Aalbersberg, 2013; Singh et al., 2015). Approximately 100 novel 
compounds (e.g., polyketides, alkaloids, fatty acids, peptides and terpenes) are isolated from 
marine bacteria per year (Kiuru et al., 2014). Since seaweed-associated bacteria are effective 
in preventing colonization and fouling by competitor, often pathogenic bacteria (Egan et al., 
2013; Egan et al., 2014; Singh et al., 2015), they can be explored as a source of biofilm and/or 
quorum sensing inhibitory compounds.  These would combat bacterial virulence instead of 
targeting bacterial survival, and potentially reduce the risk of evolution of drug resistant 
microbes (Padmavathi et al., 2014).   
 
1.2 The problem of multidrug-resistant bacteria 
1.2.1 Multi-drug resistance in the clinical environment 
The emergence of MDR bacteria a result of the use, as well as misuse of antibiotics (Ibrahim 
and Saber-Ayad, 2012). The World Health Organization (WHO) has reported high rates of 
resistance in bacteria such as Klebsiella pneumoniae against cephalosporin and carbapenems, 
Staphylococcus aureus against methicillin, and Mycobacterium tuberculosis against 
rapamycin, isoniazid and fluoroquinolone (WHO, 2014). With an increase in the number of 
immuno-compromised patients and longer periods spent in hospital settings, these pathogens 
have become a serious threat to vulnerable patients. Among these opportunistic pathogens are 
staphylococci, Pseudomonas aeruginosa and Enterococcus faecalis, which cause potentially 
lethal infections (Nair et al., 2014). These pathogens are widely distributed in hospitals and are 
increasingly being isolated from community-associated infections (Pop-Vicas and Opal, 2014). 
Many studies are now focused at finding new antimicrobial agents, however, new families of 
antibiotics have a short life expectancy (Ibrahim and Saber-Ayad, 2012). 
The burden of MDR bacteria has substantially increased world-wide, these organisms 
survive for a prolonged time in hospital settings and can easily be transferred between patients 
through the hands of health-care workers. In studies of S. aureus, blood stream mortalities 
ranged from 13 - 39% in immuno-compromised individuals (Pop-Vicas and Opal, 2014). Of 
the MDR organisms, P. aeruginosa requires special mention as this organism is resistant to all 
currently available antimicrobial agents which leaves limited options for treatment. 
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Pseudomonas aeruginosa makes use of various distinct quorum sensing (QS) systems to 
express multiple resistance mechanisms including over-expression of efflux pumps and low 
cell wall permeability (Nathwani et al., 2014). Each year, patients with hospital-acquired 
infections present with highly resistant strains. Amongst those is S. aureus an opportunistic 
organism that forms part of normal human skin flora (Thoendel et al., 2011). Staphylococcus 
aureus is the leading cause of hospital-related infections world-wide; if the epithelial barrier is 
compromised, S. aureus can cause pneumonia, bacteremia, and sepsis. Its ability to cause 
disease is linked to the expression of virulence factors such as adhesion molecules (biofilm 
formation) and toxins that affect the immune system. Quorum sensing regulates expression of 
genes encoding virulence factors, which include various enzymes and toxins. Toxins include 
superantigens, proteases, exfoliative toxins, hemolysins (alpha, beta, gamma, delta), and 
leukocidin (Rutherford and Bassler, 2012). These allow staphylococci to cause a myriad of 
infections such as subcutaneous abscesses to scalded skin syndrome, sepsis, necrotizing 
pneumonia (Desouky et al., 2013). 
Persistent infections are a global problem claiming millions of lives yearly and demand 
costly medical expenditures. Many chronic infections in humans are associated with biofilms 
(Wu et al., 2015). Typical biofilm-associated diseases are cystic fibrosis, periodontitis, 
endocarditis, and chronic wounds. Chronic wounds and implants are an ideal environment for 
biofilm formation. The necrotic tissue and debris allow bacterial attachment, and wounds are 
susceptible to infection due to impaired host immune response (Kamiya et al. 2012). Bacteria 
deploy the formation of biofilms as a survival strategy, which renders them resistant to 
antibiotics, detergents and host immune system. As a correlation between biofilm formation 
and QS has been established (Fernandes et al., 2011; Harder et al., 2012), the possibility of 
using drugs targeting QS is a potential therapeutic approach for persistent biofilm related 
infections (Rodrigues et al., 2015). With the increasing burden of MDR pathogens, there is an 
urgent need for the discovery of molecules targeting virulence factors. 
 
1.2.2 Aquaculture and the bacterial challenge 
For more than 4.3 billion people, fish are a source of animal protein and aquaculture, a vital 
complement to global capture fisheries, is one of the fastest growing sectors in the world 
(Vatsos and Rebours, 2015; Tan et al., 2016). Aquaculture is defined as the farming of 
individually or corporate owned aquatic organisms such as fish, mollusks, crustaceans, and 
aquatic plants with interventions in the rearing process so as to enhance production (Hamza et 
al., 2015a). Some of the problems associated with the intensive commercialization of 
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aquaculture includes various stressors such as crowding, handling, improper water quality 
parameters (Defoirdt, 2013; Vatsos and Rebours, 2015; Zhao et al., 2015), which leads to 
disease outbreaks by a variety of viral, bacterial, fungal, parasitic, and other undiagnosed and 
emerging pathogens. Bacterial pathogens are a major cause of diseases in fish and aquaculture 
resulting in growth retardation and mass mortalities (Hamza et al., 2015a; Vatsos and Rebours, 
2015).  
While the control of the infectious diseases in aquaculture relies on the use of effective 
prophylactic as well as therapeutic measures, their use has serious impacts on the environment 
and increases the health risks for both humans and animals. The indiscriminate and frequent 
use of antimicrobial agents induces a strong selective pressure on the pathogens leading to the 
development of MDR bacterial strains and their isolation from aquaculture environments is 
associated with horizontal transfer of antibiotic resistance and virulence genes to fish and even 
human pathogens (Defoirdt, 2013; Vatsos and Rebours, 2015). The over-use of antimicrobial 
agents in aquaculture and the emergence of MDR fish pathogens has significantly reduced 
options for treating fish diseases (Chenia and Duma, 2016). The persistence and recurrence of 
these bacterial pathogens in aquaculture systems and their role as spoilage organisms and/or 
opportunistic human pathogens associated with fish processing can be correlated with their 
biofilm-forming potential. In the aquaculture environment, bacteria adhere to surfaces of 
submerged material, pipes, and tanks of hatcheries, form biofilms, and act as reservoirs of 
pathogenic bacteria (Iyapparaj et al., 2013; Chenia and Duma, 2016). Bacteria living in 
biofilms can be up to 1,000-10000 times more tolerant to antibacterial compounds than their 
planktonic counterparts (Penesyan et al., 2015).   
Biofouling (accumulation of organisms) is a common problem on man-made objects 
submerged in the marine waters (such as in marine aquaculture) throughout the world (Satheesh 
et al., 2016). Like biofilm formation, biofouling growth on an aquatic environment surface is 
a complex process with initial biofilm formation (consisting of microbes and microalgae) 
followed by settlement of invertebrate larvae and algal spores. Biofouling assemblage in 
marine environment is composed of thousands of marine organisms such as bacteria, fungi, 
phytoplankton, polychaetes, barnacles, molluscs, ascidians and algae. Biofouling on 
submerged surfaces in the marine environment has considerable ecological and economical 
challenges in aquaculture with the loss of productivity well as the increased costs associated 
with ongoing prevention, management and control of biofouling (Satheesh et al., 2016). 
Since aquaculture pathogens cause disease primarily through gene expression regulated 
by QS (Defoirdt, 2013; Zhao et al., 2015), it can be envisaged that disruption of this system 
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can be a more suitable alternative to currently available antimicrobial agents. Thus efforts are 
being made to identify bioactive marine natural products which are able to inhibit biofilm 
formation and/or quorum sensing and decrease virulence in aquaculture-related bacteria.   
 
1.3 Seaweed as a source of bioactive compounds against microbes 
Marine macroalgae are relatively simple, chlorophyllous plants, which are not differentiated 
into root, stem and leaf, and reproduce by spores instead of seeds. Marine seaweeds are adapted 
to the marine environment and usually grow either under or partly under water. Three types of 
seaweeds are defined according to their pigments, brown seaweeds (e.g., Laminaria, Fucus, 
Sargassum), red seaweeds (e.g., Gelidium, Palmaria, Porphyra), and green seaweeds (e.g., 
Ulva, Codium). The unique structural characteristics partly explains the unique chemical 
compositions observed in seaweeds, while the marine environment induces the production of 
unique chemicals to resist the environmental stresses the seaweeds are subjected to (Habbu et 
al., 2016).   
Marine surfaces provide a habitat rich in organic material either because of the physical 
process of molecules adsorbing to surfaces, or due to the production of mucus or mucilage. 
Seaweeds release a large amount of organic carbon into the surrounding environment providing 
a nutrient-rich habitat for microorganisms. Marine seaweeds are, therefore, under constant 
colonization pressure from the millions of microorganisms within the surrounding seawater, 
some are epibiotic, others endophytic, and some are potential pathogens (Egan et al., 2014). 
The marine microbial communities covering seaweeds are complex and highly dynamic 
ecosystems, consisting of a diverse range of organisms (Goecke et al., 2010; Egan et al., 2014), 
with bacteria dominating among the primary colonizers of algal surfaces, followed by diatoms 
and fungi. While some seaweeds are heavily colonized, by contrast, other macroalgal species 
in the same habitat are almost epibiont-free (Goecke et al., 2010).  
In order to defend themselves against harmful colonizers, the seaweeds, which lack a 
cell-based, adaptive immune response, have defense capabilities that fall into two categories.  
The first of these is constitutive under normal circumstances, i.e., production of antimicrobials 
by seaweeds or bacterial symbionts and the second involves induced defenses, which are 
triggered upon tissue damage and result in oxidative bursts or hypersensitive responses (Egan 
et al., 2014). The interactions of seaweed with surface microorganisms presents a constant 
threat to the host thus they synthesis compounds as a microbial defense mechanism (Harder et 
al., 2012). The surface of a seaweed includes secreted secondary metabolites and extracellular 
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exopolymers, which apart from being defense mechanisms, trigger specific interactions 
between seaweed and colonizers (Prabhakaran et al., 2012).   
Many of the seaweed chemicals have been identified as fatty acids and hydroxyl 
unsaturated fatty acids, glycolipids, steroids, polyphenols, coumarins, terpenoids carotenoids, 
xanthophylls, chlorophylls, phycobilins, polysaccharides, vitamins, tocopherol and 
phycocyanins. Lauric acid, palmitic acid, linolenic acid, oleic acid and stearic acids are 
potential antibiotic or antifungal agents, while compounds halogenated with bromine, chlorine 
and even iodine metabolites like diterpenes, triterpenes reportedly possess diverse biological 
activities such as anti-bacterial, ichtyotoxic, antioxidant, anti-malarial, insecticidal and 
cytotoxic (Chojnacka et al., 2012). The extraction procedures and antimicrobial action of 
compounds from marine seaweeds against bacterial pathogens has been extensively reviewed 
recently by Perez et al. (2016). Majority of the seaweed antimicrobial studies have focused on 
the in vitro bactericidal or bacteriostatic properties of seaweed extracts against human bacterial 
pathogens, such as: Bacillus subtilis, Clostridium spp., Enterococcus faecalis, Escherichia coli, 
Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus spp., Salmonella typhimurium, 
Shigella sonnei, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes 
and Vibrio cholerae (Vatsos and Rebours, 2015).  
Many seaweed species successfully prevent the heavy biofouling of marine abiotic 
surfaces and have evolved a number of anti-fouling strategies to combat the growth of epiphytic 
and/or potentially pathogenic microorganisms on their surfaces. Physical mechanisms of anti-
fouling involve continuous shedding of the outer layer of cells, the mucilaginous covering and 
the continuous erosion of the distal ends of blades, and chemically, seaweeds secrete a rich 
source of bioactive secondary metabolites into the surrounding seawater to prevent fouling and 
grazing (Mieszkin et al., 2013). The anti-fouling potential has been described for the algal 
families Rhodophyceae, Phaeophyceae and a few Chlorophyceae and their roles in mediating 
seaweed–bacterial interactions have been extensively reviewed (Hollants et al., 2012; Egan et 
al., 2013; Mieszkin et al., 2013). The red alga Delisea pulchra, produces a range of halogenated 
furanones, which are localized in the central vesicle of gland cells and continuously released 
to the surface, that interfere with surface fouling of micro- and macro-organisms and maintain 
health and reproductive performance of this seaweed (Egan et al., 2013). The brown alga Fucus 
vesiculosus produces the pigment fucoxanthin, which prevents the attachment of bacterial 
isolates from co-occurring macroalgae.  In contrast, bacteria isolated from the alga itself remain 
relatively insensitive to the effect of fucoxanthin. Fucoxanthin, unlike D. pulchra furanones or 
B. hamifera polyhalogenated 2-heptanones, acts as a general inhibitor of bacterial attachment, 
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rather than a specific inhibitor of bacterial growth which impacts on community composition 
(Saha et al., 2011). A glycerol derivative, sn-3-O-(geranylgeranyl)glycerol, isolated from the 
Mediterranean brown seaweeds Taonia atomaria and Dictyota spp., is associated with 
significant anti-adhesion effects with moderate associated toxicity against marine biofilm-
associated bacteria. Yuvaraj and Arul (2014) assessed the anti-biofilm activity of crude 
methanol extracts from ten seaweeds and observed varying abilities to reduce biofilm 
formation by pathogens such as Acinetobacter baumannii, Listeria monocytogenes, P. 
aeruginosa, V. anguillarum. V. fischeri and V. parahaemolyticus. Saha et al. (2012) observed 
that common seaweed metabolites such as dimethylsulphopropionate and the amino acids 
proline and alanine inhibited surface attachment of specific bacteria (e.g. Cytophaga sp), while 
promoting the attachment of others (e.g. Rheinheimera baltica). Thus algal metabolites appear 
to influence specific members of the surface community composition and not just bacterial 
abundance (Saha et al., 2012). Alterations in bacterial community structures may thus ‘select’ 
for beneficial bacterial epibionts, while deterring potentially harmful pathogens. Undefended 
seaweeds have a significantly higher number of bacterial epibionts, an increased incidence of 
bleaching and a substantial reduction in growth compared to defended individuals (Egan et al., 
2014). Since seaweed secondary metabolites are produced and released by specific cells, strong 
local effects on the bacterial epiphytes result (Egan et al., 2013). 
 In addition to growth inhibitory metabolites, seaweed metabolites interfere with 
bacterial communication networks and gene regulation, in particular bacterial QS 
communication systems. By producing QS inhibitors, seaweeds are able to interrupt 
communication circuits in bacteria, thus inhibiting gene expression and the resulting 
colonization phenotypes (Fernandes et al., 2011; Harder et al., 2012). Quorum sensing 
inhibitors produced by the red macroalga D. pulchra include 21 derivatives of halogenated 
furanones, that mediate a variety of ecological interactions for the alga including mimicking 
acylated homoserine-lactone (AHL) signals and competing with AHL for the LuxR receptor 
site (Harder et al., 2012), thereby inhibiting virulence factor production and pathogenesis in P. 
aeruginosa. The predicted mechanism of QS inhibition involves the interference of three 
carbon aliphatic side chains, with the binding of the smaller AHLs to their cognate receptors 
(Jha et al., 2013). Sethupathy et al. (2016) demonstrated the anti-biofilm and QS inhibitory 
potential of the brown macroalga Padina gymnospora against the nosocomial pathogen 
Serratia marcescens. The methanolic extract of P. gymnospora inhibited biofilm formation and 
the production of prodigiosin and protease. The predominant compound, alpha-bisabolol was 
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responsible for the inhibition of biofilm and QS-controlled prodigiosin, protease and swarming 
in S. marcescens, without exerting a deleterious effect on its growth and metabolic activity.  
From an ecological perspective, the antimicrobial, anti-biofilm, anti-fouling and anti-
QS defense mechanisms of marine seaweeds may reduce epibiosis, inhibit premature 
decomposition and directly provide resistance to infectious diseases, by elimination or control 
of the number of pathogens, epiphytes or endophytes. Seaweeds control bacterial colonization 
by use of QS inhibitory chemical defenses to suppress the expression of specific pathogenicity 
traits, while not necessarily killing the pathogen, thus averting disease without promoting 
resistance traits (Egan et al., 2014). Marine seaweeds are thus a natural source of bioactive 
molecules with a broad range of biological activities, such as antimicrobial, anti-viral, anti-
cancer, anti-tumour, antioxidant, anti-inflammatory, anti-biofilm, anti-fouling and anti-
virulence.  
 Aquaculture-based food products can be a source of foodborne pathogenic and 
spoilage bacteria. Seaweed extracts contain compounds, which have significant positive effects 
on the growth and immune system of aquaculture, in addition to demonstrating antibacterial 
properties against many fish pathogenic and opportunistic human pathogenic bacterial species 
that infect farmed fish (Vatsos and Rebours, 2015). Bacterial fish pathogens tested include: 
Aeromonas hydrophila, Aeromonas salmonicida, Edwardsiella tarda, Pseudomonas 
anguilliseptica, Photobacterium damselae sbsp piscicida, Photobacterium damselae subsp. 
damselae, Renibacterium salmoninarum, Streptococcus iniae, Vibrio alginolyticus, Vibrio 
anguillarum, Vibrio fischeri, Vibrio harveyi, Vibrio ordalii, Vibrio parahaemolyticus, Vibrio 
salmonicida, Vibrio vulnificus, and Yersinia ruckeri (reviewed extensively by Vatsos and 
Rebours, 2015). The in vitro and in vivo antibacterial effects of aqueous extracts of bromoform 
and dibromoacetic acid from the red seaweed A. taxiformis was assessed against the fish 
pathogen S. iniae (Mata et al., 2013). When extracts were added into the water containing Lates 
calcarifer (barramundi) fingerlings already infected with S. iniae, a delay was observed in the 
growth of the bacterium in the water, but this did not affect significantly the mortalities caused 
by S. iniae. Addition of higher concentration of the extracts was more effective against the 
pathogen, but also induced mortality in the fish. However, Manilal et al. (2012) examined the 
therapeutic potential of the ethyl acetate fraction of Asparagopsis spp. in black tiger shrimp 
post-larvae challenged with lethal doses of V. harveyi, V. alginolyticus, V. parahaemolyticus 
and P. damselae. Shrimp fed with varying concentrations of extract exhibited significantly 
increased survival rate. Roohi Fatima et al. (2016) observed enhanced protection of farmed 
Mozambique tilapia fish against V. parahaemolyticus infection in housing tanks by addition of 
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an antibacterial methanol extract (1 part per trillion per litre) from the red seaweed, Portieria 
hornemannii. Cavallo et al. (2013) reported that Gracilariopsis longissimi extracts might serve 
as a potential source of antibacterial compounds with possible application in aquaculture plants 
for the treatment of fish diseases associated with Vibrio infections. Extracts from Padina 
gymnosporawere were effective against Oreochromis mossambicus infected with P. 
aeruginosa (Thanigaivel et al., 2015). Sivakumar et al. (2014) demonstrated that the 
antimicrobial properties of U. fasciata seaweed extracts against the pathogen V. harveyi, were 
due to reduced phospholipase, proteolysis, lipolysis and thermonuclease activities of treated 
bacteria and this significantly reduced mortality. Thanigaivel et al. (2014) examined the 
antimicrobial potential of an ethanol extract from the green seaweed Chaetomorpha antennina 
by immersing Penaeus monodon infected with V. parahaemolyticus into water containing 250 
mg/l of the seaweed extract for 12–48 h. This treatment resulted in survival of 98% of the 
treated shrimp, and intramuscular injection of 25 μl of the extract per shrimp protected the 
animals when they were subsequently infected by the bacterial pathogen.  
Defoirdt et al. (2006) examined the antibacterial effect of halogenated furanone 
extracted from D. pulchra against the shrimp bacterial pathogens Vibrio campbellii, V. harveyi 
and V. parahaemolyticus. At 20 mg/l, in vivo protection of brine shrimp Artemia franciscana 
was observed against these bacterial pathogens, although the substance did not have any effect 
on the growth rate of the pathogens in the water. The protective effect was suggested to be due 
to the disruption of QS, due to the observed inhibition of bioluminescence. In addition to 
disrupting AHL-mediated quorum sensing, halogenated furanones block the multichannel QS 
systems of vibrios by decreasing the DNA-binding activity of the quorum sensing master 
regulator LuxRVh. However, while halogenated furanones protect both fish and crustaceans 
against vibriosis, they are too toxic to higher organisms to be applied in practice, with toxic 
concentrations being only slightly higher than QS-disrupting concentrations (Defoirdt, 2013). 
Most seaweed extracts, however, are reported to be nontoxic and can be incorporated 
directly in the feed or added directly into the water, thus these could be used as an alternative 
to traditional antibiotics, which cause resistance (Vatsos and Rebours, 2014). The water-
soluble substances of seaweeds can be released directly from the seaweeds or extracts can be 
added directly (for long periods) into the aquatic environment of the farmed fish and shrimp, 
where they would affect the QS mechanism in bacteria in the water column, prior to infection, 
with limited effects on bacterial growth. On addition of extracts into fish/shrimp feeds (live or 
dry), the seaweed compounds can act directly against the pathogens or by stimulating the 
immune system (Vatsos and Rebours, 2014).  
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1.4 Diversity of seaweed-associated-bacteria 
Seaweeds form an integral part of the aquatic environment (Egan et al., 2013), where they serve 
as primary producers, providing shelter and food. They harbor a rich diversity of 
microorganisms (bacteria, fungi, cyanobacteria and some microalgae), some of which are 
pathogenic and others symbiotic (Kiuru et al., 2014; Singh and Reddy, 2014), due to their 
nutrient composition. Epiphytic bacterial communities are essential for normal morphological 
development of the algal host, enhance algal growth and provide nutrients (Goecke et al., 
2010), influence release and settlement of algal spores (Potin, 2012), and either enhance or 
deter secondary colonization by other microscopic and macroscopic epibiota. This seaweed 
and epiphytic bacteria interaction is considered to be a unified functional entity or holobiont 
(Harder et al., 2012).   
The diversity of bacteria colonizing seaweed ranges between 102 to 107 cells /cm-2 
alongside virus, fungi and protozoa and are found predominantly in association with the thallus 
tip and base. Surface colonization and diversity of microorganisms differ based on species of 
seaweed and season (Case et al., 2011; Egan et al., 2013). Seaweed communities also 
experience spatial and temporal shifts, which may be a reflection of the changing local 
conditions, host physiology, or chemical and physical parameters (Egan et al., 2013). The 
varied differences in bacterial communities is indicative of competitive pressure amongst 
colonizers leading to the production of bioactive compounds, QS signaling molecules, and/or 
QS inhibitors which are responsible host protection and normal morphology development 
(Singh and Reddy, 2014). 
Seaweed-associated bacteria from seaweed surfaces or within algal thalli belong to the 
(super)phyla Proteobacteria, Actinobacteria, Bacteroidetes (CFB group), Cyanobacteria, 
Firmicutes, Planctomycetes, Verrucomicrobia, Chloroflexi, Deinococcus-Thermus, 
Fusobacteria, Tenericutes, and the candidate division OP11 (Hollants et al., 2013). The γ-
proteobacteria appear to be the most common bacterial clade associated with seaweeds (37% 
relative abundance), followed by the CFB group (20%), α-proteobacteria (13%), Firmicutes 
(10%), and Actinobacteria (9%).  On a lower taxonomic level, the orders Flavobacteriales (14% 
relative abundance), Alteromonadales (12%), Vibrionales (10%), Pseudomonadales (9%), 
Bacillales (9%), Actinomycetales (8%), and Rhodobacterales (7%) were most abundant in 
seaweed-associated bacterial communities. It is surprising that only 33 bacterial genera 
including Alteromonas, Bacillus, Flavobacterium, Pseudoalteromonas, Pseudomonas, and 
Vibrio have been described from green, red, and brown seaweeds. Some genera like 
Cytophaga, Planococcus and Tenacibaculum, appear to be associated with green and red 
11 
 
seaweeds, but are virtually absent from brown seaweed surfaces (Hollants et al., 2013).   
Nutrient-rich seaweed surfaces attract many opportunistic micro- and macro-
organisms, creating a highly competitive environment in which bacteria attempt to outcompete 
other surface colonizers by the production of defensive compounds (Penesyan et al., 2013). 
Thus microorganisms synthesize bioactive metabolites in order to ensure their dominant 
positions on the host (Fig. 1.1). This leads to the production of structurally novel compounds 
(Singh et al., 2013), which could serve as a source of bioactive compounds for use in human 
therapies. The production of these antimicrobial compounds is not restricted to a certain 
bacterial group but is widespread across α-proteobacterial, β-proteobacterial, γ-proteobacterial, 
flavobacterial, actinobacterial, and bacilli clades. Micrococcus, Phaeobacter, 
Pseudoalteromonas, Shewanella, Vibrio, and various Bacillus species have been identified as 
efficient producers of compounds with antimicrobial, anti-fouling, and QS inhibiting potential, 
which allows them to be highly successful colonizers of seaweed surfaces (JanakiDev et al., 
2013; Vinoj et al., 2014). Many of these compounds are chemical weapons, which have 
evolved into highly potent inhibitors of physiological processes in the prey, predators or 
competitors of the marine organisms that utilize them for survival (Suresh et al., 2014).   
 
 
Figure 1.1: The seaweed holobiont and the factors predicted to influence bacterial colonization on 





1.5 Bioactive compounds of seaweed-associated-bacteria 
Marine surface-associated microorganisms are a rich source of novel bioactive compounds 
because of the necessity of evolving structurally diverse allelochemicals capable of protecting 
the producer microorganism from the fierce competition that exists between epiphytic and/or 
opportunistic microorganisms on the surfaces of marine eukaryotes (Fig. 1.2). The chemically-
driven interactions allow for the establishment of cross-relationships between microbes and 
their eukaryotic hosts, whereby microorganisms producing bioactive compounds may protect 
the host surface against over-colonization, fouling, etc., in return for nutrient access (Penesyan 
et al., 2010).   
 
Figure 1.2: Graphical representation of green seaweed, existing of bacterial and fungal communities 
on their surface and structure of bioactive compounds (Singh et al., 2014). 
 
Marine seaweeds are a playground for a wide diversity of bacterial associations ranging 
from beneficial (mutualistic), harmful (parasitic), and neutral (commensal), to obligate and 
facultative, to endo- and ecto-phytic interactions (Susilowati et al., 2015). Thus, a wide range 
of chemically-mediated beneficial and detrimental interactions exists between seaweeds and 
epi- and endo-symbiotic bacteria that reside either on the surface or within the algal cells based 
on the exchange of nutrients, minerals, and secondary metabolites (Susilowati et al., 2015). 
The observed positive and negative seaweed–bacterial interactions are based on seaweed 
surfaces providing a protected and nutrient-rich ‘hot spot’ for opportunistic bacteria that 
proliferate in the presence of organic material and oxygen (Singh and Reddy, 2014). In return, 
bacteria produce morphogenic factors, fixed nitrogen, enzymes, and vitamins, which promote 
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algal growth. In addition, epiphytic bacteria as well as the seaweed hosts themselves produce 
antibiotic substances that prevent colonization of the algal surface by bacterial competitors and 
pathogens (Hollants et al., 2013). Seaweeds without their own chemical defenses rely on the 
secondary metabolites produced by their associated bacteria (Goecke et al., 2010). The 
seaweed-associated bacteria produce various bioactive compounds including haliangicin, 
violacein, pelagiomicin A, korormicin, macrolactines, and chlorophyll d, which demonstrate a 
wide range of bioactivities including: antifungal, antiprotozoal, anti-settlement, antimicrobial 
activity against Gram-negative and Gram-positive, and photosynthetic activity, respectively 
(Singh et al., 2015).   
 
1.5.1 Antimicrobial activities of seaweed-associated bacteria 
Chemical interactions between different species of seaweed epibiotic bacteria affect the 
production and secretion of secondary metabolites in these microorganisms (Goecke et al., 
2010; Egan et al., 2014). Since symbiotic bacteria, pathogens, and foulers first select, then 
settle, and finally attach to the host, the first line of defense against microbial challenge is by 
the seaweed themselves which produce secondary metabolites that inhibit one or all of these 
steps.  Should bacterial adhesion not be successfully inhibited, other secondary metabolites are 
synthesized by the seaweeds or by epiphytic and endophytic microbes associated with them, 
which may inhibit the growth, survival, virulence, or reproduction of invading microbes (Case 
et al., 2011). 
Seaweed-based studies have thus led to the isolation of antagonistic bacteria which 
synthesize compounds with broad spectrum of activities (anti-biofilm, anti-cancer, 
antimicrobial, and anti-QS) (Case et al., 2011; Egan et al., 2014; Tebben et al., 2014; Singh et 
al., 2015).  Penesyan et al. (2009) obtained 325 bacterial isolates from the surface of D. pulchra 
and Ulva australis in Australia and demonstrated antibiotic activity for 12% of the strains.  The 
majority of these isolates belonged to α- and γ-proteobacteria, but a few antibacterial isolates 
belonging to the phyla Actinobacteria, Firmicutes and Bacteroidetes were also found (Penesyan 
et al., 2009).  Almost 50% of 210 isolates (belonging to 21 genera including Aeromonas, 
Bacillus, Pseudoalteromonas, Pseudomonas, Shewanella, Stenotrophomonas, Streptomyces 
and Vibrio) of the epiphytic bacterial community of the brown alga Saccharina latissima 
(Baltic Sea, Germany) inhibited the growth of at least one microorganism from a panel of 
Gram-negative and Gram-positive bacteria (Wiese et al., 2009).   
Antimicrobial activity is thus widespread among seaweed-associated bacteria, with the 
most represented bacterial genera being the Gram-positive Bacillus and Streptomyces and 
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Gram-negative Pseudomonas and Pseudoalteromonas, which are known for their ability to 
produce bioactive compounds (Bhatnagar and Kim, 2010).  Many Bacillus species are efficient 
producers of antimicrobial compounds (antibacterial and antifungal) and are, therefore, highly 
successful, dominant colonizers of seaweed surfaces (Kanagasabhapathy et al., 2006; Penesyan 
et al., 2010; Burke et al., 2011; Lachnit et al., 2011).  Seaweed-associated Bacillus isolates 
produce peptide compounds with antimicrobial activity (Janakidevi et al., 2013).  JanakiDevi 
et al. (2013) isolated 126 bacteria from five different seaweeds (Gracillaria corticata, 
Geledium pussilum, Hypnea musiformis, Padina gymnosphora, and Valoniopsis pachynema) 
which showed antibacterial activity (2.6 - 16 mm inhibitory zones) against E. coli, K. 
pneumoniae, P. aeruginosa, Salmonella sp., Serratia sp., Shigella dysenteriae, V. cholerae, 
Micrococcus and Staphylococcus spp. An important antibacterial protein (30.7 kDa) was 
obtained from Bacillus licheniformis associated with Fucus serratus, with activity against 
methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci, and 
L. monocytogenes (Jamal et al., 2006).  A bacteriocin (lichenicidin, a class of lentibiotics) was 
identified from a seaweed-associated (Polysiphonia lanosa and Ulva spp.) B. licheniformias 
(Prieto et al., 2012), while another bacteriocin (~8 kDa molecular weight) was partially 
characterized from seaweed-associated Staphylococcus haemolyticus MSM and exhibited 
strong antibacterial activity against human pathogenic bacteria (Suresh et al., 2014).  
Besides Bacillus species, Pseudoalteromonas spp. which are commonly found on 
marine seaweeds, also produce biologically active molecules that inhibit or control fouling of 
other species on the host surface.  The γ-proteobacterium Pseudoalteromonas tunicata plays a 
role in defending the algal host against surface colonisation by producing antimicrobial, anti-
larval and anti-protozoan compounds. Tebben et al. (2014) identified 13 natural products from 
Pseudoalteromonas strain J010, isolated from the surface of the crustose coralline alga 
Neogoniolithon fosliei.  Among them, a new bromopyrrole, 4-(3,4,5-tribromo- 1H-pyrrol-2-yl) 
methyl)phenol and five new korormicins G–K were obtained which exhibited antibacterial 
activity, in addition to a coral larval metamorphosis inducer compound, tetrabromopyrrole 
which demonstrates broad-spectrum activity against tested bacteria, fungi, and protozoan 
(Tebben et al., 2014).  Two important diketopiperazines, cyclo-(L-prolyl-L-glycine) and cyclo-
(L-phenylalanyl-4R-hydroxy-L-proline), and 2,4-dibromo-6-chlorophenol were extracted 
from Pseudoalteromonas luteoviolacea from the seaweed Padina australis (Jiang et al., 2001).  
Both diketopiperazines stimulated antibiotic production in this strain whereas 2,4-dibromo-6-
chlorophenol showed antibacterial activity against cystic fibrosis-associated Burkholderia 
cepacia and MRSA. 
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Seaweed-associated Pseudomonas sp. strain AMSA, isolated from a red alga 
Ceratodyction spongiosum, produced novel compound 2,4-diacetylphloroglucinol, which 
exhibited activity against MRSA at a minimal concentration of 1 mg/ml and V. 
parahaemolyticus at 24 mg/L (Wietz et al., 2013). Four massetolides A, B, C, and D (novel 
cyclic depsipeptides) were extracted from ethyl acetate fraction of a Pseudomonas sp. isolated 
from an unidentified red alga and inhibited the growth of Mycobacterium tuberculosis and M. 
avium-intracellulare (Gerard et al., 1997). Two peptides cyclo-[phenylalanyl-prolyl-leucyl-
prolyl] and cyclo-[isoleucyl-prolyl-leucyl-alanyl] obtained from a Pseudomonas sp. associated 
with Japanese seaweed Diginea sp., inhibited growth of S. aureus, Micrococcus luteus, B. 
subtilis, E. coli, and V. anguillarum (Rungprom et al., 2008). Ravisankar et al. (2013) identified 
an alkaloid from Pseudomonas sp. associated with Padina tetrastromatica, which inhibited 
growth of K. pneumoniae and Pseudomonas aeruginosa at a concentration of 300 μg. 
Vibrio alginolyticus G16 associated with Gracilaria gracilis had broad-spectrum 
antimicrobial activity against S. marcescens and anti-QS activity (Padmavathi et al., 2014).  An 
epiphytic bacterium, Pseudovibrio sp. D323 isolated from D. pulchra produced the 
antibacterial compound tropodithietic acid, which has a broad-spectrum effect against bacteria 
belonging to Proteobacteria, Actinobacteria, Firmicutes, and Bacteroidetes (Penesyan et al., 
2011).  Suvega and Kumar (2014) observed that the majority of bioactive compound 
producing-bacterial isolates (epibiotics, 39.54 % and endobiotics, 40.74 %) were obtained from 
the surface of seaweeds as compared to the seawater (8.61 %) and marine sediments (11.11 
%). These isolates produced antimicrobial compounds, which were active against plant 
pathogens (Xanthomonas axonopodis pv. citri, X. oryzae pv. oryzae and Ustilaginoidea virens).  
Proteins present in the extracellular components of these bacterial isolates were highly active 
at pH 7.0 and showed antibacterial activity up to 40 °C and antifungal property up to 60 °C, 
whereas nonpolar lipophilic compounds extracted from these active bacteria only displayed 
antifungal activity (Suvega and Kumar, 2014).   
Antimicrobial-producing marine bacteria belong to many taxonomic groups, with some 
of the most prevalent producers originating from the Actinomycetes.  This is not a surprise as 
most structurally diverse bioactive compounds have been isolated from terrestrial 
actinomycetes, particularly Streptomyces spp (Singh et al., 2015).  The antibiotics that are in 
use today are derivatives of novel natural products of actinobacteria such as indigenous marine 
actinomycetes which includes members of the genera Actinomadura, Actinosynnema, 
Amycolatopsis, Arthrobacter, Frigoribacterium, Geodermatophilus, Gordonia, Kitasatospora, 
Micromonospora, and Micrococcus (Ravikumar et al., 2012; Manivasagana et al., 2014).  
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Bacillus and Actinomycetes contain non-ribosomal polyketide synthetase (NRPS) and 
polyketide synthetase (PKS) pathways, which allow for the production of a wide diversity of 
secondary metabolites (Li et al., 2014). A polyketide, 2-hydroxy-5-((6-hydroxy-4-oxo-4H-
pyran-2-yl)methyl)-2-propylchroman-4-one, was obtained and structurally characterized from 
Streptomyces sundarbansensis strain, an endophytic actinomycete isolated from the Algerian 
marine brown algae Fucus sp (Djinni et al., 2013).  This compound exhibited selective activity 
against MRSA (MIC = 6 μΜ), with a bacteriostatic effect.  Braña et al. (2014) identified several 
bioactive compounds from seaweed-associated Streptomyces strains, Streptomyces 
cyaneofuscatus M-27 and Staphylococcus carnosus M-40. These compounds: daunomycin 
(anticancer), cosmomycin B (antitumor), galtamycin B (antitumor), maltophilins (antifungal), 
and lobophorins (anti-inflammatory, anti-BCG and antituberculosis) display several biological 
activities.  The benzaldehydes (2-hydroxy-5-(3-methylbut-2-enyl)benzaldehyde and 2-hepta-
1,5-dienyl-3,6-dihydroxy-5-(3-methylbut-2-enyl)benzaldehyde) produced by seaweed-
associated Streptomyces atrovirens Pk288-21, demonstrated pathogens E. tarda and S. iniae 
(Cho and Kim, 2012). A novel polyketide family member 7-O-methyl-5′-hydroxy-3′- 
heptenoate-macrolactin was obtained from a B. subtilis MTCC 10403 strain associated with 
the seaweed Anthophycus longifolius (Chakraborty et al., 2014).  It possesses broad-spectrum 
antibacterial activity against aquaculture pathogens A. hydrophila, V. vulnificus, and V. 
parahemolyticus (Chakraborty et al., 2014).  Sridevi and Dhevendaran (2014) antimicrobial 
activity against fish isolated 45 Streptomyces spp. isolates from 16 seaweeds, of which 25 
demonstrated antagonistic activity against V. alginolyticus, V. harveyi, V. parahaemolyticus 
and V. vulnificus.  Based on in vitro and in vivo probiotic studies, they have suggested that 
seaweed-associated Streptomyces are a promising source of probiotic and biocontrol agents 
against vibriosis in aquaculture settings. According to Tan et al. (2016), Streptomyces as 
probiotic in aquaculture would be beneficial as anti-pathogenicity agents through the 
production of various antagonistic compounds (e.g., anti-biofilm, anti-QS and anti-virulence) 
against Vibrio pathogens.  In addition to being a good protein source, Streptomyces probiotics 
secrete hydrolytic exoenzymes which improve the amylolytic and proteolytic activity in the 
digestive tract of the fish, which would allow for more efficient use of the feed allowing better 
growth performance of the livestock (Tan et al., 2016). 
Generalist bacterial species such as Bacillus, Pseudoalteromonas, or Streptomyces 
which occupy a broad spectrum of environments would be more likely to benefit from 
producing broad-spectrum antimicrobials or a cocktail of molecules targeting different 
potential competitors, while obligate epiphytes which are highly specialized for a given habitat 
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may produce antimicrobials with narrower range, targeting specific competitors (Hibbing et 
al., 2010). While bioactive compound production may promote the colonization of and 
competition on host surfaces (Rao et al., 2005; Wahl et al., 2012), they often have a fitness 
cost in terms of resource allocation, diverting energy away from growth and reproduction 
(Kumar et al., 2011; Wahl et al., 2012).   
 
1.6 Role of biofilms and quorum sensing in virulence 
Many clinically-relevant bacteria use QS regulons to regulate the collective expression of 
virulence factors. Of increasing concern is the growing inability to combat these pathogens, 
due to the toxicity of anti-fouling agents like tributylin (Cho et al., 2012) and the rapid spread 
of antimicrobial resistance, found to be fuelled by the very drugs and treatments which are 
being employed to fight it (Chankhamhaengdecha et al., 2013). Quorum sensing regulates the 
expression of biofilm formation and is a cooperative group behaviour that involves bacterial 
populations living within extracellular matrix. Quorum sensing coordinates the switch from 
planktonic to a biofilm lifestyle when the population density reaches a threshold level (Lee et 
al., 2013). Although pathogenic bacteria can be found as planktonic cells, most prefer a biofilm 
lifestyle, which provides them with a 1000-fold more resistance than they would possess alone 
(Padmavathi et al., 2014). However, for different bacterial species activation of QS is cell 
density dependent and is linked to the maturation and disassembly of the biofilm in a 
coordinated manner (Pandey et al., 2014). Enterococcus faecalis and V. harveyi utilize QS to 
coordinate their virulence expression and have emerged as important nosocomial and food 
pathogens (Hamza et al., 2015).  
 
1.6.1 Quorum sensing 
Quorum sensing (QS) is a bacterial cell–cell communication process that follows three basic 
principles the production, detection, and response to signaling molecules referred to as 
autoinducer (AIs). Three main QS systems have been reported, i.e., the acyl-homoserine 
lactone (AHL) QS system utilized by Gram-negative bacteria, the autoinducing peptide (AIP) 
QS system in Gram-positive bacteria and the autoinducer-2 system for both Gram-negative and 
positive organisms (Singh et al., 2015). Auto-inducers (AIs) accumulate in the environment as 
the bacterial population density increases, when the AI reach certain threshold collectively alter 
gene expression (Kalia, 2014). Phenotypes associated with QS systems include 
bioluminescence, competence, conjugation, biofilm formation, antibiotic production, 
swarming, nodulation, sporulation, and expression of virulence factors (toxins, siderophores, 
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lytic enzymes, and adhesion molecules) which are not related to the growth or survival of the 
organism (Brackman et al., 2011; Tan et al., 2012).   
Many Gram-negative pathogenic bacteria (Aeromonas, Edwardsiella, Pseudomonas, 
Tenacibaculum and Vibrio) utilize QS to express virulence factors (Zhao et al., 2015).  The 
Gram-negative QS mechanism involves AHL molecules, which diffuse freely through the 
plasma membrane and as the population density increases the AHL concentration also increase 
until a threshold is reached which triggers transcription of targeted genes (Defoirdt, 2013). 
The QS system of Gram-positive bacteria typically consists of signalling peptides (Fig. 
1.3) such as Agr and RNA-III activating/inhibiting peptides (RAP/RIP) in Staphylococcus 
aureus, and a two-component regulatory system made up of a membrane-bound sensor and an 
intracellular response regulator (Quave and Horswill, 2014). The autoinducer molecule is an 
AIP that is detected by a membrane-bound signal transduction system. This system works in a 
two component signal manner in which the two component regulatory system is cell-density-
dependent.  The peptide signal is secreted into the surrounding media for other organisms to 
detect. Once a particular threshold is reached the peptide signal operates by binding to a sensor 
protein, histidine kinase found on the cell membrane. Activation of histidine kinase leads to 
phosphorylation reactions, which activate the response regulating protein leading to 
transcriptional activation (Quave and Horswill, 2014; Singh and Nakayama, 2015).  
Four genes which are involved in the QS system (Fig. 1.3) are encoded by the accessory 
gene regulator (agr) locus (Singh et al., 2016). The AIP propeptide is translated from agrD and 
is subsequently processed by a cell membrane enzyme encoded by agrB. Mature AIP, 
containing a thiolactone bridge, is secreted out of the cell. As bacterial density increases, the 
AIP concentration increases, and at a specific threshold, AIP triggers the activation of the two-
component regulatory system encoded by agrC and agrA. The expression of RNAIII, a 
regulatory RNA molecule as well as mRNA of δ-hemolysin, is promoted by activated AgrA 
(Fig. 1.3). RNAIII thus transcriptionally or translationally controls the expression of a series 






Figure 1.3: Schematic overview of Staphylococcus aureus accessory gene regulatory (agr) system. The 
RNAII transcript is an operon of four genes, agrBDCA that encode factors required to synthesize AIP 
and activate the regulatory cascade (Quave and Horswill, 2014). 
 
 
Quorum sensing in Gram-positive bacteria is linked to the expression of extracellular 
toxins such as α-hemolysin encoded by hla, and cell surface adhesion factors such as Protein 
A encoded by spa (Gray et al., 2013). Their expression of virulence factors is under the control 
of the agr (accessory gene regulator) QS and fsr (Enterococcus faecalis regulator) systems. 
Virulence in Enterococcus faecalis is also controlled by a two component QS system utilizing 
a peptide based autoinducer (AI) encoded by the fsr gene locus. The fsr locus, comprised of 
four genes fsrABDC, has been identified as homologue of the S. aureus Agr QS system 
(Hirakawa and Tomita, 2013). The fsr QS system utilizes gelatinase biosynthesis activating 
pheromone (GBAP) as antoinducer (AI). FsrC the histidine receptor kinase (Fig. 1.4) is 
modulated by the binding of mature GBAP to the ligand and promotes kinase activity. FsrC is 
then able to phosphorylate the DNA binding response regulator FsrA. This actions leads to the 
upregulation of virulence factor expression (Cook and Federle, 2014). Enterococcus virulence 
is linked to the expression of gelatinase (GelE) and serine proteases (SprE) encoded by fsr gene 
cluster (Fig. 1.4). GelE and SprE are reported as regulators of biofilm formation (Hirakawa and 
Tomita, 2013; Singh and Nakayama, 2015). Biofilm formation plays an essential role in the 
development of enterococcal diseases such as endocarditis and persistent infections due to 




Figure 1.4: The Fsr QS system of Enterococcus faecalis. FsrD, the gelatinase biosynthesis activating 
pheromone (GBAP) precursor, is processed to a cyclical peptide during secretion by FsrB. Mature 
GBAP pheromone interacts with the FsrC sensor kinase on the surface of surrounding cells causing 
phosphorylation of the DNA-binding response regulator, FsrA. Phosphorylated FsrA binds to 
promoters, including those of fsrB and gelE/ sprE, and upregulates gene expression (Cook and Federle, 
2014). 
 
1.6.1.1 Mechanisms targeting quorum sensing 
To date only three mechanisms targeting QS have been documented and reported, i.e., 
inhibition of signal generation (LuxI-type synthases, agrC), QS signal degradation and 
inhibition of QS signal biosynthesis (Zhao et al., 2015). Quorum sensing signal molecules can 
be enzymatically degraded, by quorum quenching (QQ) enzymes to prevent their accumulation 
and subsequent activation of the QS system. Many natural QQ substances have already been 
identified for Gram-negative QS systems, and may be classified based on their modes of action 
as AHL-lactonases, AHL-acylases and AHL-oxidoreductases. Lactonases hydrolyze the ester 
bond of the AHL molecules yielding N-acyl-homoserine and acylases hydrolyze the amide 
bond to yield homoserine lactones and a fatty acid chain (Tang and Zhang, 2014). 
Oxidoreductase catalyzes the reduction of 3-oxo-C(8-14)-homoserine lactones (HSLs) to their 
corresponding 3-hydroxy-HSLs, thereby rendering them unrecognizable to their receptor 
molecules (Fetzner, 2015). 
To date no specific enzymatic quenchers of Gram-positive AIP signals have been 
described (Singh et al., 2016). There are three potential targets in the agr QS system (Fig. 1.5).  
AIP biosynthesis is the primary choice because it is the initial event in the QS signal circuit 
(Singh et al., 2016).  Two enzymes, AgrB and SpsB are involved in AIP biosynthesis, AgrB is 
21 
 
specifically involved in the biosynthesis of cyclic AIP, while SpsB is type-I signal peptidase 
involved in the secretion of Sec and Tat-dependent proteins. AgrB and SpsB are processing 
enzymes with protease activity and inhibition of their catalytic functions is anticipated to block 
QS signaling entirely. Enzyme inhibitors, however, are more or less bactericidal or 
bacteriostatic even when targeting AgrB that is specific to AIP biosynthesis rather than SpsB 
that is common for wide range of secretary protein (Singh et al., 2016). Blockage of the two 
component regulatory system AgrC-AgrA is the second target. The combined action of AgrC 
and AgrA, where AgrC phosphorylates and activates regulator AgrA and leads to activation of 
promoters P2 and P3 which are responsible for expression of virulence factors (Fig. 1.5) is a 
viable target for QS inhibitory compounds (Painter et al., 2014). Peptide antagonists are 
expected to have high specificity to AgrC and neither bactericidal nor bacteriostatic activity. A 
third target, i.e., kinase inhibitors targeting AgrC is a possibility, however, it appears to have 
bactericidal and/or bacteriostatic activity due to the number of diverse histidine kinases 
functioning in bacteria. Binding of heterologous AIP causes the linker ligand to bend in the 
opposite direction thus preventing the action of the kinase receptor (Painter et al., 2014). These 
three targets are available for agr-like systems of other Gram-positive bacteria, while there are 
some targets specific to each QS Gram-positive bacterial group (Singh et al., 2016).   
 
Figure 1.5: The agr quorum sensing gene regulatory system. Quorum sensing inhibitory targets are 




 A number of natural products studies have led to the discovery of QS compounds (Table 
1.1) that target the Gram-positive cyclic peptide-mediated QS (Nakayama et al., 2007; 2009; 
Mansson et al., 2011; Desouky et al., 2013; Desouky et al., 2015).  AIPs of Staphylococcus 
epidermidis and S. lugdunensis demonstrate cross inhibition (bacterial interference) towards S. 
aureus AIP, as well as interfering with S. aureus QS.  Pseudomonas aeruginosa produces a 
long chain AHL, which inhibits QS-medited virulence expression in S. aureus with an IC50 of 
6 μM through bacterial intereference (Singh et al., 2016). Pseudomonas aeruginosa secretes 
3-acyltetramic and 3-acyltetronic acids compounds, which act as negative allosteric inhibitors 
of AgrC (Rampioni et al., 2014). Another compound, colostrum hexasaccharide, was reported 
to inhibit QS-mediated factors associated with S. aureus established infections (Srivastava et 
al. 2015).  
Daly et al. (2015) reported the production of ω-hydroxyemodin by Penicillium 
restrictum that inhibits the QS signaling of all four groups of S. aureus. Marine Photobacterium 
produces six AI antagonists, i.e., solonamide A and B, as well as ngercheumicins F, G, H and 
I, that were able to inhibit QS in a methicillin-resistant S. aureus strain by binding to the 
receptor site but failing to switch on the QS cascade (Reuter et al., 2016; Singh et al., 2016). 
Avellanin C, synthesized by the fungus Hamigera ingelheimensis, displayed inhibitory effects 
on QS signaling in S. aureus (Igarashi et al., 2015). Hamamelitannin (2, 5-di-O-galloyl-d-
hamamelose) is a nonpeptide analog of RIP, originally obtained from the bark of Hamamelis 
virginiana (witch gazel), which does not affect growth of S. aureus (Kiran et al., 2008). It 
inhibited production of RNAIII and prevented biofilm formation and cell attachment under in 
vitro conditions (Kiran et al. 2008). Hamamelitannin attenuated virulence gene expression in 
methicillin-resistant S. aureus and S. epidermidis strains from a device-associated in vivo 
condition in a rat graft model (Table 1.1).  
In 2007, Nakayama et al. identified siamycin, a tricyclic peptide, produced by 
Streptomyces Y33-1, which inhibited GBAP biosynthesis by blocking the autophosphorylation 
action of FsrC, and subsequently inhibiting the expression of gelatinase in E. faecalis at 10 nM 
without affecting bacterial growth (Table 1.1). It also affected signal transduction of the two-
component regulatory system FsrC-FsrA in a noncompetitive manner. Nakayama et al. (2009) 
also identified ambuic acid as an anti fsr molecule, from fungal metabolites. Ambuic acid 
blocked the biosynthesis of GBAP through the inhibition of FsrB function in E. faecalis and 
inhibited the biosynthesis of AIP in S. aureus. Desouky et al. (2015) discovered three 
cyclodepsipeptides (tachykinin - WS9326A, WS9326B, and endothelin - cochinmicin II/III) in 
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culture extracts of actinomycetes, which were antagonists of FsrC of E. faecalis, and WS9326A 
and WS9326 repressed the production of hemolysis in S. aureus.  
 
Table 1.1: Potential quorum quenching auto-inducer peptide analogues or compounds from 












E. faecalis OU510 and 
OG1RF 
Inhibition of gelatinase 
Production 
Nakayama 
et al. (2007); (2009) 




associated infections in 
vivo; RIP analogous 
Kiran et al. (2008) 
cyclo(L-Tyr-LPro) 
and cyclo(L-Phe-L-Pro) 
S. aureus strain RN4220 Inhibition of production 
of TSST-1 
Li et al. (2011) 
Solonamide A and B 
Ngercheumicins (F, G, 
H, and I) 
S. aureus Competitive inhibitors of 
agrC 
Mansson et al. (2011); 
Kjaerulff et al. (2013) 
Phytochemicals (chrysin, 
α-cyperone) 
S. aureus Suppress the alpha-
haemolysin production 
in S. aureus via agr QS 
inhibition in mouse 
model 
Qiu et al. (2011);  
Wang et al. (2011);  
Luo et al. (2012) 
3- tetradecanoyltetronic S. aureus 
Group- 1- RN6390B 
Reducing nasal cell 
colonization and arthritis 
in a murine infection 
model 
Murray et al. (2014) 
Avellanin C obtained 
from the fungus 
Hamigera 
ingelheimensis 
S. aureus agr reporter 
strain (8325–4) with an 
IC50 value of 4.4 μM 
Reduction of agr-
signaling pathway 
Igarashi et al. (2015a) 
Arthoamide from 
Arthrobacter sp. 
S. aureus agr reporter 
strain (8325–4) with an 













cytokine transcription in 
mouse model of skin and 
soft tissue 
infectioncytokine 
Daly et al. (2015) 
Cyclodepsipeptide 
(WS9326A) 
E. faecalis OU510 and 
OG1RF (2.7 μM); S. 
aureus strains 8325–4 
(type-I AIP), K12 (type- 
II AIP), well as C. 
perfringens 13 (type A) 
(0.88)and K9 (type-IV 
AIP) (19 μM) a= 
Inhibition of gelatinase 
production in E. faecalis; 
Reducing inhibition of 
hemolysis in S. aureus; 
inhibiting transcription of 
pfoA in C. perfringens; 
inhibiting 
 
Desouky et al. (2015) 
Cyclodepsipeptide 
(WS9326B) 
S. aureus strains- 
Newman (typeI) 
and K3 (type-II) 
Attenuating the corneal 
cytotoxicity of S. aureus 
Desouky et al. (2015) 
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1.6.1.2 Anti-quorum sensing activity of seaweed-associated bacteria 
The chemical ecology of the seaweed holobiont is maintained through a diverse chemical 
communication network of all the cellular components, whereby the host modulates and 
controls its associated microbiota through bioactive metabolites, while the epibiotic bacteria 
coordinate and express their various traits through QS (Friedrich, 2012). Seaweed-associated 
bacteria produce toxins, signaling compounds, and secondary metabolites, which represent an 
interesting reservoir for the discovery of bioactive compounds (Friedrich, 2012).  Quorum 
sensing inhibitors and antimicrobial compounds produced by numerous epiphytic bacteria 
work in concert with seaweed-derived metabolites to protect the seaweed surface from 
pathogens, herbivores, and fouling organisms (Goecke et al., 2010). The ecological role of QS 
regulation in seaweed defense is observed by the lower bacterial abundance on the seaweed 
surface relative to seaweed with reduced QS inhibition, which harbour a higher abundance of 
epibiotic bacteria and have different bacterial communities (Goecke et al., 2010; Egan et al., 
2014). 
Some seaweed-associated bacteria are capable of producing AHL-like molecules to 
disrupt QS in other bacteria as a means of competition.  Kanagasabhapathy et al. (2009) 
suggested that certain epibiotic bacteria from the brown macroalgae Colpomenia sinuosa may 
play a role in defense mechanisms which influence seaweed colonization patterns and suppress 
the settlement of other competitive bacteria by producing QS inhibitors or QS inhibitor-like 
compounds.  Of the 96 bacteria isolated from C. sinuosa, 12% possessed anti-QS ability against 
indicator organism Serratia rubidaea JCM 14263, with inhibition of red pigment (prodigiosin) 
production without affecting its growth (Kanagasabhapathy et al., 2009).  Bacillaceae 
(Firmicutes), Pseudomonadaceae (Proteobacteria), Pseudoalteromonadaceae (Proteobacteria) 
and Vibrionaceae (Proteobacteria) were isolated and identified as potential sources of anti-QS 
compounds (Kanagasabhapathy et al., 2009).   
Quorum sensing inhibitory activity was also suggested to be widespread among 
bacteria of the marine genera Bacillus and Halobacillus that were isolated from diverse marine 
sources including algae, aquatic biofilms and sediments (Teasdale et al., 2011).  Although only 
a few studies have been carried out to assay the AHL-degrading activity of marine bacteria, 
more than 30 species of quorum quenching (QQ) bacteria belonging to α-proteobacteria, γ-
proteobacteria Actinobacteria, Flavobacteria and Firmicutes have been identified thus far 
(Tang and Zhang, 2014), with some QQ strains demonstrating degradative activity only against 
long-chain AHLs. Quorum quenching enzymes are classified into three major types according 
to their mechanisms (Tang and Zhang, 2014): AHL lactonase (lactone hydrolysis), AHL 
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acylase (amid hydrolysis) and AHL oxidase and reductase (oxidoreduction).  AHL lactonases 
usually exhibit broad AHL-inactivating activities while many acylases are specific to long-
chain AHLs, AHL acylases might be more common than lactonases in the ocean, which is 
consistent with the distribution of acylase and lactonase coding sequences in metagenome 
collections.  Therefore, many marine QQ bacteria may be still undiscovered, and the prevalence 
of QQ enzymes in marine bacteria may be higher than expected (Tang and Zhang, 2014).   
Bacillus, Pseudoalteromonas, Pseudomonas and Vibrio spp., isolated from marine 
sources have been reported as a source of QS antagonists (AHL-degrading lactonases and 
acylases and other small molecule antagonists), which might block the QS systems of their 
bacterial competitors to obtain a selective advantage over them and may provide the host 
seaweed with a tool to control biofouling.  Most of the isolates with high anti-fouling activity 
obtained by Burgess et al. (2003) from varying algae were identified as Bacillus species, i.e. 
B. pumilus, B. licheniformis and B. subtilis, suggesting that QS-mediated inhibition resulted in 
decreased fouling.  Almost 40% of the bacterial strains isolated from the brown macroalga F. 
vesiculosus demonstrated the ability to degrade short-chain AHLs, while 21% were able to 
degrade long chain AHLs (Romero et al., 2011).  The QQ bacteria from F. vesiculosus included 
Alteromonas, Hyphomonas, Oceanobacillus, Phaeobacter, Rhodococcus and Stappia spp., 
which contain acylases and/or lactonases. Three Bacillus spp. were isolated from green 
seaweed, which were able to inhibit QS-mediated luminescence of V. harveyi BB120 (Teasdale 
et al., 2011).  Jacobs (2015) screened 96 South African seaweed-associated bacteria for QS 
inhibitory activity against Chromobacterium violaceum and P. aeruginosa. Quorum quenching 
biosensor sandwich assays identified 30 potential bacterial isolates capable of quenching short 
and/or long chain AHLs.  Cell-free supernatant extracts from these seaweed-associated bacteria 
exhibited potential broad-spectrum activity against Chromobacterium violaceum ATCC 12472 
(Jacobs, 2015). 
Padmavathi et al. (2014) screened 33 morphologically different Gracilaria-associated 
bacteria for anti-QS activity using the QS reporter strain Chromobacterium violaceum ATCC 
12472. Phenol, 2,4-bis(1,1-dimethylethyl) of Gracilaria-associated Vibrio alginolyticus 
(Padmavathi et al., 2014) inhibited QS-regulated virulence factor production in the 
uropathogen S. marcescens and resulted in a significant (p < 0.05) reduction in protease 
(41.9%), haemolysin (69.9%), lipase (84.3%), prodigiosin (84.5%) and extracellular 
polysaccharide (84.62%) secretion without hampering growth in S. marcescens.  Lafleur et al. 
(2015) have isolated a marine seaweed epibiont Cellulophaga sp. E6, which produces a QS 
inhibitory compound active against P. aeruginosa.  Supernatant from Cellulophaga sp. E6 
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culture reduced expression of the 3-oxo-C12-HSL-dependent virulence-associated gene lasB, 
and reduced biofilm formation in a dose-dependent manner.  Based on activity-guided 
purification of the QS inhibitory activity, the active molecule appears to be smaller than 1000 
Da, water-soluble, and stable to temperatures of 50°C (Lafleur et al., 2015). 
The natural product anti-QS research has focused on Gram-negative organism, and 
there are fewer reports on inhibition of QS as a mechanism to control Gram-positive organisms.  
This is because the enzymes responsible for auto-inducer synthesis, such as ribosomes and 
peptidases, are commonly essential for the growth and survival of the bacterial cells (LaSarre 
and Federle, 2013). Gram-positive bacteria, such as Bacillus, Enterococcus and 
Staphylococcus, communicate by production, detection and response to autoinducer peptides 
(AIP). Although there are currently no reports on marine seaweed-associated bacteria which 
quench Gram-positive QS, Mansson et al. (2011) investigated crude extracts and fractions from 
a marine Photobacterium, which led to the identification of two novel depsipeptides, 
solonamides A and B, solonamide B, which interfere with agr in S. aureus 8325-4 and 
USA300, a community-acquired MRSA strain, respectively.  Cyclo (Pro-Leu) extracted from 
marine Staphylococcus saprophyticus exhibited moderate anti-QS activity without affecting 
growth.  Cyclodepsipeptides ngercheumicin F, G, H, and I extracted from Photobacterium also 
demonstrated anti-QS by interfering with expression of virulence genes of S. aureus, 
ngercheumicins increased transcription of spa and reduced expression of hla and rnaIII 
indicating the potential of ngercheumicins as agr inhibitors (Kjaerulff et al., 2013).   
The major aquatic pathogens are Aeromonas and Vibrio spp., as well as P. aeruginosa 
(Yuvaraj and Arul, 2014).  Attenuation of QS in pathogenic Aeromonas spp. and V. campbellii 
resulted in significantly reduced mortality toward their respective hosts, i.e., turbot (Natrah et 
al., 2012), larvae of brine shrimp and giant freshwater prawn (Pande et al., 2013).  Due to the 
close association between the QS system and virulence of aquatic pathogens, ecological 
strategies are the preferred option to overcome the problems of acquisition of antibiotic 
resistance and the spread of resistance genes when antibiotics or disinfectants are used to treat 
bacterial diseases (Homem and Santos, 2011; Singh et al., 2015).  Quorum sensing inhibitory 
compounds effective against these aquatic pathogens are of either of biological or chemical 
origin. Bacteria are useful since they are able to interfere with QS-related phenomena either by 
degrading AHL molecules or by producing small molecule inhibitors that can interfere with 
and inhibit QS signals in other bacteria. A number of bacteria can utilize AHL molecules as 
carbon and nitrogen sources and have been isolated and used for controlling aquaculture 
infections. Many microorganisms belonging to the phyla Actinobacteria, Bacteroidetes, 
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Firmicutes, and Proteobacteria produce enzymes that degrade AHLs, which are the main QS 
autoinducers in Gram-negative bacteria (Defoirdt et al., 2011; Romero et al., 2011; Torres et 
al., 2013). Several studies have demonstrated the potential application of AHL-degrading 
enzymes for disrupting QS of fish pathogens such as Aeromonas and Vibrio spp. as a strategy 
to control bacterial disease in aquaculture (Chu et al., 2014; Romero et al., 2014; Torres et al., 
2016).  The addition of AHL-degrading bacteria to diseased aquaculture systems has improved 
the survival rate of the aquaculture organisms (Cao et al., 2012; Romero et al., 2014; Vinoj et 
al., 2014; Torres et al., 2016). Some seaweeds commonly encountered in aquaculture setups 
are also reported to inherently produce QS inhibitor molecules.  Quorum quenching enzymes 
may be used in combination with prebiotics, probiotics, immune-stimulants and vaccines to 
control and protect fish against a wide spectrum of pathogens.  By seeding bacterial consortia 
(capable of degrading signaling molecules) or algae (producing such inhibitors), self-regulated 
systems limiting the growth of aquatic pathogens may be developed. The use of QSIs in 
controlling aquatic pathogens may in the future provide an effective and sustainable alternative 
to the use of commonly used antibiotics or sanitizers (Hamza et al., 2015b).  The trend of using 
probiotic microorganisms to control disease in aquaculture is encouraging, as they can disrupt 
the QS systems of pathogens. The positive effect of AHL-degrading Bacillus spp. and 
Streptomyces as probionts in aquaculture may result from inactivation of QS autoinducers, 
inhibition of virulence, inhibition of biofilm formation, in addition to the production of growth-
inhibiting substances (Tan et al., 2016; Zhang and Li, 2016).  
 
1.6.2 Biofilms 
Biofilms can be described as communities of cells bound to a surface and to each other, 
embedded into extracellular polymeric substances (EPS) (Spano et al., 2015). The initial 
attachment of bacteria to surfaces is crucial for biofilm formation which is mediated by cell-
surface charges, QS and hydrophobicity. The cells that attach to surfaces begin cell division, 
form microcolonies, and produce the extracellular polymers that define a biofilm (Fig. 1.6). 
EPS consists primarily of polysaccharides and can be detected microscopically and by 
chemical analysis. The final step in biofilm formation is cellular dispersion in which bacteria 
revert back to their planktonic lifestyle to colonize other surfaces (Spano et al., 2015).  
Biofilms increase the chances of survival of the organisms and also enhance its growth 
by providing protection and required nutrients. Bacterial biofilm formation is the preferred 
growth for microorganisms, as this gives them a competitive survival advantage (Rodrigues et 
al., 2015). The virulence stage of pathogenic bacteria is usually characterized by biofilm 
28 
 
formation, and cells enclosed in the biofilm are more resistant to antibiotics. Biofilms are 
known to be problematic in most environments, having economic, environmental and health 
implications. The formation of biofilms on water pipes, food processing systems and food 
contributes to the spread of pathogenic bacteria that are resistant to treatment (Chari et al., 
2014). About 60% of all microbial infections are linked to the development of biofilms, thus 
making biofilm formation an important virulence mechanism. Pathogens such as P. aeruginosa 
are known to cause cystic fibrosis lung disease in humans, E. coli causes urinary and 
gastrointestinal infection, these are just some of the health problems caused by biofilm-forming 
bacterial pathogens (Majik and Parvatkar, 2014). 
 
Figure 1.6: Biofilm formation is a process in which bacteria adhere to surfaces, through the production 
of pili, fimbriae, and exopolysaccharides. After initial attachment, biofilm development starts with the 
building of microcolonies. Biofilm maturation, is dependent on matrix production, which ensures 
cohesion and structure of mature biofilms. The final step in biofilm formation is cellular detachment or 
dispersion, by which bacteria regain the planktonic lifestyle to colonize other surfaces. Microbial 
interferences can inhibit biofilm formation or enhance biofilm dispersion through different mechanisms 
and strategies at different stages of their development (Rendueles and Ghigo, 2012). 
 
Opportunistic bacteria P. aeruginosa and S. aureus are two of the main pathogens 
responsible for nosocomial and wound infections (Castillo-Juárez et al., 2016). These 
important bacterial pathogens utilize QS cell communication to coordinate the expression of 
multiple virulence factors and associated behaviours such as swarming and biofilm formation 
(Gellatly and Robert, 2013). Pseudomonas aeruginosa possesses at least three functional QS 
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circuits, two of them are mediated by N-acyl homoserine lactones (HSL) signals and the other 
mediated by quinolones, which function in a hierarchical manner (Dorotkiewcz-Jach et al., 
2015). The regulation of virulence factors by these three QS systems controls the expression 
of virulence factors, such as phenazines, exotoxin and improve biofilm formation via the Las 
QS system (Castillo-Juárez et al., 2016). The LasI QS systems is expressed during the initial 
stage of biofilm formation, while the RhlR/RhlI system is activated during the maturation stage 
of P. aeruginosa biofilm development (Castillo-Juárez et al., 2016). The rhl system has been 
reported to contribute to biofilm formation in P. aeruginosa by enhancing Pel polysaccharide 
biosynthesis. Furthermore, the control of swarming, twitching motilities, as well as 
rhamnolipids and lectins production in biofilm formation is also coordinated by the rhl system 
(Gellatly and Robert, 2013). LecA and LecB lectins play a role in adhesion and biofilm 
formation. Swarming motility is implicated in early stages of P. aeruginosa biofilm formation, 
while twitching motility is required for the assembly of a monolayer of P. aeruginosa cells into 
microcolonies (Gellatly and Robert, 2013). Pseudomonas quinolone signal (PQS)-mediated 
QS systems function as regulators for extracellular DNA (eDNA) generation (Al-Wrafy et al., 
2016).           
Implanted medical devices (catheters, prosthetic heart valves, cardiac pacemakers) are 
susceptible to colonization by staphylococci causing acute to life-threatening infections 
(McCarthy et al., 2015). Similarly, QS controls the expression of virulence factors such as 
hemolysins, leukocidins, cell surface adhesins, exoenzymes, and biofilm formation via the Agr 
system in S. aureus, which relies on the autoinducing peptide (AIP). Among the QS-controlled 
virulence factors in S. aureus, RNAIII regulates biofilm formation, antibiotic resistance and 
the establishment of chronic infections (Castillo-Juárez et al., 2015). Activation of the agr 
system increases the production of extracellular proteases via RNAIII. The link between QS 
and biofilm formation in S. aureus strongly suggests that QS is important for the development 
and establishment of its chronic infections (Quave and Horswill, 2014). Thus, antibiofilm 
compounds could be interesting antibiotic adjuvants to prevent or treat chronic infections 
(Rasamiravaka et al., 2015). 
 
1.6.2.1 Mechanisms of biofilm inhibition 
Research is focused on the discovery of anti-biofilm agents that are nontoxic and do not oppose 
selective pressure on the organisms, as it is believed that such molecules will not contribute to 
future drug resistance (Galloway et al., 2012). A potential drug is one, which will promote the 
dispersion of pre-formed biofilm or inhibit the initial formation of a biofilm. Anti-biofilm 
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molecules can have a variety of actions at several stages of the biofilm formation process 
(Christiaen et al., 2014). Strategies, which include utilization of QS inhibition molecules can 
be applied to disrupt cell-to-cell communication which is required to form a quorum (Fig 1.6). 
Several reports have indicated that mutations affecting signal synthesis in QS have an effect on 
biofilm formation (Galloway et al., 2012; Brackman and Coenye, 2015; Singh et al., 2015). 
The resulting loss of AIP and RNAIII production affects biofilm formation in S. aureus 
(Brackman and Coenye, 2015). As such, blocking signal production or degrading the signal is 
a promising strategy. Other strategies include altering surfaces (biosurfactant production, 
surface blanketing), which reduces the ability of bacteria to colonize by weakening bacteria-
surface interactions (Rendueles and Ghigo, 2012). Bacillus subtilis synthesizes a surfactin, 
which is essential for swarming. Interestingly the same surfactin also inhibited biofilm 
formation of Proteus mirabilis and Salmonella enterica (Rendueles and Ghigo, 2012). 
In hospital settings, patients present with advanced infections (mature biofilms) prior 
to seeking therapeutic interventions, thus compounds with the ability to disperse mature 
biofilms are required (Rendueles et al., 2011). The EPS play a crucial role in the structural 
integrity of the biofilm by maintaining bacterial cohesion (Musthafa et al., 2011). The EPS is, 
therefore, an ideal target for compromising the structural matrix of biofilms. Degradation of 
the matrix could possibly disperse a mature biofilm. Enzymes degrading matrix 
polysaccharides have been identified (Korea et al., 2011; Rendueles and Ghigo, 2012). 
Streptococcus salivaris produces matrix-degrading enzyme that targets sucrose leading to 
mature biofilm dispersion of Streptococcus mutans (Ogawa et al., 2011). Degradation of 
nucleic acid component of the matrix utilizing DNase and RNase was shown to affect integrity 
of biofilms by degrading nucleic acid scaffold components of the extracellular matrix. Some 
bacteria release DNase into the medium and can inhibit biofilm formation of other DNA-
dependent biofilm-forming strains (Nijland et al., 2010). Due to the possible bactericidal effect 
of DNase/RNase, more natural nontoxic compounds need to be investigated.  
 
1.6.2.2 Anti-biofilm/anti-fouling activity of seaweed-associated bacteria 
The aquatic environment favors the development of biofilms on biotic and abiotic surfaces, 
with seaweed being especially susceptible to epibiosis. Seaweeds not only live in an 
environment with strong competition for space amongst benthic organisms but the seaweed 
surfaces also provide a nutrient-rich habitat. Seaweeds release large amounts of organic carbon 
into the surrounding environment, providing nutrients for microorganisms and triggering 
chemotactic behavior of bacteria.  Most primary metabolites such as carbohydrates, amino 
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acids, peptides, and proteins are inducers of microbial colonization.  The surface of a seaweed 
provides a protected micro-niche favorable for bacterial colonization and reproduction, thus 
marine seaweeds are continuously challenged by microorganisms as well as by grazers 
(Goecke et al., 2010). Once attached, epiphytic bacteria must compete with other microbial 
epiphytes for nutrients and space within the seaweed surface biofilm, producing anti-fouling 
compounds that work in concert with the seaweed-derived compounds to protect the seaweed 
surface (Chari et al., 2014).   
Bacteria producing antibiotic substances are more prevalent in epibiotic biofilms than 
in other habitats, such as seawater (Wahl et al., 2012). The biofilm communities on seaweed 
surfaces constitute a highly competitive environment for space and nutrients and thus select for 
bacteria with inhibitory activities against other surface colonizers (Egan et al., 2008). Increased 
antimicrobial compound production by bacteria when they are exposed to a different strain of 
bacteria suggests that competition for space between epibiotic bacteria may provide anti-
fouling protection to the algal basibiont. Some bacteria that previously identified as non-
antimicrobial producers are induced to produce bioactive metabolites on exposure to other 
bacterial species or extracellular products from other bacteria. Since surface-associated bacteria 
would be exposed to similar pressures in the seaweed surface biofilm, the numbers of bacteria 
isolated from seaweed surfaces that are producing active compounds is increased.  Bacteria 
when on the surface of seaweed may thus produce greater amounts of compounds, therefore, 
protecting the seaweed surface from further fouling (Spano et al., 2015). 
An ideal seaweed-bacterium anti-biofilm/anti-fouling compound will act in different 
ways on the targeted organisms. Ideally, the compound should prevent the formation of 
biofilms, which is considered as a cue for the further settlement of invertebrate larvae in the 
marine environment. The main mechanisms of these anti-biofilm activities of seaweed-
associated microbial strains should include antibiotic activity, anti-adhesion potential and 
should affect the extracellular polymer production, which is essential for biofilm formation 
(Satheesh et al., 2016).  Phenol, 2,4-bis(1,1-dimethylethyl) from Vibrio alginolyticus G16-T 
was effective in controlling the initial stages of S. marcescens attachment and subsequent 
biofilm formation as well as disrupting pre-formed mature biofilms. Phenol, 2,4-bis(1,1-
dimethylethyl) control involves a dual approach: it controls QS-mediated biofilm formation 
and simultaneously increases the hydration of the cell wall, which results in reduced biofilm 
formation (Padmavathi et al., 2014). Cho (2012) isolated two active anti-fouling steroids (17-
(1,2-dihydroxyl-5-methyl-hexane)-2,3-dihydroxyl-cholest-4-en-6-one and 13-acetate-17- 
(1,5-dimethylhexane)-cholest-7-en-3,5,6,15-tetraol) from the seaweed epiphyte, filamentous 
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bacterium Leucothrix mucor.  Fouling bacteria, Alteromonas sp. KNS-8 and P. aeruginosa 
KNP-3 were sensitive to those compounds. Viju et al. (2014) found that extracellular polymeric 
substances secreted by Pseudomonas taiwanensis strain S8, a symbiont of seaweed 
(Gracillaria, Sargassum, and Ulva spp.) inhibited the formation of biofilms by Pseudomonas 
and Alteromonas spp.  Epiphytic bacteria Pseudomonas sp. (UR4) and Bacillus sp. (UR7) 
isolated from U. reticulata demonstrated activity against marine biofilm bacteria (Mahadevan 
et al., 2012).  Both P. tunicata and Phaeobacter sp. 2.10, epibiotic isolates from U. lactuca, 
displayed antibacterial activity against monospecies biofilms under laboratory conditions (Rao 
et al., 2005), and monospecies biofilms of P. tunicata and Phaeobacter sp. 2.10 inhibited the 
settlement and attachment of fouling organisms (Rao et al., 2007).  The green alga, U. lactuca 
relies on the epibiotic bacterium P. tunicata to block biofilm formation by the synthesis of 
pigmented substances that inhibit AHL-dependent transcriptional control (Egan et al., 2002).  
Pseudoalteromonas tunicata was able to prevent biofouling by growth inhibition of other 
surface-associated microorganisms: producing at least five target-specific compounds 
including a large antibacterial protein, a small polar heat-stable anti-larval molecule, a putative 
anti-algal peptide, an antifungal alkaloid and violacein, which inhibits protozoan grazing (Matz 
et al., 2008). The seaweed-associated actinomycete Streptomyces praecox 291-11 isolated 
from Undaria pinnatifida was evaluated for its anti-fouling activity by Cho et al. (2012) who 
identified two diketopiperazines (6S,3S)-6-benzyl-3-methyl-2,5-diketopiperazine and (6S,3S)-
6-isobutyl-3-methyl-2,5-diketopiperazine) as the active metabolites.  The epibiotic bacterium 
Streptomyces violaceoruber, isolated from Undaria pinnatifida, produces two furanone 
derivatives: 3-octa-10, 30-dienyl-4-methylfuran-2(5H)-one and 3-octa-10-enyl-4-methylfuran-
2(5H)-one, which demonstrate anti-fouling activities against the zoospores of Ulva pertusa and 
Mytilus edulis (Hong and Cho, 2013). It has been noted that the presence of the 2-furanone 
functional group is responsible for inhibition of P. aeruginosa biofilm formation (Qian et al., 
2015). Glycoglycerolipids (2R-1,2-di-12-methylhexadecanoic acid-3-O-[β-D-
galactopyranosyl-(1''-6')-O-β-D-galactopyranosyl]-glycerol, 2R-1-12-methylhexadecanoic 
acid-2-hydroxyl-3-O-[β-D-galactopyranosyl-(1''-6')-O-β-D-galactopyranosyl]-glycerol, 2R-
1,2-di-12-methylhexadecanoic acid-3-O-β-D-galactopyranosyl-glycerol, and 2R-1,2-di-14-
methylhexadecanoic acid-3-O-β-D-galactopyranosyl-glycerol) were isolated from seaweed-
associated actinomycete Streptomyces coelescens, and were active against the fouling bacteria 
Alteromonas sp. KNS-8 and P. aeruginosa KNP-3 zoospores of Ulva pertusa, the diatom 
Navicula annexa, and the mussel Mytilus edulis.   
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Bacterial biofilms are a major problem in the aquaculture sector as they are resistant to 
antimicrobial treatments (Hamza et al., 2015b). Bacteria belonging to the genera Vibrio and 
Pseudomonas genus have been noted in many reports to be important aquaculture pathogens 
(Yuvaraj and Arul, 2014).  The extracellular polymeric substance of Bacillus sp. ICN-SS01, an 
epibiotic bacterium from the surface of the seaweed Sargassum wightii reduced the adhesion 
of biofilm-forming V. harveyi on hard coupon surfaces as well as exhibiting inhibitory activity 
against the settlement of biofouling organisms (Rajasree et al., 2012). As indigenous species 
of the marine environment, actinomycetes predominantly from the genera of Streptomyces, 
Micromonospora, and Salinispora could offer interesting options for probiotics in aquaculture 
(Natrah et al., 2011). The diversity of broad-spectrum chemical compounds synthesized by 
Streptomyces suggests that they can be valuable as probiotics in aquaculture due to the 
production of potential antagonistic and antimicrobial compounds. The ability to produce 
antagonistic compounds may help the probionts to compete for nutrients and attachment sites 
in the host gastrointestinal tract. Streptomyces spp. have also been implicated in the production 
of inhibitory compounds and metabolites involved in the attenuation of biofilm formation, anti-
quorum sensing activity and anti-virulence activity in Vibrio sp. (Tan et al. 2016). 
 
1.7 Rationale for study 
The use of antimicrobial agents in aquaculture and clinical medicine has significantly reduced 
options for treating diseases due to emergence of multi-drug resistant organisms. Clinical 
treatment that focuses on bactericidal and bacteriostatic effects on pathogens has imposed 
selective pressure on organisms to mutate and become resistant (Tang and Zhang, 2014). The 
increase in emergence of multi-drug resistant organisms has had a tremendous negative effect 
on public health and food industries (De Schryver et al., 2014; Defoirdt, 2016). Most bacteria 
coordinate their virulence through QS and biofilm formation (Singh et al., 2016). Biofilms pose 
a serious problem for public health because of the increased resistance to antimicrobial agents 
and the potential for these organisms to cause persistent infections in patients with indwelling 
medical devices (Pop-Vicas and Opal, 2014). Given the link between QS and pathogenicity, 
QS is a promising target for anti-virulence therapy whereby inhibition of virulence occurs 
instead of a bactericidal effect.  This delays the evolution of development of MDR as less 
selective pressure is imposed (Tang and Zhang, 2014). Quorum sensing inhibitors (QSI) are 
non-bacteriostatic organisms/molecules that can limit/down-regulate the virulence of 
pathogens through interference with QS, facilitating the use of host-defense mechanisms to 
control pathogens (Natrah et al., 2011). Research has now shifted to searching for alternative 
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sources for novel bioactive compounds as traditionally utilized antimicrobials have proved 
ineffective, and discovery of novel bioactive compounds from terrestrial environment has 
significantly declined (Chen et al., 2013; Cho et al., 2013; Viju et al., 2014).  
Marine waters comprise a high diversity of microbial life including bacteria, fungi, 
viruses, spores, and actinomycetes (Singh et al., 2014). Bioactive compounds obtained from 
marine-associated microorganisms are known for their broad range of biological effects such 
as antimicrobial, anti-fouling and antitumor activity (Chakraborty et al., 2014; Sri and 
Dhevendara, 2014; Tan et al., 2016). Seaweed has become a prime resource in the search for 
organisms, which produce novel bioactive products. These organisms produce diverse 
metabolites that can be used for the development of new drugs to combat antimicrobial 
resistance (Rodrigues et al., 2015). Limited information is currently available on the anti-
virulence potential of seaweed-associated bacteria especially those against Gram-positive 
bacterial pathogens. This study focused on the identifying of seaweed-associated bacteria 
isolates with the ability to synthesize bioactive compounds with diverse antimicrobial, anti-
biofilm, and anti-QS-associated abilities that may be used as a weapon in targeting MDR 
strains. These isolates may become potential candidates for identifying compounds involved 
in anti-virulence activity with the ability to inhibit QS-mediated virulence factor production by 
pathogenic microorganisms such P. aeruginosa, S. aureus and E. faecalis.   
 
1.8  Objectives 
The following objectives have been established: 
1.8.1. To establish whether bacteria isolated from seaweed demonstrate antimicrobial 
activity; 
1.8.2. To characterize bioactive compounds synthesized by seaweed-associated 
bacteria; 
1.8.3. To identify the anti-biofilm potential of seaweed-associated isolated bacteria; 
and 
1.8.4 To investigate the ability of isolated bacteria to produce Gram-positive QS 
inhibitory compounds. 
 
1.9  Aims 
The following aims were pursued: 
1.9.1. To perform primary screening of isolates for antimicrobial activity against 
indicator organisms using the cross-streak assay; 
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1.9.2. To obtain secondary metabolites through fermentation and ethyl acetate 
extraction; 
1.9.3. To perform secondary screening of extracts for antimicrobial activity using the 
agar well diffusion assay; 
1.9.4. To analyse crude extracts of seaweed-associated bacteria using thin-layer 
chromatography (TLC), gas chromatography mass spectrometry (GCMS), and 
nuclear magnetic resonance (NMR); 
1.9.5. To identify isolates capable of inhibiting initial attachment and mature biofilm 
using microtitre plate assay; and 
1.9.6. To screen for extracts with Gram-positive QSI properties using phospholipase 
assay, S. aureus agr and E. faecalis fsr inhibition assays. 
 
1.10 Key questions to be answered 
A number of specific questions were relevant to this topic 
1.10.1 Do microbial strains isolated from seaweed have the ability to produce bioactive 
compounds that will inhibit microbial growth? 
1.10.2. Do seaweed-associated bacteria produce bioactive compounds, which have an 
inhibitory effect on microbial adhesion and/ or mature biofilm formation? 
1.10.3. Do microbial communities associated with seaweed possess anti-quorum 
sensing activity? 
1.10.4. Do bioactive compounds produced by seaweed-associated bacteria possess anti-
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ANTIMICROBIAL AND ANTI-BIOFILM POTENTIAL OF SEAWEED-
ASSOCIATED-BACTERIA ISOLATED FROM SOUTH AFRICAN SEAWEED 
AGAINST RESISTANT Pseudomonas aeruginosa AND Staphylococcus aureus 
 
Abstract 
Marine substrata are colonized by a variety of marine microorganisms, which are capable of 
producing novel compounds due to their diverse and often extreme environmental conditions 
as well as interactions with their associated eukaryotic host organisms.  The antibacterial and 
anti-biofilm potential of bacteria associated with ten South African seaweeds was assessed.  
Cultivable seaweed-associated bacteria (n = 96) were screened for antibacterial activity against 
five resistant clinical bacterial strains utilizing the primary cross streak screening assay. 
Following shake flask fermentations and ethyl acetate extractions extracts, from 30 selected 
isolates were screened using the agar-well diffusion assay and minimum inhibitory 
concentrations were determined for 14 extracts. Selected bacteria were identified by 16S rRNA 
gene amplification and sequencing. Active crude extract of MAB24-SW1 was then analysed 
using nuclear magnetic resonance (NMR) and gas chromatography-mass spectrometry. 
Extracts capable of inhibiting initial adhesion and detachment of mature biofilm were identified 
using the crystal violet microtitre plate assay. Primary screening indicated that 38% (37/96) of 
isolates displayed varying antimicrobial activity against the five bacterial indicator strains. 
Isolate MAB24-SW1 was found to be active with MICs as low as 0.39 mg/ml. The isolate was 
identified as Bacillus velezensis, with a potential analogue of surfactin being identified through 
NMR following partial purification of the crude extract of B. velezensis. The initial attachment 
of Pseudomonas aeruginosa was inhibited by 90% (27/30) of extracts in comparison to 53% 
(16/30) against Staphylococcus aureus at 5 mg/ml, with limited antimicrobial effect. 
Detachment of mature biofilms showed significant variation between the indicators, with 70% 
(21/30) of extracts dispersing P. aeruginosa biofilms and 97% (29/30) effective against S. 
aureus at the highest concentration of 10 mg/ml. The present study indicates that bacteria 
associated with seaweed inhabiting South African coastal waters could be used as a potential 







The largely unexplored marine world is a complex ecosystem with an enormous diversity of 
different life forms often existing in close associations. Among these, microorganism-
eukaryote associations have gained significant attention (Penesyan et al., 2013).  Marine 
organisms have become the focus of a worldwide effort for the discovery of novel natural 
products (Thirunavukkarasu et al., 2014), producing natural products that encompass a wide 
variety of chemical classes such as terpenes, polyketides, acetogenins, peptides and alkaloids 
with novel modes of action. A small number of marine plants, animals and microbes have 
already yielded more than 12,000 novel chemicals with hundreds of new compounds still been 
discovered every year (Penesyan et al., 2013; Singh et al., 2015). Due to increasing resistance 
to traditionally utilized antibiotics, marine-derived extracts are of interest as sources of 
antimicrobial molecules. In contrast to terrestrial bacteria, which are relatively well studied in 
the context of natural product discovery, marine microorganisms are only beginning to be 
recognized for their biotechnological potential (Penesyan et al., 2013; Singh et al., 2015).  
Macroalgae or seaweeds form an integral part of the marine environment as providers 
of food and shelter. Seaweeds harbor a diversity of microbial life including bacteria, fungi, 
viruses, spores, and actinomycetes (Singh et al., 2014). Due to their nutrient-rich surface, these 
relationships can be mutualistic or parasitic to the host (Susilowati et al., 2015). Furthermore, 
nutrient limitation leads to high competition on the host surface, forcing bacteria to evolve and 
produce antagonistic chemical metabolites, which are advantageous for the survival of bacteria 
(Egan et al., 2013). These bioactive compounds and enzymes produced by microorganisms in 
their interaction with the seaweed might be useful in pharmaceutical and industrial applications 
for treatment of multi-drug resistant (MDR) organisms (Singh et al., 2015). Screening of 
marine bacteria isolated from the surface of marine algae and invertebrates has shown that a 
high percentage produce novel bioactive metabolites with a broad range of antimicrobial 
activity (Djinni et al., 2013; Ramalingam and Amutha, 2013; Suvega and Kumar, 2014).  
Although the utilization of antimicrobials to treat infections has been a method of 
choice for many decades, this has also been a contributing factor to MDR bacteria (Defoirdt, 
2016). There is, therefore, a need for an alternative disease control strategy against bacterial 
infections. Shutting down cell-to-cell communication, known as quorum sensing inhibition 
(QSI), has been identified as one such strategy (Fetzner, 2015). It combats bacterial virulence, 
instead of targeting bacterial survival and will potentially reduce the risk of evolution of drug 
resistant microbes (Padmavathi et al., 2014).  
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In recent years, S. aureus and P. aeruginosa have emerged as problematic pathogens, 
because of multiple efflux pumps, mobile genetic elements and the presence of quorum sensing 
signals to regulate biofilm formation and virulence factor production (Gellatly and Robert, 
2013; Dorotkiewcz-Jach et al., 2015). Biofilms are known to be problematic in most 
environments, causing economic, environmental and health problems. The formation of 
biofilms on water pipes, food processing systems and food itself contributes to the spread of 
pathogenic bacteria that are resistant to treatment (Chari et al., 2014). Viju et al. (2014) found 
that extracellular polymeric substances secreted by a Pseudomonas taiwanensis strain S8, a 
symbiont of seaweed (Gracillaria, Sargassum, and Ulva spp.) inhibited the formation of 
biofilms by Pseudomonas and Alteromonas spp. Two furanone derivatives: 3-octa-10, 30-
dienyl-4-methylfuran-2(5H)-one and 3-octa-10-enyl-4-methylfuran-2(5H)-one from 
Streptomyces violaceoruber, which were isolated from marine seaweed Undaria pinnatifida 
showed anti-biofilm activities (Hong and Cho, 2013). Since seaweed-associated bacteria are 
effective in preventing colonization and fouling by competitor, often pathogenic bacteria 
(Singh et al., 2015), they can be explored as a source of biofilm and/or quorum sensing 
inhibitory compounds.  The required number of new antimicrobial agents is higher than ever 
due to the rapid incidence of new infections and emergence of multi-drug resistance in common 
pathogens (Singh and Reddy, 2014; Singh et al., 2015). The use of marine isolates to inhibit 
the formation of biofilms in clinical settings is been regarded as a potential solution to the 
problem faced worldwide. The current study explores the potential of seaweed-associated 
bacteria as a reservoir for the discovery of bioactive compounds with antimicrobial and anti-
biofilm activity.  
 
2.2 Materials and methods 
 2.2.1 Bacterial isolates 
Ninety-six bacterial isolates were cultured from ten South African intertidal seaweeds 
(Amphiroa bowerbankii Harvey, Cheilosporum cultratum Areschoug (Harvey), Codium 
duthieae (P. Silva), Codium spp., Gelidium pteridifolium (R.E, Norris, Hommersand & 
Fredericq), Gracilaria spp., Jania verrucosa (Lamourous), Laurencia brongiartii (J. Agarah), 
Ulva rigida (C. Agarah) collected along the coastline of Durban, South Africa (Fig. 2.1.). 
Seaweed samples were collected in ziplock bags, transported to the lab on ice, and processed 







Figure 2.1: Brown, green and red seaweed collected along the coast of Durban, South Africa for 
isolation of associated bacteria (A) Amphiroa bowerbankii Harvey (B) Cheilosporum cultratum 
Areschoug (Harvey), (C) Codium duthieae (P. Silva) (D) Codium spp., (E) Gelidium pteridifolium (R.E, 
Norris, Hommersand & Fredericq), (F) Jania verrucosa (Lamourous), (G) Laurencia brongiartii (J. 
Agarah) and (H) Ulva rigida (C. Agarah). 
 
At the lab, seaweeds were rinsed with sterile distilled water and macerated in a 
liquidizer.  Serial dilutions were set up (neat, 10-2 and 10-4) and 100 µl aliquots were spread, in 
duplicate, on a selection of media: Enriched Anacker and Ordal’s agar + seawater (EAOA-S), 
Luria-Bertani agar (LBA), Seawater yeast extract (SWYE; Crawford et al. 1993), 
Actinomycetes Isolation agar (AIA, HiMedia), and Glycerol-asparagine agar (GAA, HiMedia).  
Luria-Bertani agar and EAOA-S were used as nutrient-rich and nutrient-poor media, 
respectively.  Three antibiotics were incorporated into SWYE, AIA and GAA media: nystatin 
(0.05 g/l) and cycloheximide (0.02 g/L) to inhibit fungal growth, while nalidixic acid (0.02 
g/L) was added to inhibit fast-growing bacteria (Qin et al., 2009).  Plates were incubated at 30 
°C for 5-30 d and observed at regular intervals.  Every culture that was at least 1 mm in diameter 
was inoculated on fresh agar plate until pure cultures were obtained, while pin point cultures 
were incubated further.  For short-term storage, isolates were maintained at 4 °C on ISP2 
media, while for long-term storage spore suspensions were stored in 50% glycerol at -80 °C.  
For preliminary characterization, isolates were examined and differentiated according to 
colony characteristics, Gram reaction and cellular morphology. 
 
 
A D C B 
F E G H 
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2.2.2 Primary screening of isolates for antimicrobial activity 
Primary antibacterial screening was conducted using the cross-streak method (Kvennefors et 
al., 2012). A panel of resistant clinical indicators (Enterococcus faecalis ATCC 51299, 
Escherichia coli ATCC 35218, Klebsiella pneumoniae ATCC 700603, Pseudomonas 
aeruginosa ATCC 27583 and Staphylococcus aureus ATCC 43300) were used.  Streptomyces 
griseus ATCC 15468 was used as a positive antibiotic-producing control.  Mueller-Hinton agar 
(MHA) plates were prepared and inoculated with seaweed isolates by a single perpendicular 
streak of inoculum in the centre of the petri-dish and incubated at 30 °C for 5-7 d. Indicator 
organisms were then streaked perpendicularly to the initial streak (Shnit-Orland and Kushmaro, 
2013) and plates were incubated at 37 °C for 24 h.  Each indicator organism was preliminarily 
grown individually on MHA to ensure that any lack of growth was not dependent on the 
medium used for screening. The experiment was performed in triplicate and the inhibition 
zones recorded (Kvennefors et al., 2012). The antagonistic effect was indicated by the failure 
of the indicator strain to grow in the confluence area.  Inhibition was measured from the edge 
of the vertical streak with the ‘test isolate’ to the first colony of ‘indicator isolate’ cross-streak 
and divided into distance-dependent categories. Inhibition was graded as follows (- = no 
activity, + = weak activity [inhibition zone of 1-4 mm], ++ = moderate activity [inhibition zone 
of 5-8 mm], +++ = strong activity (inhibition zone of 9-15 mm), ++++ = highly active 
[inhibition zone of 16-25 mm) and total growth inhibition = TGI). 
  
 2.2.3 Fermentation and ethyl acetate extraction 
Thirty bacterial strains exhibiting antagonistic activity in the cross-streak assay together with 
a further 30 quorum quenching (QQ) seaweed-associated bacteria (Jacobs, 2015) were pre-
cultured in 5 ml of International Streptomyces Project media 2 (ISP2; Shirling and Gottlieb 
1966) broth for 2 d, then inoculated in 250 ml of ISP2 broth and incubated with shaking for 7 
d at 30 °C. The QQ activity had been assessed by Jacobs (2015) using the QQ biosensor 
sandwich assay and identified isolates capable of quenching short and/or long chain AHLs 
produced by C. violaceum. Bacterial cells were pelleted at 9500 rpm for 10 min to collect 
supernatants.  An equal volume (1:1) of ethyl acetate was added to each cell-free supernatant 
followed by agitation for 1 h at 30 °C.  The ethyl acetate layer was collected and then subjected 
to a second extraction (1:1 volume ethyl acetate) with agitation of flasks for 4 h after which the 
ethyl acetate layer was collected.  Ethyl acetate was evaporated in a rotary evaporator (Ilmvac, 
ROdist digital 230V 50/60Hz) and each crude extract obtained was weighed (Nithya et al., 
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2011).  Thereafter, crude extracts were dissolved in dimethyl sulfoxide (DMSO) to a final 
concentration of 50 mg/ml. 
2.2.4 Secondary screening of isolates for antimicrobial activity 
2.2.4.1 Screening of potential antagonistic bacteria against clinical 
pathogens by disc diffusion method 
Antibacterial activity of the 30 crude antagonistic bacterial extracts was assessed by loading 
0.5, 1 and 2 mg/ml of respective extracts onto 6 mm blank discs (Oxoid, UK).  Mueller-Hinton 
agar plates were prepared and uniformly swabbed with resistant clinical pathogens: E. faecalis 
ATCC 51299 (vancomycin-resistant), E. coli ATCC 35218 (TEM-β-lactamase), K. 
pneumoniae ATCC 700603 (extended spectrum β-lactamase), P. aeruginosa ATCC 27583 
(multidrug resistant) and S. aureus ATCC 43300 (methicillin-resistant).  DMSO alone was 
used as a negative control.  Plates were incubated overnight at 37 °C (optimal temperature of 
indicator bacteria) and observed for the zones of inhibition.  The diameter of the inhibition 
halos after 24 h of incubation was measured and was considered to be indicative of bioactivity 
(Nithya et al., 2011).   
 
2.2.4.2 Minimum inhibitory concentration determination of extracts 
The minimum inhibitory concentrations (MIC) of 14 extracts demonstrating antimicrobial 
activity following secondary screening was performed using a modified broth microdilution 
assay (Motyl et al., 2006). Indicator bacteria suspensions (multidrug-resistant P. aeruginosa 
ATCC 27853 and methicillin-resistant S. aureus (MRSA) ATCC 43300), equivalent to a 0.5 
McFarland standard, were added to 96-well plates containing Mueller-Hinton broth (Sigma) 
supplemented with extracts (50 mg/ml stock solution) serially diluted two-fold to give final 
concentrations ranging from 12.5 – 0.01 mg/ml and incubated at 37 °C for 24 h.  After 
incubation, 30 µl of 0.02% resazurin (oxidation-reduction indicator) dye was added to each 
well, and plates were again incubated at 37 °C for 4 h in dark and observed for a colour change.  
A pink colour indicated growth and blue was indicative of inhibition of growth.  The MIC was 
recorded as the lowest concentration at which a colour change occurred (Sarker et al., 2007). 
 
2.2.5 Characterization of MAB24-SW1 extract 
2.2.5.1 Thin layer chromatography and bioautography  
Chemical constituents of the crude MAB24-SW1 extractwere separated on aluminium-backed 
thin layer chromatography (TLC) plates (Merck, silica gel 60). The TLC plate was spotted with 
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sample with the help of a capillary tube. The plate was placed in the solvent system 
(methanol/acetone/ethyl acetate (3:1:1)), placed in a developing beaker and left to run until the 
solvent front was approximately half a centimeter from the top of the plate. Separated chemical 
compounds were detected using methanolic 10% H2SO4 solution (Dewanjee et al., 2015).  
Contact bioautography was performed with Chromobacterium violaceum ATCC 
12472, E. coli ATCC 35218, P. aeruginosa ATTC 27853 and S. aureus ATCC 43300 
(Suleiman et al., 2010). The developed chromatogram was placed on a swabbed MHA plate 
for 30 min to facilitate diffusion of compounds.  A heavy object (mortar) was placed on top of 
the chromatogram to ensure good contact between the agar and TLC plate. After diffusion, the 
TLC plate was removed and the agar plates were incubated at appropriate temperatures for 24 
h. After incubation, all plates were sprayed with a 2 % (w/v) 2, 3,5 – triphenyltetrazolium salt 
stain which stains live cells red.  Clear zones represented inhibition of growth due to 
antimicrobial activity of compound. The areas of inhibition, coloured yellow, were compared 
with the RF of the related spots on the reference TLC plate (Suleiman et al, 2010). 
 
2.2.5.2 Gas chromatography-mass spectrometry 
The crude extract of MAB24-SW1 was subjected to GC–MS analysis in order to identify 
secondary metabolites. A sample ionization energy of 70 eV was used for GC–MS detection. 
Helium was used as the carrier gas at a pressure of 60 kPa, with the oven temperature 
programmed at 100 °C (for 2 min) to 280 °C (for 30 min) at a ramping rate of 4 C per min. A 
2 ll sample was manually injected. The injection temperature was at 280 °C with a split ratio 
of 1:50. The system software was driven by Agilent Chemstation software. The relative amount 
of each component as a percentage was calculated by comparing the area of the peak to the 
total area. The identification of the various compounds was carried out by comparing their 
fragmentation peaks with those of known compounds in the NIST/NBS 2005 mass spectral 
database of the GC–MS (Aliyu et al., 2015).  
 
2.2.5.3 Preparative thin layer chromatography and nuclear magnetic    
resonance analysis 
MAB 24-SW1 crude extract was carefully applied to a prep-TLC plate and developed using a 
mixture of solvent as eluant, MeOH: EtOH: Acetone (3.5:0.8:0.7). NMR data were recorded 
on a Bruker Avance III 400 MHz spectrometer. The sample was acquired with deuterated 
chloroform (CDCl3) or deuterated dimethyl sulfoxide (DMSO-d6). The spectra were 
referenced according to the deuteriochloroform signal at dH 7.24 (for 1 H NMR spectra) and 
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dC 77.0 (for 13C NMR spectra) for CDCl3 and dH 2.50 and dC 39.51 for DMSO-d6 (Aliyu et 
al., 2015). 
2.2.6 Detection of anti-biofilm activity of seaweed-associated bacteria extracts 
Prior to the anti-biofilm assay, the 30 selected QQ extracts were tested for antibacterial activity 
with sub-inhibitory and inhibitory concentrations (1, 5 and 10 mg/ml), utilizing the disc 
diffusion assay.  Extracts were tested against P. aeruginosa ATTC 27853 and S. aureus ATCC 
43300, in order to assess their effect on initial adhesion and detachment of mature biofilms.  
Overnight cultures were used to prepare cell suspensions, which were standardized 
equivalent to a 0.5 McFarland standard (Basson et al., 2008). For initial adhesion studies, 
extracts were added to 90 µl TSB and 10 µl of standardized cell suspension (to a final volume 
of 200 µl) and incubated for 24 h at 37 ˚C with agitation.  For pre-formed biofilm detachment 
assays, 24 h biofilms were established following addition of 90 µl TSB and 10 µl of 0.5 
McFarland standardized cell suspension to microtitre plate wells, and incubation at 37 ºC for 
24 h.  Microtitre plates were washed three times with sterile deionised water and allowed to 
air-dry.  Following air-drying, 90 µl TSB as well as extracts at the relevant, respective 
concentrations were added to wells (to a final volume of 200 µl) and microtitre plates were 
incubated for 24 h with agitation at 37 ˚C.  The negative control contained only broth, while 
positive controls contained respective cell suspensions with no extracts added.  After 
incubation, growth OD600 nm values were determined using the Glomax multi + detection 
system (Promega) and wells with ≥50% reduction in growth were considered unsuitable for 
analysis.  Thereafter, planktonic cells were removed by discarding the liquid media.  Plates 
were processed for biofilm inhibition as described by Basson et al. (2008).  Microtiter plates 
were washed three times with sterile dH2O.  Cells were fixed with 200 µl of methanol for 15 
min, then air-dried.  Wells were stained with 150 µl of 2% Hucker's crystal violet for 5 min.  
Wells were rinsed gently under running tap water then plates were allowed to dry.  Glacial 
acetic acid (150 µl; 33% (v/v)) was used to re-solubilise cells (Basson et al., 2008).  The OD 
was read at 600 nm using the Glomax multi + detection system (Promega).   
Tests were conducted in triplicate on two separate occasions. A measure of efficacy 
called percentage reduction was calculated from the blank, control, and treated absorbance 
values (Pitts et al., 2003): Percentage reduction =[
(C−B)−(T−B)
C−B
] × 100, where B denoted the 
average absorbance per well for blank wells (no biofilm, no treatment), C denoted the average 
absorbance per well for control wells (biofilm, no treatment), and T denoted the average 
absorbance per well for treated wells (biofilm and treatment). The difference in biofilm OD 
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values with and without the addition of varying concentrations of extracts was determined 
using One-way repeated measures ANOVA with p ≤ 0.05 being considered significant 
(SigmaPlot 13.0, Systat Software Inc., San Jose, CA, USA).  To identify the concentrations 
that differed from the others, the Holm-Sidak multiple pairwise comparison procedure was 
carried out, with p ≤ 0.05 being considered significant.  
 
2.2.7 Molecular identification of bacterial isolates 
2.2.7.1 Genomic DNA isolation purification 
Genomic DNA isolation was carried out using GeneJet Genomic DNA purification kit (Thermo 
Scientific) according to to manufacterer’s instruction. Following overnight incubation on ISP2 
plates, agar plates were flooded with 1 ml sterile distilled water and bacterial cells were scraped 
off using a glass Pasteur pipette into 1.5 ml microfuge tube. Thereafter the contents in the 
microfuge tube were centrifuged for 10 min at 5000 × g. The DNA was eluted in 100 µl of 
DNA elution buffer and stored at -20 °C until required. 
 
2.2.7.2 16S rRNA gene amplification and sequencing 
The 16S rRNA gene amplification for selected isolates was performed using F1 5’-
AGAGTTTGATCCTGGCTCAG-3’; R5 5’-GGYTACCTTGTTAACGACTT-3’ (Weisburg 
et al., 1991; Bintrim et al., 1997) and F1 5’-AGTTGATCCTGGCTCAG-3’; R5 5’ 
TACCTTGTTACGACTTCACCCA-3’ (Vaneechoutte et al., 2000) universal primers. PCR 
reaction mixtures included 2 µl of template DNA, 18 µl ddH20, 2.5 µl buffer, 1.2 µl dNTPs, 
0.2 µl of each primer set, 1.2 µl MgCl2 and 0.1 µl DNA polymerase (Super Therm). 
Amplification was performed in a PCR machine (MJ MINITM personal Thermal cycler; Bio-
Rad) using the following conditions: DNA denaturation at 94 °C for 1 min, followed by 35 
cycles of denaturation at 94 °C for 30 s, primer annealing at 52 °C for 1 min and extension at 
72 °C for 1 min. A total of 5 µl of PCR mixture and 2 µl gel loading buffer were loaded into 
agarose gels together with the molecular weight marker, GeneRuler 100 bp plus DNA ladder 
(Thermo Scienfic). Amplified PCR products were subjected to gel electrophoresis in 1% (w/v) 
agarose gel at 70 V for 90 min in 1% TAE buffer. PCR products were visualized by UV 
transillumination (Syngene, UK) after staining in 0.1 mg/ml ethidium bromide for 15 min. 
DNA was sequenced, sequences were processed using BioEdit (version 7.0) and subjected to 




2.3.1 Antimicrobial activity of crude seaweed-associated bacteria extracts  
Ninety-six bacterial isolates were cultured from seaweed. Primary screening utilizing cross-
streak assay identified 36% (35/99) of active isolates that inhibited one or more of the resistant 
indicator organism (Fig. 2.2). Of these, 8% (8/96) demonstrated broad-spectrum antimicrobial 
activity (to varying degrees) against at least one Gram-negative and one Gram-positive 
indicator (Table 2.1).  Majority of active isolates (54.29%; 19/35) demonstrated antibacterial 
activity against the methicillin-resistant S. aureus ATCC 43300, while the least activity was 
observed against P. aeruginosa ATCC 27853.   
 
 
Figure 2.2: Primary screening of (A) MAB4-SW1, (B) MAB11-SW1, (C) MAB19B-SW1 and (D) 
AB3-SW8 against (1) E. coli ATCC 35218, (2) P. aeruginosa ATCC 27853, (3) C. violaceum ATCC 
12472, (4) K. pneumoniae ATCC 700603, (5) E. faecalis ATCC 51299 and (6) S. aureus ATCC 43300 






























MAB4-SW1 +++# - - - - 
MAB7-SW1 + - - ++++ - 
MAB10A-SW1 - TGI - - - 
MAB10B-SW1 +++ - - - +++ 
MAB11-SW1 +++ - - + + 
MAB12-SW1 - - - - ++ 
MAB16-SW1 - - - - + 
MAB17-SW1 - - - - + 
MAB19A-SW1 TGI - - - - 
MAB20-SW1 - + - - - 
MAB22-SW1 - - - - +++ 
MAB24-SW1 - TGI - - TGI 
MAB25A-SW1 TGI - - TGI ++++ 
MAB27-SW1 TGI - - TGI ++++ 
MAB36-SW1 ++ - - - - 
MAB37-SW1 - - - - +++ 
AB1-SW2 - - - ++ - 
AB5-SW2 - - ++ - +++ 
AB6-SW2 - - - - ++ 
AB10-SW2 - + - - - 
AB11-SW2 - - - - ++ 
AB12-SW2 - ++ - - - 
AB3-SW5 - - - - +++ 
AB6-SW5 - - - - +++ 
AB7-SW5 + - - - - 
AB8-SW5 - ++ - - - 
AB5-SW6 - - ++ - - 
AB6-SW6 - - - + - 
AB1-SW8 - - - - +++ 
AB2-SW8 ++ - - - - 
AB7-SW8 - - - +++ - 
AB9-SW8 - + - - - 
AB12-SW8 - - - - ++ 
AB1-SW9 - - - - +++ 
AB1-SW10 - +++ - - ++ 
S. griseus 
ATCC 15468 
++ ++ +++ - - 
* SW1 - Gracilaria spp, SW2 – Codium spp., SW5 - Amphiroa bowerbankii (Harvey), SW6 - Laurencia 
brongniartii (J. Agarah), SW8 - Gelidium pteridifolium (R Norris, Hommersand and Fredericq), SW9 - Ulva 
rigida (C. Agarah), SW10 - Codium duthieae (P. Silva). 
# Grading: - = no activity; + = weak activity (zone of inhibition of 1-4 mm); ++ = moderate activity (zone of 
inhibition of 5-8 mm); +++ = strong activity (zone of inhibition 9-15 mm); ++++ = highly active (zone of 






2.3.2 Secondary screening of crude seaweed-associated bacterial extracts     
Based on the primary screening results, 60 inhibitory isolates were selected for further 
investigation: 30 with antimicrobial potential from cross-streak assay and 30 with potential 
quorum sensing inhibition activity (Jacobs, 2015). Crude extracts of the 30 potential 
antimicrobial-producing isolates were subjected to secondary screening using the disc diffusion 
assay. No antibacterial activity was observed for extracts following treatment with 0.5 and 1 
mg/ml with the exception of MAB24-SW1, which demonstrated growth inhibitory activity at 
all concentrations tested. However, at 2 mg/ml the crude extracts exhibited antibacterial 
activity with the highest activity observed against E. coli and K. pneumoniae (Table 2.2). 
 
Table 2.2: Antibacterial activity of 30 crude seaweed-associated bacterial extracts using the 
Kirby–Bauer disk diffusion method.   













MAB7-SW1 10 7 14 6 9 
MAB10B-SW1 9 0 0 8 0 
MAB11-SW1 10 0 15 12 7 
MAB12-SW1 11 7 11 10 9 
MAB16-SW1 8 6 13 11 8 
MAB17-SW1 10 0 11 9 0 
MAB20-SW1 11 7 14 11 8 
MAB22-SW1 9 0 11 10 6 
MAB24-SW1 17 15 15 30 25 
MAB25A-SW1 10 0 11 12 6 
MAB27-SW1 10 0 9 8 7 
MAB37-SW1 13 0 11 9 7 
AB1-SW2 9 7 13 7 10 
AB5-SW2 11 8 12 8 9 
AB6-SW2 10 0 11 0 9 
AB10-SW2 9 0 12 0 8 
AB11-SW2 10 8 12 8 6 
AB12-SW2 11 7 11 10 10 
AB3-SW5 9 0 10 13 9 
AB6-SW5 12 0 10 9 11 
AB7-SW5 8 0 12 11 10 
AB8-SW5 7 6 10 10 8 
AB6-SW6 6 0 11 9 0 
AB1-SW8 8 0 9 9 0 
AB2-SW8 11 0 11 8 9 
AB7-SW8 10 7 10 7 8 
AB9-SW8 11 8 11 9 7 
AB12-SW8 8 7 12 6 9 
AB1-SW9 11 6 8 9 6 
AB1-SW10 10 0 9 8 0 
* SW1 - Gracilaria spp., SW2 – Codium spp., SW5 - Amphiroa bowerbankii (Harvey), SW6 - Laurencia 
brongniartii (J. Agarah), SW8 - Gelidium pteridifolium (R Norris, Hommersand and Fredericq), SW9 - Ulva 
rigida (C. Agarah), SW10 - Codium duthieae (P. Silva)
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2.3.3 Minimum inhibitory concentration of crude seaweed-associated bacterial 
extracts 
The MICs of 14 active crude extracts were assessed against MRSA ATCC 43300 and MDR P. 
aeruginosa ATCC 27583. An MIC value of 0.78 mg/ml was exhibited by MAB24-SW1 against 
P. aeruginosa and 0.39 mg/ml against S. aureus. In contrast, the remaining thirteen extracts 
had MIC values of 6.25 mg/ml against MRSA. An MIC value of 12.5 mg/ml was observed for 
the AB2-SW8, AB1-SW9 and AB1-SW10 extracts against MDR P. aeruginosa, whereas the 
remaining extracts exhibited MIC values of 6.25 mg/ml (Table 2.3). These results were used 
to inform for the selection of sub-inhibitory and inhibitory concentrations to be used in the 
biofilm inhibition assays. 
 
Table 2.3: Minimum inhibition concentration (mg/ml) determination of 14 crude seaweed-
associated bacterial extracts against clinical indicator bacteria.  
Extracts* P. aeruginosa ATCC 27853 
(mg/ml) 
S. aureus ATCC 43300 
(mg/ml) 
MAB7-SW1 6.25 6.25 
MAB11-SW1 6.25 6.25 
MAB24-SW1 0.78 0.39 
AB1-SW2 6.25 6.25 
AB5-SW2 6.25 6.25 
AB3-SW2 6.25 6.25 
AB7-SW5 6.25 6.25 
AB8-SW5 6.25 6.25 
AB1-SW8 6.25 6.25 
AB2-SW8 12.5 6.25 
AB12-SW8 6.25 6.25 
AB1-SW9 12.5 6.25 
AB1-SW10 12.5 6.25 
AB4-SW10 12.5 6.25 
* SW1= Gracilaria spp. ; SW2 – Codium spp.; SW5 - Amphiroa bowerbankii;  
SW8 - Gelidium pteridifolium; SW9 - Ulva rigida; SW10 - Codium duthieae. 
 
 
2.3.4 Characterization of MAB24-SW1 
2.3.4.1 Thin layer chromatography and Bioautography 
One absorbing band was observed under UV light (254 nm and 336 nm). A dark blue spot with 
RF value of 0.38 was observed on the TLC plate, which indicated the presence of phenol. The 
presence of this phytochemical constituents was re-confirmed on the TLC-developed plates by 





Figure 2.3: Chromatograms of crude extract of (A) MAB24-SW1 and (B) DMSO control developed in 
methanol/acetone/ethyl acetate (3:1:1) and sprayed with methanolic 10% H2SO4 solution.  
 
TLC bioautography of the ethyl acetate and methanol extract of MAB24-SW1 indicated 
significant inhibition of S. aureus, E. coli and C. violaceum, respectively. No inhibition was 















Figure 2.4: Inhibition of growth on bioautographic TLC plates by ethyl and methanol extract of 
MAB24-SW1 extract against (A) C. violaceum ATCC 12472, (B) E. coli ATCC 35218, (C) P. 









2.3.4.2 Gas-chromatography-mass spectrometry 
The major components in the extract were butanoic acid, 2-amino-3-hydroxy-Threonine, 
methylsulfonylmethane and acetic acid, however, two compounds provided no hits from the 
database (Table 2.4). Figure 2.5 shows the major compounds identified from MAB24-SW1 
crude extracts using GC-MS and the NIST/NBS 2005 mass spectral database. The compounds 
are representatives of the various amino acid and fatty acid residues and probable conversion 
products of cyclohexanone. The five-carbon chain carbonyl fragments may be a result of 
dihydroxylation of the open chain pentose sugar present in the compound.  
 
Table 2.4: Chemical composition of MAB24-SW1 crude extracts. 
Chemical constituents RT (min) 
No hit* 7.338 
No hit* 7.364 
DL-2-Amino-3-hydroxybutanoic acid 7.450 
Threonine L-Threonine, L-butanoic acid,2-amino-3-hydroxy-Threonin  
Butanoic acid, 2-amino-3-hydroxy-Threonine 7.519 
Disulfide sulfone Methane, sulfonylbis-MSM Methyl sulfone   
Disulfide, Dimethyl 2.3-Dithiabutane Methyl disulfide (Methyldithio)methane  
Dimethyl methylphosphonate, Phosphonic acid, methyl,-dimethyl ester  
No hit 7.588 
Methylsulfonylmethane,Diethylacetic acid 7.763 
Pentanonic acid, 2-methyl, methyl ester , Valeric acid  
Acetic acid 7.813 
2-amino-2-ethyl-1,3-propanediol 2-amino-1.3-dihydroxy-2-ethylpropane  
3-Methylpyridazine 7.845 
Phenol Carbolic acid, Hydroxybenzene  
3-Methylpyridazine, Pyridazine, 3-methyl  
Benzene,[(3-methyl-2-butenyl) oxy]-Ether,3-methyl-2-butenyl phenyl  
No hit 8.623 
Phenylethyl alcohol 9.226 
Hydrazine, (phenylmethyl)-Hydrazine, benzyl-Benzylhydrazine  
Toluene Benzene, methyl Methacide Methylbenzene  
No hit 10.831 
Butylated hydroxytoluene, Phenol, 2,6-bis(1,1-dimethylethyl)-4-methyl-p-Cresol 16.714 
No hit 26.005 










2.3.4.3 Preparative thin layer chromatography and nuclear magnetic 
resonance 
One zone was observed in the chromatogram. The zone was scrapped off and re-constituted in 
methanol, vacuum-filtered and concentrated. The extract was subjected to 1H-NMR analysis 
following a TLC comparison of the zone.  The characteristic chemical shifts observed in the 
1H-NMR spectrum of the partially purified MAB24-SW1 extract revealed the presence of the 








Figure 2.6: General chemical structure of surfactins (Chen et al., 2015). 
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Chemical shifts between 6.7 and 8.1 ppm were assigned to the N-H protons of the 
peptide backbone. The α-hydrogen resonated between 3.9 and 4.4 ppm. A singlet was observed 
at 3.58 ppm, which may be assigned to the methoxy group on either of the glutamic or aspartic 
amino residues. The repeating CH2 units on the fatty chain were observed between 1.27 and 
1.32 ppm while the terminal methyl groups on the surfactin macrocycle and the fatty acid tail 
have overlapping signals between 0.88 and 0.99 ppm (Fig. 2.7).   
Figure 2.7: 1H-NMR spectrogram of partially purified MAB24-SW1 extract. 
 
2.3.5 Effect of seaweed-associated bacterial extracts on the adhesion and 
detachment of biofilm-forming bacteria 
Potential quorum quenching seaweed-associated bacterial extracts (n=30) were screened for 
their ability to inhibit initial adherence and for detachment of mature biofilms of P. 
aeruginosa and S. aureus on polystyrene microtitre plates. To determine whether the inhibitory 
effect on biofilm development was related to general growth inhibition or a change in the 
bacterial growth rate, growth was measured prior to assessing biofilm inhibition. Those 
extracts noted to have antibacterial activity were excluded from the analysis.  
Following treatment (1 and 5 mg/ml) with seaweed-associated bacterial extracts, 
statistically significant (p < 0.001) decreases in initial adhesion of P. aeruginosa were noted 
(Fig 2.8B). After treatment with 1 mg/ml, 90% (27/30) of extracts had an anti-adhesion effect 
against P. aeruginosa (p < 0.001), however, 10% (3/30) of the extracts resulted in increased
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adhesion (Fig. 2.8B). Due to significant growth inhibition (≥ 50%) at 10 mg/ml in the initial 
adhesion assay, results for this concentration were not considered as biofilm inhibition and 
were excluded from analysis (Fig. 2.8A).  A ≥ 50% reduction in crystal violet binding was 
obtained at 1 mg/ml for only two extracts: MAB10B-SW1 and AB4-SW9 against MDR P. 
aeruginosa at the time of inoculation (Table 2.5). While 80% (24/30) of extracts inhibited 
adhesion of P. aeruginosa at 5 mg/ml (p < 0.001), exposure to six extracts (MAB5-SW1, AB1-
SW6, AB8-SW8, AB4-SW9, AB5-SW9 and AB3-SW10) resulted in ≥ 50% growth inhibition.  
 
Table 2.5: Percentage biofilm reduction of P. aeruginosa ATCC 27853 and S. aureus ATCC 
43300 following treatment with 1 – 5 mg/ml crude seaweed-associated bacterial extracts 
targeting initial attachment. 
* SW1 - Gracilaria spp., SW2 – Codium spp., SW5 - Amphiroa bowerbankii (Harvey), SW6 - Laurencia 
brongniartii (J. Agarah), SW8 - Gelidium pteridifolium (R Norris, Hommersand and Fredericq), SW9 - Ulva 
rigida (C. Agarah), SW10 - Codium duthieae (P. Silva). 
# Biofilm reduction calculated according to Pitts et al. (2003).  
¥ Negative values are indicative of an increase in attachment/biofilm formation. 
 €  Differences in the BFR values among the treatment groups were statistically significant (p < 0.001). 
Extracts* 
 
Percent biofilm reduction at time of 
inoculation of P. aeruginosa# 
Percent biofilm reduction at time of 
inoculation of S. aureus# 
1 mg/mL€ 5 mg/mL€ 1 mg/mL€ 5 mg/mL€ 
MAB2-SW1 17.68 67.95 39.68 55.92 
MAB4-SW1 35.12 71.06 42.28 52.59 
MAB5-SW1 24.37 81.62§ 50.25 62.59 
MAB6-SW1 2.60 88.43 74.94 92.28 
MAB10A-SW1 72.73 94.05 -30.56¥ -36.42 
MAB10C-SW1 45.74 83.98 -36.37 -25.79 
MAB21-SW1 43.67 88.05 11.63 66.73 
MAB24-SW1 36.38 96.90 19.52 70.39§ 
MAB34A-SW1 -3.67 71.45 -55.95 83.79 
MAB35-SW1 -0.53 69.23 -37.29 24.48 
AB4-SW2 24.09 97.08 24.50 53.47 
AB9B-SW2 36.97 77.14 24.59 61.68 
AB27-SW2 2.86 77.18 50.41 75.11§ 
AB2-SW5 0.64 47.12 -53.61 -47.60 
AB4-SW5 9.95 84.04 -28.64 -12.97 
AB1-SW6 28.75 65.84§ 40.22 33.78 
AB3-SW6 22.51 91.97 -13.30 9.62 
AB5-SW6 2.58 60.83 25.83 73.78 
AB1-SW7 7.90 69.35 5.17 65.55 
AB2-SW7 20.65 68.71 33.71 37.12 
AB6-SW8 -0.65 68.65 38.59 53.78 
AB8-SW8 37.49 71.65§ 46.36 70.05 
AB11-SW8 7.17 60.17 -42.70 8.80 
AB14-SW8 25.89 80.35 -38.59 30.81 
AB3-SW9 45.43 79.20 23.17 34.23 
AB4-SW9 53.38 80.14§ 27.87 53.38 
AB5-SW9 3.16 74.09§ 14.72 42.75 
AB2-SW10 12.27 67.53 29.42 64.57 
AB3-SW10 10.86 60.17§ 8.31 53.41 
AB4-SW10 5.96 82.49 -14.90 32.33 
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Figure 2.8: The potential effect of crude seaweed-associated bacterial extracts on initial bacterial growth of (A) and initial adhesion (B) of Pseudomonas 
aeruginosa ATCC 27583 as quantified by crystal violet staining in a microtiter plate assay. The mean values of two independent replicate experiments ± SD 





































































Of note was that 97% (23/24) of extracts which had a ≥ 50% adhesion reduction 
potential at 5 mg/ml concentration (Fig. 2.8B; Table 2.5). The increase in activity could be 
potentially attributed to the higher concentration.  Biofilm inhibition activity of ≥ 90% by 
extracts from MAB10B-SW1, MAB24-SW1, AB4-SW2 and AB3-SW6 was also observed 
against P. aeruginosa. Responses to the treatment targeting initial adhesion appeared to be 
extract-specific and dose-dependent. 
The effects of three concentrations (1, 5 and 10 mg/ml) were investigated during 
detachment studies, with a higher concentration of extract required to effectively detach mature 
biofilms of P. aeruginosa (Fig. 2.9B). Treatment with extracts resulted in a greater detachment 
of biofilms as compared to initial adhesion inhibition.  
Following treatment with 1 mg/ml, 30% (9/30) of extracts detached biofilms (Fig 2.9B) 
of P. aeruginosa, with the % reduction ranging from 1.20 - 47.27%, while 70% (21/30) of 
extracts demonstrated increased adhesion (Fig. 2.9B; Table 2.6). From the detachment assay 
(Fig. 2.9; Table 2.6), majority of extracts enhanced the biofilm formation of MDR P. 
aeruginosa at 1 mg/ml. Upon exposure to 5 mg/ml, 56% (17/30) of extracts were observed to 
detach P. aeruginosa, with a biofilm reduction index ranging from 0.61 - 52.68% (p = 0.816). 
However, only three extracts, i.e., MAB24-SW1, AB2-SW5 and AB4-SW5 were observed to 
have ≥ 50% detachment activity. None of the extracts had ≥ 90% reduction potential at this 
concentration (Table 2.6). The best results were noted for 10 mg/ml, with all extracts 
demonstrating detachment activity with a biofilm reduction index of 33.01 - 104.34% with no 
growth inhibitory effect (p < 0.001). Majority of extracts (70%; 21/30) were observed to have 
a ≥ 50% biofilm reduction potential.  Four extracts (MAB24-SW1, MAB34A-SW1, AB4-SW2 
and AB4-SW5) demonstrated ≥ 90% reduction potential at this concentration (Fig. 2.9B). The 
increase in the number of extracts, together with the increasing percent reduction index of 
extracts detaching MDR P. aeruginosa suggests a dose-dependent effect.
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Figure 2.9: The potential effect of crude seaweed-associated bacterial extracts on bacterial growth of (A) and mature biofilm detachment (B) of Pseudomonas 
aeruginosa ATCC 27583 as quantified by crystal violet staining in a microtiter plate assay. The mean values of two independent replicate experiments ± SD 


































































Table 2.6: Percentage biofilm reduction following treatment with crude seaweed-associated 
bacterial extracts against mature biofilm of clinical indicator bacteria. 
* SW1= unidentified red seaweed, SW2 – Codium spp., SW5 - Amphiroa bowerbankii (Harvey), SW6 - Laurencia 
brongniartii (J. Agarah), SW8 - Gelidium pteridifolium (R Norris, Hommersand and Fredericq), SW9 - Ulva 
rigida (C. Agarah), SW10 - Codium duthieae (P. Silva). 
# Biofilm reduction calculated according to Pitts et al. (2003).  
¥ Negative values are indicative of an increase in attachment/biofilm formation.  
€  Differences in the BFR values among the treatment groups were statistically significant (p < 0.001). 
 
 
Upon exposure to low concentrations of seaweed-associated bacterial extracts, 
inhibition of initial adhesion was noted for 67% (20/30) of extracts against MRSA (Fig. 2.10) 
in the range of 5.17-74.94% (Table 2.5), however, 30% (10/30) stimulated biofilm formation 
(p = 0.132). Four extracts (MAB5-SW1, MAB6-SW1 and AB27-SW2) demonstrated ≥ 50% 
reduction potential. None of the extracts could effectively reduce adherence by ≥ 90% without 
causing any growth inhibitory effect (Table. 2.5). At 5 mg/ml, 80% (24/26) of extracts 
demonstrated biofilm reduction potential, without a growth inhibitory effect (Fig 2.10B). While 
Extracts* Percent biofilm reduction against 24 h 
pre-formed biofilm of P. aeruginosa# 
Percent biofilm reduction against 24 h 
pre-formed biofilm of S. aureus# 
1 mg/ml€ 5 mg/ml€ 10 mg/ml€ 1 mg/ml€ 5 mg/ml€ 10 mg/ml€ 
MAB2-SW1 -1.06¥ 17.26 64.25 -0.07 55.89 94.97 
MAB4-SW1 5.63 48.06 64.13 -14.55 77.47 94.56 
MAB5-SW1 7.94 37.96 78.46 12.90 78.69 100.19 
MAB6-SW1 -60.77 -63.02 61.87 60.47 65.26 84.73 
MAB10A-SW1 -79.22 -81.98 27.59 36.41 68.63 82.73 
MAB10C-SW1 47.27 46.75 52.76 38.73 66.45 79.54 
MAB21-SW1 -14.50 -77.97 33.89 43.18 59.71 94.45 
MAB24-SW1 -73.31 50.88 91.46 78.81 93.36 99.12 
MAB34A-SW1 -14.79 25.83 104.34 15.02 17.92 85.68 
MAB35-SW1 -17.83 0.61 47.82 12.97 23.11 87.02 
AB4-SW2 31.72 30.93 101.54 60.84 64.05 83.57 
AB9B-SW2 -68.70 -64.20 28.93 33.33 91.03 96.83 
AB27-SW2 -37.00 -28.09 76.64 18.94 69.41 76.86 
AB2-SW5 -39.72 52.68 97.34 19.60 36.99 79.88 
AB4-SW5 39.54 51.13 102.27 6.86 22.29 69.93 
AB1-SW6 -69.81 0.66 69.09 57.24 59.86 97.04 
AB3-SW6 19.18 25.14 66.57 16.83 42.95 82.10 
AB5-SW6 -88.57 -75.03 57.72 -2.21 63.37 92.84 
AB1-SW7 -26.36 -11.37 40.42 36.28 38.67 65.08 
AB2-SW7 -28.75 0.25 38.78 18.77 64.28 97.34 
AB6-SW8 1.20 31.42 74.97 -11.22 80.88 97.67 
AB8-SW8 -89.73 -44.93 52.78 6.05 63.78 68.21 
AB11-SW8 -27.74 -7.06 45.83 20.90 58.18 92.19 
AB14-SW8 2.00 44.60 68.89 44.82 41.93 68.90 
AB3-SW9 -33.90 -10.63 32.92 26.30 76.02 83.42 
AB4-SW9 -10.73 -30.56 65.43 43.95 54.55 84.89 
AB5-SW9 -61.01 3.20 77.52 11.18 11.61 13.21 
AB2-SW10 -20.46 -24.38 53.04 5.07 39.22 70.25 
AB3-SW10 -61.67 -7.39 33.01 9.59 17.20 55.43 
AB4-SW10 5.00 14.45 55.27 70.09 76.14 90.02 
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53% (16/30) of extracts reduced biofilm adherence by ≥ 50% at 5 mg/ml (p < 0.001), the best 
result was noted for extract MAB6-SW1, which was the only extract capable of reducing 
biofilm adherence by ≥ 90% (Table 2.5). 
Similarly, when detachment assays were conducted, 10% (4/30) of extracts increased 
adhesion of MRSA at 1 mg/ml (Fig. 2.11B), while 90% (26/30) of extracts effectively dispersed 
the biofilm (p < 0.001) with biofilm reduction index of 6.05 - 78.81% (Table 2.6). Extract 
MAB24-SW1 was the most potent with ≥ 70% biofilm reduction potential and no significant 
effect on growth. At 5 mg/ml, all extracts dispersed mature biofilms of MRSA (p < 0.001). 
Detachment of ≥ 50% was observed for 60% (18/30) of the extracts, with ≥ 90% inhibition by 
extracts AB8-SW2 and AB6-SW8. Furthermore, extract AB6-SW8 also demonstrated 
inhibition of initial adhesion suggesting broad-spectrum anti-biofilm activity (Table 2.5). The 
most prominent effect of these extracts was their ability to detach mature biofilms at 10 mg/ml, 
without inhibiting growth (p < 0.001). At 10 mg/ml, 97% (29/30) of extracts demonstrated ≥ 
50% reduction potential, with 40% (12/30) having a ≥ 90% reduction potential.  
Overall the best activity was observed against P. aeruginosa in initial adherence assay 
with a biofilm reduction index of 0.64 - 97.08% (Table 2.5). However, extracts’ activity against 
mature biofilm of P. aeruginosa was much weaker (Table 2.6). Pronounced activity of extracts 
against mature biofilm of MRSA was observed at 10 mg/ml, with ≥ 90% reduction potential 
noted for 40% (12/29) of extracts (Table 2.7). 
 
 
Table 2.7: Comparison of biofilm reduction potential of seaweed-associated bacterial extracts 
against inhibition of initial adherence and pre-formed biofilms. 
Indicator 
bacteria 
Concentration Percent biofilm reduction 
against initial adherence 
Percent biofilm reduction 














P. aeruginosa 1 mg/ml 2 0 0 0 
 5 mg/ml 23 4 3 0 
 10 mg/ml - - 21 5 
S. aureus 1 mg/ml 3 0 5 0 
 5 mg/ml 15 1 20 2 
 10 mg/ml - - 29 12 
*-Results omitted due to significant growth inhibition (≥ 50%) compared to untreated control.
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Figure 2.10: The potential effect of crude seaweed-associated bacterial extracts on growth (A) and initial adhesion (B) of Staphylococcus. aureus ATCC 43300 
as quantified by crystal violet staining in a microtiter plate assay. The mean values of two independent replicate experiments ± SD are shown. Differences in 




































































Figure 2.11: The potential effect of crude seaweed-associated bacterial extracts on mature biofilm growth (A) and mature biofilm detachment (B) of 
Staphylococcus aureus ATCC 43300 as quantified by crystal violet staining in microtiter plate assay. The mean values of two independent replicate experiments 

































































 2.3.6 Molecular characterization of seaweed-associated bacteria 
Genomic DNA was isolated from selected seaweed-associated bacteria and amplified to obtain 
16S rRNA gene fragments of ~1500 bp, which were compared with 16S rRNA gene sequences 
in the GenBank database following sequencing of amplimers. The predominant isolates were 
Bacillus and Streptomyces spp. (Table 2.8). 
 
Table 2.8: Colony characteristics of selected antimicrobial and anti-qourum sensing seaweed-
associated bacteria and their identities.  
Isolation code Colony characteristics 16S rRNA confirmation 
MAB6-SW1 smooth glistening orange Rhodococcus fascians 
MAB7-SW1 smooth bright yellow Bacillus pumilus 
MAB10B-SW1 whitish cream glossy surface Bacillus sp.  
MAB11-SW1 glistening cream opaque Bacillus pumilus 
MAB12-SW1 glossy white with white borders Bacillus cereus 
MAB24-SW1 cream wrinkled butyrous surface Bacillus velezensis 
MAB25A-SW1 glistening smooth cream transparent Bacillus pumilus 
MAB37-SW1 glossy cream with white boarders Bacillus cereus 
AB1-SW2 cream pink-purple; powdery Streptomyces sp. 
AB5-SW2 light yellow smooth Stenotrophomonas maltophila  
AB8-SW2 Pinkish with rough boarders Streptomyces sp. 
AB7-SW5 milky white light yellow transparent; mucoid Stenotrophomonas maltophila  
AB8-SW5 grey circles Streptomyces diastaticus 
AB6-SW6 milky white butyrous very shiny Streptomyces sp. 
AB1-SW8 white matt Streptomyces sp. 
AB2-SW8 olive green with white spores Streptomyces sp. 
AB6-SW8 White powdery Streptomyces sp. 
AB7-SW8 Greyish yellow with wrinkles Streptomyces sp. 
AB12-SW8 Cream transparent and smooth Streptomyces sp. 
AB1-SW9 opaque white milky and smooth Microbacterium oxydans  
AB4-SW10 grey spores with white edges; powdery Streptomyces labedae 
 
2.4 Discussion 
The lack of treatment options for MDR pathogens highlights the urgent need for the discovery 
and development of alternative therapeutic strategies. The marine environment remains 
relatively untapped, thus is in the limelight for novel natural product discovery (Suvega and 
Kumar, 2014; Suresh et al., 2014). Marine seaweed and their associated bacteria have become 
an important target for the biotechnology industry because of the large number of bioactive 
compounds discovered from them (Yung et al., 2011; Tebben et al., 2014). Seaweeds and 
seaweed-associated bacteria contain many different secondary metabolites, which have a wide 
spectrum of biological activities (anti-viral, anti-bacterial, anti-biofilm, etc.) (Prieto et al., 
2012; Ravisankar et al., 2013b). It has been suggested that, in addition to their own defense 
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mechanisms, seaweed-associated bacteria have the ability to mimic secondary metabolites 
synthesized by their host (Egan et al., 2014). The highly competitive, nutrient-limited 
environments in which seaweed-associated bacteria live (Cho and Kim, 2012) induces them to 
produce secondary metabolites, such as allelochemicals, (Singh et al., 2015), antibiotics 
(Sugathan et al., 2012), siderophores, proteases, bacteriocins, lysozymes, biosurfactants and 
organic acids which threaten the survival of their competitors (Soria-Mercado et al., 2012). 
Seaweed-associated bacterial communities produce plant-growth promoting substances, 
specific vitamins bioactive compounds, quorum sensing (QS) signalling molecules and other 
substances which play an important role in the health (Sugathan et al., 2012) and development 
of their hosts (Singh and Reddy, 2014).  
In the present study, Gracilaria spp. (SW1) yielded the most microorganisms with 
antimicrobial activity. Red algae are generally considered as the most important source of many 
biologically active metabolites in comparison to other algal classes (Ali and Gamal, 2009). 
Majority of seaweed-associated bacteria displayed good antibacterial activity (Table 2.1). 
Isolate MAB24-SW1 exhibited the highest level of antimicrobial activity against all pathogens 
tested. These results reflect those of Susilowati et al. (2015) who isolated 23 marine bacterial 
strains from three species of brown algae Sargassum, ultimately acquiring only one strain 
active against MRSA and S. epidermidis. Bacterial isolate MAB24-SW1 was distinguished as 
Bacillus velezensis, a heterotypic synonym of B. amyloliquefaciens (Silva et al., 2015). The 
genome of a plant endophytic B. velezensis was sequenced and reported to harbor an array 
of gene clusters that produce novel secondary metabolites with antimicrobial activity (Cai 
et al., 2016). Characteristics of this strain include plant growth promotion, biocontrol of 
phytopathogens and methanol utilization (Cai et al., 2016). Analysis of crude extract of 
MAB24-SW1 through NMR and GC-MS supported the elucidation of a possible surfactin 
analogue. The biosynthesis of surfactin a secondary metabolite from B. subtilis has been 
described previously by Chen et al. (2008) and is encoded by non-ribosomal peptide synthetase 
(NRPS) gene cluster. Several cyclic lipopetides biosurfactants are produced mainly by 
members of Bacillus spp. (Chen et al., 2008; Cai et al., 2016) and possess good antimicrobial 
activity and surface tension reduction (Cai et al., 2016; Das et al., 2008). Biosurfactant have 
been reported to exhibit antimicrobial activity against clinical pathogens, anti-biofilm activity 
and detachment of pre-formed biofilms (Gudiña et al., 2016). Bacillus circulans produces a 
biosurfactant with antimicrobial activity against Acinetobacter calcoaceticus, Citrobacter 
freundii, Enterobacter cloacae, E. coli, Micrococcus luteus, P. mirabilis, Proteus vulgaris, 
Serratia marcescens and MDR E. coli, K. pneumoniae and S. aureus (Gudiña et al., 2016). 
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Although biosurfactants have been widely studied in past few years, the marine environment 
still remains mostly unexplored and only a few reports regarding biosurfactant production by 
marine micro-organisms have been reported (Cai et al., 2016). Microorganisms from marine 
origin have shown to produce novel biosurfactants with excellent bioactivity (Padmavathi and 
Pandian, 2014). The possible surfactin analogue characterized in the present study might 
provide a potential novel biosurfactant from the seaweed environment with potential 
applications in pharmaceutical and food industries. Our preliminary results suggest that a 
substantial fraction of secondary metabolites from this isolate still remains to be explored and 
could include a wide array of compounds such as lipopeptides, and other antimicrobial 
metabolites. 
The incidence of biofilm-mediated infections, especially as a result of the medical use 
of implantable devices and catheters, is increasing tremendously (Gellatly and Robert, 2013). 
This indicates an urgent need for the discovery and identification of novel compounds with the 
capability to inhibit bacterial colonization and biofilm formation. Through the production of 
secondary metabolites, seaweed-associated bacteria are capable of producing AHL-like 
molecules to disrupt QS in other bacteria as a means of competition. The production of 
bioactives, in particular antimicrobials synthesized by seaweed-associated bacteria is well 
documented (Egan et al., 2014; Tebben et al., 2014; Singh et al., 2015). In contrast, limited 
studies have covered the anti-biofilm potential of these strains (Braña et al., 2014; Egan et al., 
2008). Quorum sensing controls gene expression that is beneficial when performed by groups 
of bacteria acting in synchrony. Processes controlled by QS include pigment formation, 
biolumniscence, sporulation, antibiotic production and biofilm formation (Jha et al., 2013). 
Inhibition of QS-mediated virulence factors including biofilm formation is a recognized anti-
pathogenic drug target. The search for safe and effective anti-QS and anti-biofilm agents is 
expected to be useful to combat diseases caused by multidrug-resistant bacteria (Braña et al., 
2014).  
In this study, 30 potential QQ seaweed-associated bacterial extracts (predominantly 
Streptomyces and Bacillus spp.) were screened for the production of anti-biofilm compounds 
against MDR P. aeruginosa and MRSA, which are commonly associated with biofilm-related 
infections such as cystic fibrosis and nosocomial infections (Hurley et al., 2012). Initial 
adhesion of P. aeruginosa biofilms was found to be susceptible to seaweed-associated bacterial 
extracts, whereas MRSA was found to be less susceptible. Overall, extracts’ activity against 
initial adhesion was extract- and dose-dependent. These results are similar to those of Lafleur 
et al. (2015) who isolated a marine seaweed epibiont Cellulophaga sp. E6, which produces a 
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QS inhibitory compound active against P. aeruginosa.  Supernatant from Cellulophaga sp. E6 
culture reduced expression of the 3-oxo-C12-HSL-dependent virulence-associated gene lasB, 
and reduced biofilm formation in a dose-dependent manner (Lafleur et al., 2015).  
Several bacteria with QQ enzymes capable of inhibiting biofilm formation have been 
reported (Romero et al., 2012; Chankhamhaengdecha et al., 2013). The majority of the 
seaweed-associated bacterial isolates identified in this study were Bacillus species. Bacillus 
species inhibit QS through the production of lactonases which hydrolyze the ester bond of the 
AHL molecules yielding N-acyl-homoserine thus degrading QS signals (Martin et al., 2014), 
Bacillus spp., utilize AHL-lactonases in QQ to boost competitive strength in their immediate 
environment (Vinoj et al., 2014). Actinobacteria are one of the most efficient groups of 
secondary metabolite producers. They have been investigated as potential sources of anti-
biofilm compounds due to their production of QQ enzyme acylase (Tan et al., 2016). 
Streptomyces sp. produce AhIM acylases, which degrades short and long chain AHL, thus inhibiting 
QS-mediated virulence factor production (Chankhamhaengdecha et al., 2013). Younis et al. (2016) 
reported the anti-biofilm activity of marine Streptomyces against biofilm formation of Proteus 
mirabilis on urinary catheter. Analysis of extracts derived from Streptomyces gandocaensis 
resulted in the discovery of three peptidic metabolites (cahuitamycins A–C) which inhibited 
biofilm formation of Acinetobacter baumannii (Park et al., 2016). Manickam et al. (2014) 
emphasized the role of Streptomyces spp. crude fatty acid extract, inhibiting the biofilm 
formation of S. pyogenes. Seaweeed-associated Streptomyces with biofilm reduction activity 
were identified in this study. The potential production of QQ enzymes or inhibitory small 
molecules by the seaweed-associated actinomycetes could be responsible for degrading AHL 
signals, shutting down QS and limiting biofilm adhesion or stimulating biofilm dispersal of P. 
aeruginosa.  
Blockage of the QS circuit and thus biofilm formation in S. aureus can occur through 
inhibition of biosynthesis of auto-inducer peptides, inhibition of processing enzymes, blockage 
of receptor interactions by use of peptide antagonists (Singh et al., 2016). Due to the relatively 
non-bactericidal nature of tested extracts, data obtained suggests that seaweed-associated 
bacterial extracts could be analogues of AIP thus acting as receptor antagonists of agrC or they 
interfere with phosphorylation of agrA as cell viability was maintained. Nakayama et al. (2009) 
identified ambuic acid as AIP biosynthesis inhibitor of S. aureus and Listeria innocua 
suggesting that the compound targets a common point in the biosynthesis process of cyclic 




Biofilms are enclosed within an exopolymer matrix that can restrict the diffusion of 
substances and bind antimicrobials. This provides effective resistance for biofilm cells against 
large molecules such as antimicrobials (Nithya et al., 2011). Hence, mature biofilms are more 
difficult to eradicate than the planktonic bacteria. When detachment studies were conducted 
the lowest concentration tested (1 mg/ml), had no effect on detachment of mature biofilm. 
However, upon exposure to higher concentrations the number of extracts observed to detach 
the isolates increased. Only the extract of MAB24-SW1 (B. velezensis) demonstrated ≥ 90% 
reduction potential against mature biofilms of both MRSA and MDR P. aeruginosa at 10 
mg/ml, suggesting broad-spectrum anti-biofilm activity. The possible production of an 
analogue of surfactin by this isolate, as well as other lipopeptides synthesised by non-ribosomal 
peptide synthetases could have contributed to its anti-biofilm activity. Gudiña et al. (2016) 
demonstrated that biosurfactant produced by B. circulans exhibited the highest anti-biofilm 
activity at 10 mg/ml, microbial adhesion was inhibited between 84 - 89%, and pre-formed 
biofilms were removed (ranging from 59 - 94%) for all the pathogenic microorganisms tested 
including S. aureus. Quinn et al. (2012) reported lipopeptide biosurfactant from B. cereus that 
inhibited biofilm and dispersed biofilms of S. aureus, P. aeruginosa, Streptococcus bovis and 
Micrococcus luteus. Biosurfactants are an emerging therapy, which possess antibacterial, 
antifungal and viral properties with the ability to disperse or disrupt biofilms and seaweed-
associated bacterial extracts will have to be chemically characterized in order to ascertain their 
role in the documented anti-biofilm activity.  
The mature MRSA biofilms were susceptible to seaweed-associated bacterial extracts, 
whereas mature P. aeruginosa biofilms were less susceptible. Pseudomonas aeruginosa makes 
use of three distinct QS systems (LasI/LasR system, the RhlI/RhlR system, Pseudomonas 
quinolone signalling system) often simultaneously and in a heirachical manner (Dorotkiewcz-
Jach et al., 2015). This renders P. aeruginosa difficult to eradicate, as inhibition of all three 
systems would be required to inhibit QS whereas MRSA only utilizes one QS system making 
it easier to eradicate (Nithya et al., 2010). These findings are similar to those of Nithya et al. 
(2010) who reported on mature biofilm disruption of P. aeruginosa by 70–74% after treatment 
with an anti-biofilm compound S6-15 isolated from the marine environment. 
Furthermore, it was noted that a few extracts enhanced the formation of biofilms. This 
indicates that some of the extracts are potentially capable of mimicking the actions of auto-
inducers, which subsequently stimulate transcriptional activity of the QS cascade. A greater 
number of extracts stimulated biofilm formation at the lower concentrations (1 mg/ml) but 
above this concentration, biofilm formation was inhibited by most extracts. Corral-Lugo et al. 
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(2016) reported similar results from rosmarinic acid, a plant-derived compound that functioned 
as a homoserine lactone mimic. In vitro assays showed that rosmarinic acid bound to the 
quorum-sensing regulator RhlR of P. aeruginosa PAO1 and competed with the bacterial ligand 
N-butanoyl-homoserine lactone (C4-HSL). Furthermore, rosmarinic acid induced QS–
dependent gene expression and increased biofilm formation and the production of the virulence 
factors pyocyanin and elastase. 
The biofilm inhibiting activity of the bacterial extracts observed in the current study, 
without any/or limited antibacterial activity demonstrates their potential as anti-biofilm agents. 
Interfering with QS, which is linked to biofilm formation, is expected to reduce resistance due 
to a decrease in selective pressure on pathogens (Quinn et al., 2012). The combination of QS 
inhibitory agents and antibiotics has also been suggested as a novel strategy to combat MDR 
strains (Elbur et al., 2014). Lipopeptides isolated from B. licheniformis were reported to 
possess synergistic activity against mature biofilms of E. coli when combined with ampicillin, 
cefazolin and ciprofloxacin, these combinations led to total eradication of biofilms (Rivardo et 
al., 2011). The pronounced antimicrobial and anti-biofilm bioactivities observed for B. 
velezensis (MAB24-SW1) suggests the potential of this extract to be utilized on its own or 
perhaps in conjunction, with commonly used antibiotics, which may prove more effective 
against MDR pathogens. This may also equate to lower doses or antimicrobials being used, 
thereby reducing the toxicity to the patients. 
Based on the data, seaweed-associated bacterial extracts have the potential to produce 
bioactive compounds with broad-spectrum activity. While some extracts demonstrated 
antibacterial activity, other extracts with QQ potential demonstrated biofilm dispersion and 
disruption activity. Such extracts would have great clinical significance, given the current 
difficulties encountered with treating multi-drug resistant pathogens. Furthermore, the current 
study highlights the potential of marine bacterial extracts as a valuable target for developing 
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ANTIMICROBIAL AND ANTI-BIOFILM POTENTIAL OF SEAWEED-
ASSOCIATED BACTERIA ISOLATED FROM SOUTH AFRICAN SEAWEED 
AGAINST RESISTANT AQUACULTURE PATHOGENS 
 
Abstract 
The use of antimicrobial agents in aquaculture has significantly reduced options for treating 
fish diseases, due to the emergence of antimicrobial resistant fish and opportunistic human 
pathogens. Research is now focused on the discovery of novel bioactive compounds, with 
seaweed being a prime resource in the search for microorganisms, which demonstrate novel 
bioactivities. The antimicrobial and anti-biofilm potential of (n=96) seaweed-associated-
bacteria from ten South African seaweeds, was thus investigated. Isolates were tested for their 
antimicrobial activity utilizing primary screening (cross streak assay) against six bacterial fish 
pathogens. Following shake flask fermentation and ethyl acetate extraction, the efficacy of 
extracts was assessed by secondary screening (agar well diffusion assay) against six bacterial 
fish pathogens and their minimum inhibitory concentrations were determined. Extracts, at 
concentrations ranging from 1 - 10 mg/ml, capable of inhibiting initial adhesion and mature 
biofilm were assessed using utilizing the crystal violet microtiter plate assay. Primary screening 
indicated that 67% of isolates displayed activity against Aeromonas salmonicida, 51% against 
Edwardsiella tarda, 16% against Vibrio parahaemolyticus, 12% against Salmonella enterica, 
11% against Yersinia ruckeri and 4% against Aeromonas hydrophila. Extract MAB24-SW1 
(B. velezensis) demonstrated antibacterial effect against all aquaculture indicator strains. The 
total range of biofilm inhibition by extracts was between 0.08 - 113.84%. Inhibition of initial 
adhesion was observed with 70% of extracts, with ≥ 50% activity against Y. ruckeri, V. 
parahaemolyticus, and A. hydrophila in a dose-dependent manner with limited effect on 
growth. Extracts were most effective in the dispersal of mature biofilms with the best results 
been observed against V. parahaemolyticus, A. hydrophila and Edwardsiella tarda. Biofilm 
reduction activity of ≥ 90% was noted for 53% of the extracts against V. parahaemolyticus. 
Seaweed-associated bacteria could be used as a potential source for the isolation of bioactive 







Aquaculture is becoming a more intensive industry with a growing number of larger farms 
(Romero et al., 2012; Tan et al., 2016). Although there is rapid growth within the sector, it is 
also faced with challenges, such as water scarcity and the lack of control of infectious 
microbiota in aquaculture systems (Santhakumari et al., 2015). A major group of causative 
bacterial strains include Aeromonas and Vibrio spp. (Defoirdt et al., 2011a). The water column 
of aquaculture systems harbour pathogenic bacteria due to the abundance of faecal pellets and 
uneaten feed stocks these become the breeding ground and can lead to high mortality rates 
(Attramadal et al., 2014). The excessive use of antimicrobial agents in aquaculture systems to 
either treat established infections or as prophylactic measure has resulted in the development 
of multi-drug resistant (MDR) bacteria (Santhakumari et al., 2015). It is well-recognized that 
issues of antimicrobial use in food animals is a global concern (Defoirdt et al., 2016). 
Prevention and control of bacterial disease in aquatic animals is essential to minimize the use 
of antimicrobial agents and to avoid negative impacts of MDR. Thus, new strategies and novel 
compounds that will target virulence of pathogens need to be investigated (Natrah et al., 2011). 
  Marine flora and fauna have a variable relationship with the diverse community of 
associated marine microbes. The relationship between marine fauna and flora with marine 
microbes can be either beneficial or fatal to the host organism. Marine substrata are colonized 
by a variety of marine microorganisms, which are capable of producing novel compounds due 
to their diverse and often extreme environmental conditions and interactions with their 
associated marine eukaryotic host organisms (Egan et al., 2013). Studies have indicated that 
seaweeds produce secondary metabolites that can be used against harmful marine microbes 
(Harder et al., 2012; Thanigaviel et al., 2015). Secondary metabolites from green, brown and 
red marine algae have been intensively studied for their bioactive compounds demonstrating 
anticancer, antimicrobial and antitumor activity (Martin et al., 2014). Research is now focused 
on bioactive discovery from marine-associated microorganisms (Chen et al., 2013; Singh et 
al., 2015; Defoirdt, 2016). Bioactive compounds such as benzaldehydes, isolated from 
seaweed-associated Streptomyces atrovirens Pk288-21 were reported to demonstrate 
antimicrobial activity against fish pathogens Edwardsiella tarda and Streptococcus iniae (Cho 
and Kim, 2012). Macrolactin which was isolated from Bacillus subtilis MTCC 10403, was 
reported to possess antibacterial activity against Vibrio vulnificus and V. parahaemolyticus 




Quorum sensing (QS) is an intercellular communication mechanisms utilized by 
microorganism, whereby signal molecules known as autoinducers are synthesized and secreted 
by bacteria to communicate (Vinoj et al., 2014). Many aquatic bacterial pathogens such as 
Aeromonas, Vibrio, and Edwardsiella spp. use QS to regulate virulence factor production (Chu 
and Mclean, 2016). Gram-negative bacteria use acyl homoserine lactones (AHL), while Gram-
positive bacteria use processed peptide-signalling molecules known as autoinducing peptides 
(AIPs) (Padmavathi et al., 2014). Quorum sensing regulates and coordinates the expression of 
virulence factors, and other functions that are important to the survival of bacteria; such as 
biofilm formation, pigment production, swarming, and the biosynthesis of antibiotics 
(Brackman et al., 2011). Studies have suggested that by inhibiting cell-to-cell communication 
(QS) within or among bacterial species could prevent biofilm formation and the spread of 
pathogenicity (Harder et al., 2012; Santhakumari et al., 2015; Chu and McLean, 2016). Marine 
microorganisms and macroalgae demonstrates the ability to produce bioactive compounds that 
influence bacterial settlement, cell multiplication and biofilm formation by interfering with 
bacterial metabolism or bacterial QS (Salaün et al., 2013). Sethupathy et al. (2016) 
demonstrated the anti-biofilm and QS inhibitory potential of the brown macroalga Padina 
gymnospora against the nosocomial pathogen Serratia marcescens. Padmavathi et al. (2014) 
reported the anti-QS activity of Gracilaria-associated bacteria against Chromobacterium 
violaceum. The potential benefits of inhabiting QS, is that it will reduce MDR bacteria and also 
aid in the destruction of persistent bacterial infections (Padmavathi et al., 2014). 
In most aquatic ecosystems bacteria can be found mostly in two forms, either as a 
bacterial community known as a biofilm that attach themselves to abiotic and biotic surfaces 
or as planktonic cells (Salaün et al., 2013). Biofilms are simply cells that are encased in 
extracellular polymeric substances (EPS) (Mieszkin et al., 2013), which protects bacteria from 
harsh environmental conditions, and contributes to their resistance to antimicrobial agents 
(Padmavathi et al., 2014). Economic problem arises when biofilms cause disease outbreaks in 
aquaculture production systems (Salta et al., 2013). Bacteria belonging to the genera Vibrio 
and Pseudomonas are important aquaculture pathogens that form biofilms (Yuvaraj and Arul, 
2014). Biofilms are a major concern in food and medical environments where their presence 
serves as a reservoir of contamination for humans or animals (Dheilly et al., 2010). The 
discovery of anti-biofilm agents is, therefore, of major importance in which environmentally-
friendly, anti-biofilm molecules or organisms are highly valuable (Natrah et al., 2011).  
Marine bacteria are often found in association with marine eukaryotes, and their ability 
to produce a variety of biological activities has attracted particular attention (Nithya and 
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Pandian, 2010; Defoirdt et al., 2011; Natrah et al., 2011). Viju et al. (2014) observed that 
extracellular polymeric substances secreted by a Pseudomonas taiwanensis strain S8, a 
symbiont of seaweed (Gracillaria, Sargassum, and Ulva spp.) inhibited the formation of 
biofilms by Pseudomonas and Alteromonas spp. Substances currently being utilized to control 
biofilms, have proved to have detrimental side effects and accumulate in the environment 
(Prabhakaran et al., 2012), thus environmentally-friendly treatment options are required. The 
current study places special emphasis on the ability of seaweed-associated-bacterial isolates to 
serve as reservoir for discovery of bioactive compounds with potential therapeutic activity to 
combat biofilms and MDR bacteria in an aquaculture setting.  
 
3.2 Materials and methods 
3.2.1 Bacterial isolates 
Ninety-six bacterial strains were isolated previously from ten South African intertidal seaweeds 
(Amphiroa bowerbankii Harvey, Cheilosporum cultratum Areschoug (Harvey), Codium 
duthieae (P. Silva), Codium spp., Gelidium pteridifolium (R.E, Norris, Hommersand & 
Fredericq), Gracilaria sp., Jania verrucosa (Lamourous), Laurencia brongiartii (J. Agarah), 
Ulva rigida (C. Agarah) collected along the coastline of Durban, South Africa. Isolates were 
examined and differentiated according to colony characteristics, Gram reaction and cellular 
morphology.  
 
3.2.2 Primary screening of isolates for antimicrobial activity 
Primary antibacterial screening was conducted using cross-streak method (Kvennefors et al., 
2012). A panel of resistant aquaculture indicators (Aeromonas hydrophila ATCC 7966, 
Aeromonas salmonicida ATCC 33658, Edwardsiella tarda ATCC 15947, Salmonella enterica 
serovar Arizonae ATCC 13314, Vibrio parahaemolyticus ATCC 17802 and Yersinia ruckeri 
ATCC 29473) was used. Streptomyces griseus ATCC 15468 was used as a positive antibiotic-
producing control.  Mueller-Hinton agar (MHA) plates were prepared and inoculated with 
seaweed-associated bacterial isolates by a single perpendicular streak of inoculum in the centre 
of the petri-dish and incubated at 30 °C for 5-7 d.  Indicator organisms were then streaked 
perpendicularly to the initial streak (Shnit-Orland and Kushmaro, 2013) and plates were 
incubated at 30 °C for 24 h.  Each indicator organism was first grown individually on MHA to 
ensure that any lack of growth was not dependent on the medium used for screening. The 
antagonistic effect was indicated by the failure of the indicator strain to grow in the confluence 
area.  Inhibition was measured from the edge of the vertical streak with the ‘test isolate’ to the 
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first colony of ‘indicator isolate’ cross-streak and divided into distance-dependent categories. 
Inhibition was graded as follows (- = no activity, + = weak activity [inhibition zone of 1-4 mm], 
++ = moderate activity [inhibition zone of 5-8 mm], +++ = strong activity (inhibition zone of 
9-15 mm), ++++ = highly active [inhibition zone of 16-25 mm) and total growth inhibition = 
TGI). Experiments were performed in triplicate and the inhibition zones recorded (Kvennefors 
et al., 2012). 
 
3.2.3 Fermentation and ethyl acetate extraction 
Thirty bacterial isolates which exhibited antagonistic activity in the cross-streak assay (Table 
3.1) and 30 potential quorum quenching (QQ) isolates (Jacobs, 2015) were pre-cultured in 5 
ml of ISP2 broth (Shirling and Gottlieb 1966) for 2 d, then inoculated in 250 ml of ISP2 broth 
and incubated with shaking for 7 d at 30 °C. Bacterial cells were pelleted at 9500 rpm for 10 
min to collect supernatants. An equal volume (1:1) of ethyl acetate was added to each cell-free 
supernatant followed by agitation for 1 h at 30 °C. The ethyl acetate layer was collected and 
then subjected to a second extraction (1:1 volume ethyl acetate) with agitation of flasks for 4 h 
after which the ethyl acetate layer was collected. Ethyl acetate was evaporated in a rotary 
evaporator (Ilmvac, ROdist digital 230V 50/60Hz) and each crude extract obtained was 
weighed (Nithya et al., 2011). Thereafter, crude extracts were dissolved in dimethyl sulfoxide 
(DMSO) to a final concentration of 50 mg/ml. 
 
3.2.4 Secondary screening of isolates for antimicrobial activity 
3.2.4.1 Screening of potential antagonistic bacteria against clinical 
pathogens by disc diffusion method 
Antibacterial activity of the 30 antagonistic crude bacterial extracts was assessed by loading 
0.5, 1 and 2 mg/ml of respective extracts onto 6 mm blank discs (Oxoid, UK).  Muller-hinton 
plates were prepared and uniformly swabbed with resistant aquaculture pathogens: A. 
hydrophila ATCC 7966, A. salmonicida ATCC 33658, E. tarda ATCC 15947, S. enterica 
serovar Arizonae ATCC 13314, V. parahaemolyticus ATCC 17802 and Y. ruckeri ATCC 
29473. DMSO was used as a negative control.  Plates were incubated overnight at 30 °C 
(optimal temperature of indicator bacteria) and observed for the zones of inhibition. The 
diameter of the inhibition halos after 24 h of incubation was measured and was considered to 





3.2.4.2 Minimum inhibitory concentration determination of extracts 
The minimum inhibitory concentrations (MIC) of 14 extracts demonstrating antimicrobial 
activity following secondary screening were determined using a modified broth microdilution 
assay (Motyl et al., 2006). Indicator bacteria suspensions (A. hydrophila ATCC 7966, E. tarda 
ATCC 15947 and Y. ruckeri ATCC 29473), equivalent to a 0.5 McFarland standard, were 
added to 96-well plates containing Mueller-Hinton broth (Sigma). Wells were supplemented 
with extracts (50 mg/ml stock solution) serially diluted two-fold to give final concentrations 
ranging from 12.5 – 0.01 mg/ml and incubated at 30 °C for 24 h. After incubation, 30 µl of 
0.02% resazurin (oxidation-reduction indicator) dye was added to each well, and plates were 
again incubated at 30 °C for 4 h in dark and observed for a colour change. A pink colour 
indicated growth and blue was indicative of inhibition of growth. The MIC was recorded as the 
lowest concentration at which a colour change occurred (Sarker et al., 2007). 
 
3.2.5 Detection of anti-biofilm activity of seaweed-associated bacteria extracts 
Prior to the anti-biofilm assay, the 30 selected potential QQ extracts were tested for 
antibacterial activity to determine sub-inhibitory and inhibitory concentrations (1, 5 and 10 
mg/ml), utilizing the disc diffusion assay. Extracts were tested against A. hydrophila ATCC 
7966, E. tarda ATCC 15947, V. parahaemolyticus ATCC 17802 and Y. ruckeri ATCC 29473, 
in order to assess their effect on initial adhesion and detachment of mature biofilms.  
Overnight cultures were used to prepare cell suspensions, which were standardized equivalent 
to a 0.5 McFarland standard (Basson et al., 2008). For initial adhesion studies, extracts were 
added to 90 µl TSB and 10 µl of standardized cell suspension (to a final volume of 200 µl) and 
incubated for 24 h at 24 ˚C with agitation. For pre-formed biofilm detachment assays, 24 h 
biofilms were established following addition of 90 µl TSB and 10 µl of 0.5 McFarland 
standardized cell suspension to microtitre plate wells, and incubation at 30 ºC for 24 h. 
Microtitre plates were washed three times with sterile deionised water and allowed to air-dry. 
Following air-drying, 90 µl TSB as well as extracts at the relevant, respective concentrations 
were added to wells (to a final volume of 200 µl) and microtitre plates were incubated for 24 h 
with agitation at 30 ˚C. The negative control contained only broth, while positive controls 
contained respective cell suspensions with no extracts added. After incubation, growth OD600 
nm values were determined using the Glomax multi + detection system (Promega) and wells 
with ≥ 50% reduction in growth were considered unsuitable for analysis. Thereafter, planktonic 
cells were removed by discarding the liquid media.  Plates were processed for biofilm inhibition 
as described by Basson et al. (2008). Microtiter plates were washed three times with sterile 
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dH2O.  Cells were fixed with 200 µl of methanol for 15 min, then air-dried. Wells were stained 
with 150 µl of 2% Hucker's crystal violet for 5 min. Wells were rinsed getly under running tap 
water then plates were allowed to dry. Glacial acetic acid150 µl; 33% (v/v)) was used to re-
solubilise cells (Basson et al., 2008). The OD was read at 600 nm using the Glomax multi + 
detection system (Promega).   
Tests were conducted in triplicate on two separate occasions. A measure of efficacy 
called percentage reduction was calculated from the blank, control, and treated absorbance 
values (Pitts et al., 2003): Percentage reduction =[
(C−B)−(T−B)
C−B
] × 100, where B denoted the 
average absorbance per well for blank wells (no biofilm, no treatment), C denoted the average 
absorbance per well for control wells (biofilm, no treatment), and T denoted the average 
absorbance per well for treated wells (biofilm and treatment). The difference in biofilm OD 
values with and without the addition of varying concentrations of extracts was determined 
using One-way repeated measures ANOVA with p ≤ 0.05 being considered significant 
(SigmaPlot 13.0, Systat Software Inc., San Jose, CA, USA).  To identify the concentrations 
that differed from the others, the Holm-Sidak multiple pairwise comparison procedure was 
carried out, with p ≤ 0.05 being considered significant.  
 
3.3 Results 
3.3.1 Primary antimicrobial activity screening of seaweed-associated bacteria   
Preliminary screening of antibacterial activity of 96 seaweed-associated bacteria against 
resistant pathogenic bacteria identified 73% (71/96) of isolates, which demonstrated 




Figure 3.1: Primary screening results of (A) MAB17-SW1, (B) AB8-SW8, (C) AB9-SW8 and (D) 
AB12-SW8 against (1) E. tarda ATCC 15947, (2) A. hydrophila ATCC 7966, (3) S. enterica Arizone 
ATCC 13314, (4) A. salmonicidia ATCC 33658, (5) Y. ruckeri ATCC 29473 and (6) V. 
parahaemolyticus ATCC 17802 aquaculture indicator bacteria using cross streak method. The 
antagonistic activity was indicated by inhibition of growth away from the vertically streaked indicator. 
 
Of those, 14% (14/96) demonstrated activity against three indicator organisms. 
Majority of isolates (67%; 64/96) demonstrated antibacterial activity against A. salmonicida, 
while isolates had weak activity against A. hydrophila (4%; 4/96) and S. enterica (6%; 6/96). 









Table 3.1: Primary antibacterial activity screening of seaweed-associated bacterial isolates 
against aquaculture pathogens.  
*SW1 – Gracilaria spp., SW2 – Codium spp., SW5 - Amphiroa bowerbankii (Harvey), SW6 - Laurencia 
brongniartii (J. Agarah), SW8 - Gelidium pteridifolium (R Norris, Hommersand and Fredericq), SW9 - Ulva 
rigida (C. Agarah), SW10 - Codium duthieae (P. Silva).  
#Grading: - = no activity; + = weak activity (zone of inhibition of 1-4 mm); ++ = moderate activity (zone of 
inhibition of 5-8 mm); +++ = strong activity (zone of inhibition 9-15 mm); ++++ = highly active (zone of 
























MAB7-SW1 - TGI# TGI - - - 
MAB10B-SW1 - TGI - - - - 
MAB11-SW1 - TGI - - - - 
MAB12-SW1 - TGI + - - - 
MAB16-SW1 - - - - +++ - 
MAB17-SW1 ++ TGI + - +++ TGI 
MAB20-SW1 - TGI 5 -  - 
MAB22-SW1 - TGI ++ - - - 
MAB24-SW1 + + - TGI - - 
MAB25A-SW1 - TGI ++ +++  +++ 
MAB27-SW1 - +++ - -  - 
MAB37-SW1 - TGI +++ - +++ +++ 
AB1-SW2 - TGI ++++ - - - 
AB5-SW2 - - - - - - 
AB6-SW2 - TGI +++ - - - 
AB10-SW2 - TGI + - - - 
AB11-SW2 - TGI +++ - - - 
AB12-SW2 - 0 - - - - 
AB3-SW5 - TGI TGI - + TGI 
AB6-SW5 - TGI TGI + - - 
AB7-SW5 - - - - - - 
AB8-SW5 - TGI +++ - - - 
AB6-SW6 - TGI ++ - - - 
AB1-SW8 - TGI TGI - - - 
AB2-SW8 - TGI ++ - - - 
AB7-SW8 - TGI ++ - + ++ 
AB9-SW8 - TGI TGI - TGI - 
AB12-SW8 - TGI +++ - - + 
AB1-SW9 - TGI TGI - - - 
AB1-SW10 - TGI +++ - - ++ 
AB4-SW10 - TGI +++ - - - 
S. griseus 
ATCC 15468 




3.3.2. Secondary screening of crude seaweed-associated bacterial extracts 
Thirty isolates, selected from primary screening for shake-flask fermentation and secondary 
metabolite extraction using ethyl acetate were subjected to secondary screening using the disc 
diffusion assay. No antibacterial activity was observed for extracts at 0.5 and 1 mg/ml with the 
exception of MAB24-SW1 (Fig. 3.2; Table 3.2), which demonstrated growth inhibitory activity 
at all concentrations tested. However, at 2 mg/ml, the crude extracts exhibited antibacterial 
activity predominantly against A. salmonicida ATCC 33658 and A. hydrophila ATCC 7966 




Figure 3.2: Bacteriostatic and bactericidal activity of crude MAB24-SW1 extract (0.5 - 1 mg/ml) 
against (A) A. hydrophila ATCC 7966, (B) V. parahaemolyticus ATCC 17802, (C) S. enterica serovar 
Arizone ATCC 13314, (D) E. tarda ATCC 15947, (E) Y. ruckeri ATCC 29473 and (F) A. salmonicidia 
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Table 3.2: Antibacterial activity of extracts from seaweed-associated bacterial isolates against 
aquaculture indicators using the Kirby–Bauer disk diffusion method.           
 
*SW1 – Gracilaria spp., SW2 – Codium spp., SW5 - Amphiroa bowerbankii (Harvey), SW6 - Laurencia 
brongniartii (J. Agarah), SW8 - Gelidium pteridifolium (R Norris, Hommersand and Fredericq), SW9 - Ulva 




























MAB7-SW1 10 10 0 10 0 0 
MAB10B-SW1 11 7 0 11 0 0 
MAB11-SW1 7 9 8 9 0 8 
MAB12-SW1 10 0 8 0 0 9 
MAB16-SW1 9 9 0 10 0 0 
MAB17-SW1 10 7 9 0 0 0 
MAB20-SW1 0 7 0 9 0 0 
MAB22-SW1 7 8 0 0 0 0 
MAB24-SW1 15 14 13 10 12 16 
MAB25A-SW1 0 0 9 0 0 0 
MAB27-SW1 0 0 8 0 0 0 
MAB37-SW1 10 10 0 11 0 9 
AB1-SW2 9 12 0 10 0 10 
AB5-SW2 10 0 0 9 0 9 
AB6-SW2 12 9 0 0 0 10 
AB10-SW2 10 8 0 9 0 10 
AB11-SW2 9 10 0 8 0 0 
AB12-SW2 10 7 0 9 0 8 
AB3-SW5 11 8 0 10 0 0 
AB6-SW5 0 8 0 0 0 10 
AB7-SW5 0 10 0 9 7 11 
AB8-SW5 11 8 12 10 0 0 
AB6-SW6 10 8 8 11 0 8 
AB1-SW8 8 7 8 10 0 10 
AB2-SW8 9 7 9 11 0 12 
AB7-SW8 9 0 0 10 8 0 
AB9-SW8 10 0 0 12 0 9 
AB12-SW8 8 7 10 9 0 8 
AB1-SW9 10 8 0 10 0 10 
AB1-SW10 10 10 9 10 0 11 
AB4-SW10 9 11 10 12 0 10 
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3.3.3 Minimum inhibitory concentration of crude seaweed-associated bacterial  
extracts 
The MICs of fourteen active seaweed-associated bacteria crude extracts were determined for 
A. hydrophila ATCC 7966, E. tarda ATCC 15947 and Y. ruckeri ATCC 29473. An MIC of 
0.78 mg/ml was obtained with MAB24-SW1 against Y. ruckeri ATCC 29473, A. hydrophila 
ATCC 7966 and 0.39 mg/ml against E. tarda ATCC 15947. In contrast, the remaining thirteen 
extracts had MIC values of 6.25 mg/ml against all three indicators (Table 3.3). These results 
were used to inform for the selection of sub-inhibitory and inhibitory concentrations to be used 
in the biofilm inhibition assays. 
 
Table 3.3: Minimum inhibitory concentration of seaweed-associated bacterial extracts against 
selected aquaculture pathogens. 
Extracts A. hydrophila ATCC 
7966 
E. tarda ATCC 15947 Y. ruckeri ATCC 
29473 
MAB7-SW1 6.25  6.25  6.25  
MAB11-SW1 6.25  6.25  6.25  
MAB24-SW1 0.78  0.39  0.78  
AB1-SW2 6.25  6.25  6.25  
AB5-SW2 6.25  6.25  6.25  
AB3-SW5 6.25  6.25  6.25  
AB7-SW5 6.25  6.25  6.25  
AB8-SW5 6.25  6.25  6.25  
AB1-SW8 6.25  6.25  6.25  
AB2-SW8 6.25  6.25  6.25  
AB12-SW8 6.25  6.25  6.25  
AB1-SW9 6.25  6.25  6.25  
AB1-SW10 6.25  6.25  6.25  
AB4-SW10 6.25  6.25  6.25  
*SW1= Gracilaria spp.; SW2 – Codium spp.; SW5 - Amphiroa bowerbankii; SW8 - Gelidium pteridifolium; SW9 
- Ulva rigida; SW10 - Codium duthieae. 
 
3.3.4. Effect of seaweed-associated bacterial extracts on the adhesion and 
detachment of biofilm-forming bacteria 
Thirty seaweed-associated bacterial extracts with quorom quenching potential (Jacobs, 2015) 
were screened for their ability to inhibit initial adherence and to disperse mature biofilms of A. 
hydrophila ATCC 7966, E. tarda ATCC 15947, V. parahaemolyticus ATCC 17802 and Y. 
ruckeri ATCC 29473 on polystyrene microtitre plates. To determine whether the inhibitory 
effect on biofilm development was related to general growth inhibition or a change in the 
bacterial growth rate, growth was measured prior to biofilm inhibition calculations. Those 
extracts noted to have antibacterial activity were excluded from the analysis. The effect of 
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seaweed-associated bacterial extracts relative to untreated samples are depicted in Figs. 3.3-
10.  
 Aquaculture indicators were treated with 1, 5 and 10 mg/ml concentrations. Due to 
significant growth inhibition (≥ 50%) been observed at 10 mg/ml during initial adherence 
assay, this concentration was not considered as inhibition. At 1 mg/ml, 43% (13/30) of extracts 
increased the initial adherence of A. hydrophila, however, 57% (17/30) decreased initial 
adherence (p = 0.296) with biofilm reduction ranging from 0.28-58.66 (Table 3.4). When the 
extracts’ concentration was increased to 5 mg/ml, only 7% (2/30) retained their ability to 
increase adherence (Fig. 3.3B; p < 0.001). Of note was that 36% (11/30) of extracts 
demonstrated ≥ 50% reduction potential with 13% (4/30) demonstrating ≥ 90% reduction 
potential (Table 3.4).  
In the present study, effects of three concentrations (1, 5 and 10 mg/ml) were 
investigated during detachment studies. Upon exposure to 1 mg/ml, biofilm detachment 
activity was noted for 77% (23/30) of extracts against A. hydrophila (Fig. 3.4; p = 0.228), with 
biofilm reduction ranging from 0.18-77.96% (Table 3.5). At 5 mg/ml, AB5-SW9 was the only 
extract observed to increase adhesion of A. hydrophila (Fig. 3.4B), while 97% (29/30) of the 
extracts detached biofilm (ranging from 4.49-83.08%; p < 0.001). Of the extracts with 
inhibitory potential, 50% (15/30) demonstrated ≥ 50% reduction potential. Biofilm inhibition 
activity of ≥ 90% by 27% (8/30) of the extracts, could also be detected against A. hydrophila 
after treatment with 10 mg/ml (p < 0.001). Moreover, 73% (22/30) of extracts demonstrated ≥ 
50% biofilm reduction potential. The results obtained showed a concentration-dependent 




Figure 3.3: The effect of crude seaweed-associated bacterial extracts on growth (A) and initial adhesion (B) of Aeromonas hydrophila ATCC 7966 as quantified 
by crystal violet staining in microtitre plate assay. Data represents the mean values of two independent, replicate experiments ± SD are shown. Differences in 





































































Table 3.4: Percentage biofilm reduction following treatment with seaweed-associated bacterial extracts against initial adherence of aquaculture 
indicator bacteria 
Extract* 
Percent biofilm reduction at 
time of inoculation of A. 
hydrophila ATCC 7966 
 
1 mg/ml€             5 mg/ml€ 
Percent biofilm reduction at 
time of inoculation of E. tarda 
ATCC 15947 
 
1 mg/ml€             5 mg/ml€ 
Percent biofilm reduction at 
time of inoculation of V. 
parahaemolyticus 
ATCC 17802 
1 mg/ml€             5 mg/ml€ 
Percent biofilm reduction at 
time of inoculation of Y. ruckeri 
ATCC 29473 
 
1 mg/ml€             5 mg/ml€ 
MAB2-SW1 -72.53¥ -3.37 38.23 9.21 39.53 96.57 52.12 95.35 
MAB4-SW1 -12.70 -20.18 -5.12 29.28 83.47 97.17 27.20 88.19 
MAB5-SW1 3.31 101.41 63.58 20.97 84.67§ 100.16§ 43.12 62.07 
MAB6-SW1 -6.05 26.61 63.67 40.17 76.84 93.42 24.17 62.88§ 
MAB10A-SW1 18.98 36.49 33.67 29.83 76.96§ 98.76§ 19.86 38.50 
MAB10C-SW1 1.68 25.44 50.94 17.81 65.00 85.79§ 51.13 56.67§ 
MAB21-SW1 3.30 31.23 15.51 24.89 63.30§ 38.40§ 23.39 87.76 
MAB24-SW1 2.92 83.85 81.51 54.32 81.67§ 78.75§ 95.29§ 100.07§ 
MAB34A-SW1 32.92 28.01 22.95 48.98 68.02§ 97.78§ 13.60 67.97 
MAB35-SW1 -26.73 26.59 79.33 18.07 77.67§ 80.77§ 5.81 57.54§ 
AB4-SW2 29.65 66.08 72.67 37.77 76.58 89.64 22.41 28.87 
AB9B-SW2 -5.13 31.01 83.25 46.31 68.69§ 82.30§ 54.19 58.64 
AB27-SW2 -15.37 17.45 74.02 10.39 81.37§ 95.23§ 44.41 70.21§ 
AB2-SW5 -23.47 11.80§ 57.84 38.35 81.06§ 75.30 3.68 39.27 
AB4-SW5 -1.37 64.09 41.01 -23.25 68.98§ 73.63§ 11.92 4.61 
AB1-SW6 25.46 41.66§ 38.81 39.86 71.92§ 90.32§ 54.78 76.20 
AB3-SW6 21.36 44.92 5.18 -5.26 78.82§ 70.79§ 2.02 38.53 
AB5-SW6 -6.04 22.80 64.14 -14.48 81.69§ 77.84§ 71.07 65.72 
AB1-SW7 12.65 89.49 -1.09 30.56 68.91 84.44 20.43 38.69 
AB2-SW7 0.28 23.26 46.36 -23.80 89.69§ 85.32§ 43.20 72.95 
AB6-SW8 -9.14 47.33 39.59 28.39 86.60§ 100.54§ 44.44 66.45§ 
AB8-SW8 32.08 85.89 2.77 -41.74 63.21 73.96 12.35 68.03 
AB11-SW8 48.68 95.79 14.88 -35.14 73.53 79.20 36.44 47.67 
AB14-SW8 -1.85 17.97 38.09 -37.88 76.21 102.08§ 6.69 59.79 
AB3-SW9 30.73 72.98 7.41 -23.55 49.89 74.85 29.46 73.01 
AB4-SW9 58.66 91.01 42.55 -2.94 57.06 82.70 26.95 73.08 
AB5-SW9 19.73 95.96 20.63 7.59 58.86 79.34 28.32 55.03 
AB2-SW10 1.80 61.67 61.96 -3.19 71.61§ 89.22 21.63 65.61 
AB3-SW10 -0.60 37.11 55.55 -35.90 50.23§ 88.75 23.75 54.13 
AB4-SW10 -4.12 17.55 46.86 25.09 60.50§ 94.39 53.71 65.24 
* SW1 – Gracilaria spp., SW2 – Codium spp., SW5 - Amphiroa bowerbankii (Harvey), SW6 - Laurencia brongniartii (J. Agarah), SW8 - Gelidium pteridifolium (R Norris, 
Hommersand and Fredericq), SW9 - Ulva rigida (C. Agarah), SW10 - Codium duthieae (P. Silva). 
# Biofilm reduction calculated according to Pitts et al. (2003). § ≥50% growth reduction in comparison to untreated control reflected growth inhibitory effect. ¥ Negative 
values are indicative of an increase in attachment/biofilm formation. €  Differences in the BFR values among the treatment groups were statistically significant (p < 0.001).  
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Figure 3.4: The effect of crude seaweed-associated bacterial extracts on (A) mature biofilm growth and (B) mature biofilm detachment of Aeromonas hydrophila 
ATCC 7966 quantified by crystal violet staining.in microtitre plate assay. Data represents the mean values of two independent, replicate experiments ± SD are 


































































Table 3.5: Percentage biofilm reduction following treatment with seaweed-associated bacterial extracts against mature biofilm of aquaculture 
indicator bacteria 
Extract Percent biofilm reduction 
against 24 h pre-formed biofilm 
of A. hydrophila ATCC 7966 
 
 1 mg/ml€     5 mg/ml€   10mg/ml€ 
Percent biofilm reduction 
against 24 h pre-formed biofilm 
of E. tarda ATCC 15947 
 
 1 mg/ml€     5 mg/ml€   10mg/ml€ 
Percent biofilm reduction 
against 24 h pre-formed biofilm 
of V. parahaemolyticus ATCC 
17802 
1 mg/ml€     5 mg/ml€   10mg/ml€ 
Percent biofilm reduction against 
24 h pre-formed biofilm of Y. 
ruckeri ATCC 29473 
 
1 mg/ml€     5 mg/ml€   10mg/ml€ 
MAB2-SW1 13.04 24.93 96.27 46.48 40.41 99.81 42.78 102.65 104.41 -9.81 23.62 90.24 
MAB4-SW1 48.23 65.58 93.16 49.03 67.00 100.84 77.76 100.48 110.13 29.10 19.63 92.60 
MAB5-SW1 24.61 71.00 88.70 39.64 70.00 95.96 98.48 107.29 113.84 -3.35¥ -9.72 41.93 
MAB6-SW1 62.87 60.06 71.42 21.35 30.09 50.54 47.87 70.59 102.54 15.86 47.80 33.69 
MAB10A-SW1 69.38 66.62 70.04 18.25 21.49 73.38 29.70 52.19 70.12 0.71 1.93 36.71 
MAB10C-SW1 55.01 83.08 84.90 29.33 38.22 45.23 14.48 22.30 94.58 -3.81 -10.47 8.50 
MAB21-SW1 55.09 75.35 73.75 14.07 10.59 60.11 -11.10 66.86 86.33 2.81 15.29 51.90 
MAB24-SW1 8.59 34.81 56.40 43.99 74.31 93.59 41.25 60.03 96.51 20.22 32.57 95.87 
MAB34A-SW1 61.43 62.71 81.78 0.68 17.45 48.29 3.09 67.14 80.59 -0.27 -6.84 7.40 
MAB35-SW1 52.36 69.76 91.50 1.24 8.18 46.94 53.71 84.85 75.38 65.33 49.10 40.87 
AB4-SW2 71.59 82.51 88.29 8.07 3.96 70.32 68.12 95.57 106.97 4.69 43.37 53.78 
AB9B-SW2 -2.65 55.49 89.76 30.36 34.32 73.38 70.77 95.61 101.39 31.55 5.16 97.23 
AB27-SW2 2.25 70.38 93.65 41.97 58.46 99.55 79.64 91.28 107.23 -7.27 15.59 103.24 
AB2-SW5 59.22 75.97 98.50 9.01 15.08 67.68 30.72 95.48 97.35 9.57 55.27 46.20 
AB4-SW5 77.96 75.82 89.53 12.68 14.68 18.54 90.36 97.17 88.00 15.45 29.11 53.91 
AB1-SW6 64.41 75.80 90.93 24.79 45.96 64.54 43.38 95.13 96.84 -30.78 -23.79 61.50 
AB3-SW6 35.07 51.58 86.86 3.17 10.75 37.58 0.93 85.80 96.74 0.08 45.38 48.63 
AB5-SW6 -6.93 38.25 94.52 15.54 75.94 63.87 84.24 94.18 97.35 0.67 34.10 88.58 
AB1-SW7 -8.50 13.38 44.98 21.63 30.19 27.67 10.93 24.34 67.23 -3.25 -2.01 37.14 
AB2-SW7 16.63 41.83 85.22 32.40 41.08 86.94 9.43 86.97 109.14 -24.09 -0.04 97.05 
AB6-SW8 -0.74 34.48 91.85 12.20 47.68 89.33 43.78 105.86 107.42 -8.42 46.76 94.77 
AB8-SW8 0.18 24.42 55.39 22.93 24.64 35.04 14.72 49.87 71.51 -4.18 -3.03 26.41 
AB11-SW8 27.41 38.90 74.93 28.09 49.37 49.04 28.00 78.06 84.96 5.17 48.27 54.61 
AB14-SW8 -5.94 4.49 -2.13 12.70 32.48 42.88 10.14 62.55 93.81 19.30 40.21 75.81 
AB3-SW9 10.08 15.27 38.49 13.14 7.51 41.61 12.31 65.18 80.71 -1.66 4.00 19.82 
AB4-SW9 36.81 26.73 28.12 31.08 38.72 60.63 51.54 60.17 49.44 7.91 17.72 32.71 
AB5-SW9 -3.21 -1.10 40.19 30.33 24.58 29.03 21.20 60.12 86.83 16.44 34.91 52.66 
AB2-SW10 11.41 14.97 24.90 26.40 30.06 25.83 9.71 49.49 50.97 -5.40 -0.34 51.94 
AB3-SW10 -0.09 15.68 27.92 15.92 6.09 8.12 -6.94 69.67 70.27 -19.51 40.21 38.24 
AB4-SW10 9.21 12.06 45.95 20.70 25.65 46.93 17.86 42.66 49.28 -7.47 20.17 22.49 
* SW1 – Gracilaria spp., SW2 – Codium spp., SW5 - Amphiroa bowerbankii (Harvey), SW6 - Laurencia brongniartii (J. Agarah), SW8 - Gelidium pteridifolium (R Norris, 
Hommersand and Fredericq), SW9 - Ulva rigida (C. Agarah), SW10 - Codium duthieae (P. Silva). 
# Biofilm reduction calculated according to Pitts et al. (2003). ¥ Negative values are indicative of an increase in attachment/biofilm formation.  
€  Differences in the BFR values among the treatment groups were statistically significant (p < 0.05). 
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The extracts’ ability to decrease initial adhesion of E. tarda was also observed, 
following treatment with 1 mg/ml (p < 0.001), where 93% (28/30) of extracts had anti-adhesion 
effect (Fig. 3.5) with biofilm reduction ranging from 2.77 - 83.25%. A ≥ 50% biofilm reduction 
potential for 40% of extracts was also observed, however, 7% (2/30) of the extracts 
demonstrated increased adhesion. Following treatment with 5 mg/ml, 63% (19/30) of extracts 
decreased adhesion of E. tarda (Fig. 3.5; p < 0.001) with biofilm reduction ranging between 
7.59 - 54.32% (Table 3.4). MAB24-SW1 demonstrated the highest reduction potential of 
54.32% at this concentration. 
Detachment of mature biofilm of E. tarda was observed with all extracts tested (Fig. 
3.6), with percentage biofilm reduction ranging from 0.68 - 49.03%. None of the extracts 
demonstrated ≥ 50% reduction potential at 1 mg/ml (Table 3.4; p = 0.026). At 5 mg/ml, all 
extracts maintained their detachment activity (p < 0.001) with an increase in percentage biofilm 
reduction (3.96 - 75.94%). The best anti-biofilm activity was observed for extract AB5-SW6. 
Pronounced activity was observed for 10 mg/ml (p < 0.001), with a reduction range of 8.12 - 
100.84%. Greater than 50% biofilm reduction was also observed for 53% (16/30) of the 
extracts. Extracts MAB2-SW1, MAB4-SW1, MAB5-SW1, MAB24-SW1 and AB9B-SW2 
demonstrated ≥ 90% reduction potential (Fig 3.6B).  
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Figure 3.5: The effect of crude seaweed associated bacterial extracts on (A) growth and (B) initial adhesion of Edwardsiella tarda ATCC 15947 quantified by 
crystal violet staining using microtitre plate assay. Data represents the mean values of two independent, replicate experiments ± SD are shown. Differences in 





















































































































































































































































Figure 3.6: The effect of crude seaweed-associated bacterial extracts on (A) mature biofilm growth and (B) mature biofilm detachment of Edwardsiella tarda 
ATCC 15947 quantified by crystal violet staining using microtitre plate assay. Data represents the mean values of two independent, replicate experiments ± SD 





































































At 1 mg/ml, 40% (12/30) of extracts were noted to have anti-adhesion (Fig 3.7; p < 
0.001)), with % biofilm reduction ranging from 39.53 - 83.47% against V. parahaemolyticus. 
Of those extracts, 33% (10/30) demonstrated ≥ 50% biofilm reduction activity (Table 3.4). 
Majority of the extracts (60%; 18/30) were observed to have an antibacterial effect rather than 
anti-adhesion effect. A similar growth inhibitory effect was observed at 5 mg/ml for 53% 
(16/30) of the extracts (Fig 3.7A). However, 47% (14/30) of the extracts demonstrated ≥ 50% 
reduction potential and 13% (4/30) demonstrated ≥ 90% biofilm reduction (Fig. 3.7B; p < 
0.001).  
The mature biofilm of V. parahaemolyticus was detached by 93% (28/30) of extracts 
(Fig. 3.8; p = 1.00) with percentage biofilm reduction ranging from 0.93 - 98.48% at 1 mg/ml. 
Of those extracts, MAB5-SW1 demonstrated the highest reduction potential (Table 3.5). 
Treatment with extracts MAB21-SW1 and AB3-SW10 increased the adhesion of V. 
parahaemolyticus. Upon exposure to 5 mg/ml, all extracts displayed detachment activity (p = 
0.026), with biofilm reduction ranging from 22.30 - 107.29%. Of these 37% (11/30) 
demonstrated ≥ 90% reduction potential (Table 3.6). At 10 mg/ml (p < 0.001), 53% (16/30) 
had ≥ 90% reduction potential, with MAB5-SW1 maintaining the best activity against the 







Figure 3.7: The effect of crude seaweed extracts on (A) growth of and (B) initial adhesion of Vibrio parahaemolyticus ATCC 17802 quantified by crystal violet 
staining in microtitre plate. Data represents the mean values of two independent, replicate experiments ± SD are shown. Differences in the mean values of 1 




































































Figure 3.8: The effect of crude seaweed-associated bacterial extracts on (A) mature biofilm growth and (B) mature biofilm detachment of Vibrio 
parahaemolyticus ATCC 17802 quantified by crystal violet staining in microtitre plate assay. Data represents the mean values of two independent replicate 

































































 Anti-adherence activity ranging from 2.2 - 71.09% was observed against Y. ruckeri at 
1 mg/ml with 97% (29/30) of the extracts (p = 0.556). Biofilm reduction of ≥ 50% was observed 
for 16% (5/30) extracts. The activity of MAB24-SW1, however, was due to its antibacterial 
activity (Fig. 3.9A). At 5 mg/ml, 20% (6/30) of the extracts had a growth inhibitory effect, 
while 80% (24/30) decreased attachment (p < 0.001) with biofilm reduction ranging from 4.61 
- 93.35% (Table 3.4). Biofilm reduction of ≥ 50% for 56% (17/30) extracts was observed at 
this concentration. Extract MAB2-SW1 was the only extract that effectively decreased 
adhesion with ≥ 90% biofilm reduction. 
Furthermore, 53% (16/30) of extracts demonstrated weak detachment of Y. ruckeri (Fig. 
3.10; p < 0.001) with percentage biofilm reduction ranging from 0.08 - 65.33%. None of the 
extracts had ≥ 90% reduction potential, with only MAB43-SW1 demonstrating ≥ 50% biofilm 
reduction activity. Inhibition was observed at 5 mg/ml with 73% (22/30) of extracts without 
growth inhibitory effect (p < 0.001). None of the extracts could effectively disperse the biofilm 
by ≥ 90% (Table 3.5). The most promising results were displayed at 10 mg/ml (p < 0.001), 
with percentage biofilm reduction ranging from 7.40 - 103.24% (Fig. 3.10; Table 3.5). 
Inhibition of ≥ 50% was noted for 53% (16/30) of extracts. Futhermore, 23% (7/30) of the 
extracts had ≥ 90% biofilm reduction activity. Extract AB27-SW2 was observed to completely 
eradicate the mature biofilm of Y. ruckeri. 
Overall from the inhibiton of initial adherence assay, extracts demonstrated the best 
effect against Y. ruckeri, V. parahaemolyticus, and A. hydrophila at 5 mg/ml with majority of 
extracts demonstrating ≥ 50% biofilm reduction activity (Table 3.6). Based on the detachment 
assay, extracts demonstrated stronger activity against V. parahaemolyticus and A. hydrophila 
when compared to the other indicators. Biofilm reduction activity of ≥ 90% was noted for 53% 
of the extracts against V. parahaemolyticus. The activity of extracts was more pronounced 
against detachment rather than inhibition of initial adherence (Table 3.6). 
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Figure 3.9: The effect of crude seaweed-associated bacterial extracts on (A) growth and (B) inhibition of adhesion of Yersinia ruckeri ATCC 29473 quantified 
by crystal violet staining in microtitre plate assay. Data represents the mean values of two independent replicate experiments ± SD are shown. Differences in 






































































Figure 3.10: The effect of crude seaweed-associated bacterial extracts on (A) mature biofilm growth and (B) mature biofilm detachment of Yersinia ruckeri 
ATCC 29473 as quantified by crystal violet staining. Data represents the mean values of two independent replicate experiments and ± SD are shown. Differences 


































































Table 3.6: Comparison of biofilm reduction potential of extracts against inhibition of initial 
adherence and pre-formed biofilms. 
Indicator bacteria Concentration Percent biofilm reduction 
against initial adherence 
Percent biofilm reduction 
















1 mg/ml 1 0 10 0 
5 mg/ml 11 2 25 0 
10 mg/ml - - 22 8 
E. tarda ATCC 
15947 
1 mg/ml 12 0 0 0 
5 mg/ml 1 0 5 0 




1 mg/ml 10 0 9 2 
5 mg/ml 14 4 25 11 
10 mg/ml - - 28 16 
Y. ruckeri ATCC 
29473 
1 mg/ml 5 0 1 0 
5 mg/ml 17 1 1 0 
10 mg/ml - - 16 7 
*- Results omitted due to significant growth inhibition (≥ 50%) 
 
3.4 Discussion 
Aquaculture is a fast developing industry, which has the potential to alleviate food shortages 
due to its remarkable production increases. However, this growth is associated with problems, 
which threaten its production globally, including disease outbreaks (Vatsos and Rebours, 
2015). The use of seaweed-associated bacteria as a source of new therapeutic products is of 
huge interest because the surface of seaweed is known as a “gold-mine” for microorganisms 
that produce bioactive compounds (Sugathan et al., 2012; Egan et al., 2013). The bacteria 
found on the surface of seaweed have anti-fouling, cytotoxic activities, antibacterial, 
anticoagulant and anti-virulence potential (Goecke et al., 2013).  
Screening of marine bacteria isolated from the surface of seaweed and invertebrates has 
shown that a high percentage produce bioactive metabolites (Singh and Reddy, 2014). To the 
best of our knowledge, there is no previous report on the antibacterial and anti-biofilm activity 
of seaweed-associated bacterial strains isolated from the Durban coast against aquaculture 
pathogens. In the present study, antagonism by seaweed-associated bacteria was indicated by 
interruption in the growth of the tested aquaculture pathogens. Antimicrobial activity of 
seaweed-associated bacteria was more pronounced against A. salmonicidia, E. tarda and V. 
parahaemolyticus. Bacillus pumilus isolated from brown algae Padina pavonica, displayed the 
largest spectrum of growth inhibition against a panel of 12 pathogenic bacteria (Ismail et al., 
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2016). Thilakan et al. (2016) observed that 22% of bacteria from two major phyla Firmicutes 
and Proteobacteria were active against at least one tested pathogen (A. hydrophila, V. 
alginolyticus, V. anguillarum, V. harveyi, V. parahaemolyticus, and V. vulnificus). Among the 
isolates in the present study, MAB24-SW1, a B. velezensis isolate exhibited the highest level 
of antimicrobial activity against all pathogenic aquaculture indicators. Bacillus velezensis 
isolated from wheat anthers has been reported to possesses antibacterial activity against clinical 
and plant pathogens due to the synthesis of bioactive compounds such as lantibiotic and ericin, 
which are unique to this strain (Palazzini et al., 2016). Palazzini et al. (2016) reported the 
production of ericin by a B. velezensis strain, which demonstrated antagonist activity against 
Fusarium graminearum plant pathogen. Furthermore, genome mining of B. velezensis has 
identified polyketides and non-ribosomal synthetase genes, which are responsible for synthesis 
of structurally novel bioactive compounds with potential pharmaceutical application 
(Kadaikunnan et al., 2015). There are a limited number of studies that have reported on the 
antibacterial potential of the B. velezensis against aquaculture pathogens, as most studies have 
focused on its biocontrol properties for agriculture use (Borriss et al., 2011; Dunlap et al., 
2015). Cao et al. (2011) reported the isolation of B. amyloliquefaciens with antibacterial 
activity against aquaculture A. hydrophila isolate The close relatedness of B. velezensis to B. 
amyloliquefaciens (Wang et al., 2008) and results obtained in this study demonstrate the 
potential of the isolate to control disease outbreaks in aquaculture settings.  
The misuse of antibiotics has given rise to the emergence of antibiotic resistant bacteria 
in the aquaculture industries (Huang et al., 2015). To overcome the continuous emergence of 
antibiotic resistance pathogens due to abuse of antibiotics in aquaculture, an alternative to 
antibiotics is urgently needed for disease prevention and treatment. (Tan et al., 2016). 
Probiotics could be a promising alternative to antibiotics in aquaculture. Benefits of using 
probiotics include improved immune response, growth and water quality (Dharmaraj and 
Rajendren, 2014). Bacillus spp. and actinomycetes have shown great potential as probiotics 
due to their ability to produce inhibitory compounds (Prieto et al., 2014). The seaweed-
associated bacteria in this study were predominantly Bacillus and Streptomyces spp. The 
production of a variety of wide-spectrum antagonistic and antimicrobial chemical compounds 
by Streptomyces can be valuable as probiotics in aquaculture (Tan et al., 2016). Bacillus and 
Streptomyces species identified in this study thus have potential use as probiotics in 
aquaculture. Furthermore, the activity demonstrated by isolates as a result of production of 
various antagonistic compounds (e.g. anti-biofilm, anti-quorum sensing and antibacterial) 
suggests that the use of these isolates could influence the growth of aquaculture pathogens. 
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Silvia et al. (2015) evaluated and reported the positive effect of probiotic B. amyloliquefaciens 
on the growth performance and intestinal morphometry in Nile tilapia (Oreochromis niloticus) 
reared in cages. The action of seaweed-associated bacterial could potentially regulate 
microflora by outcompeting pathogenic organisms thus enhancing the growth performance of 
livestock. Probiotics which produce siderophores are reported to limit the bioavailability of 
iron which is essential for growth and biofilm formation (Tan et al, 2016).  
Biofilm-associated bacteria are a very serious problem in many infections because they 
show an innate resistance to antibiotics. Biofilms form on a variety of surfaces including 
medical implants, water systems and living tissue (Pandey et al., 2014). The attachment and 
growth of these biofilms serve as reservoirs for opportunistic bacteria, which leach out into the 
aquaculture systems (Natrah et al., 2011). Steps to control biofilm formation and dispersion of 
already formed biofilms are important for the development of commercially viable aquaculture 
industries (Defoirdt, 2014). Procedures which included frequent cleaning and sanitization of 
tanks and water systems, prove not to be feasible as biofilm formation resumes soon after, thus 
more practical methods are required (Defoirdt et al., 2011). When bacteria adhere to a surface, 
growth occurs rapidly and during the first few hours the adhesion is reversible (Singh and 
Nakayama, 2015). Hence, preventing bacterial adhesion at the preliminary stage itself can 
reduce the risk of biofilm formation.  
Although several reports describing antibacterial activity of seaweed-associated 
bacteria are available in literature, studies on the anti-biofilm potential of these isolates are very 
limited (Ben Ali et al., 2012). To provide a strategy for biofilm prevention, control, and 
eradication, extracts from 30 potential quorum quenching seaweed-bacterial isolates were 
screened against aquaculture indicators, which utilize AHL-autoinducers as part of their 
virulence and survival strategies (Reuter et al., 2015). Seaweed-bacterial extracts inhibited 
initial adherence ≥ 50% when a concentration of 5 mg/ml was tested. The extracts demonstrated 
the best effect against V. parahaemolyticus, followed by Y. ruckeri and A. hydrophila. 
Although the interaction of extracts with bacterial cells is not fully understood, the inhibition 
effect against initial adherence indicate that they could possibly be disrupting the first 
attachment stages which include communication, motility, attachment and colonization (Chu 
and Mclean, 2016). Quorum sensing is involved in regulation of virulence of pathogens in 
aquaculture. Virulence factors of the opportunistic pathogen include biofolm formation, 
extracellular toxin and siderophore production (Zhoa et al., 2015). Due to the close association 
between QS system and virulence expression, disruption of QS is implicated in decreasing the 
pathogenicity of strains (Pande et al., 2013). Vibrio species, such as V. cholerae, V. vulnificus 
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and V. anguillarum utilize autoinducer AI-2, a furanosyl borate diester for QS-mediated 
virulence expression (Zhoa et al., 2015). Thus, it may be possible that the extracts degraded 
AI-2 and down-regulated the expression of QS signals which are necessary for biofilm 
formation and expression of virulence factors. Teasdale et al. (2011) isolated three Bacillus 
spp. from green seaweed, which demonstrated to QS inhibition against V. harveyi BB120. The 
present data also indicate that extracts could be exerting anti-biofilm activity at different stages 
of biofilm formation depending on the target bacterium. It is possible that crude extracts contain 
several different anti-biofilm molecules such as acylases, lactonases, oxidoreductases and/or 
small QSI compounds with complementary activities (Zhang et al., 2015). Nithya and Pandian 
(2010) also reported on the activity of a marine isolate, which effectively dispersed mature 
biofilm of Vibrio spp., while Rodrigues et al. (2015) reported on the activity of a marine 
Pseudoalteromonas sp. 3J6 which inhibited and dispersed biofilm of V. tapetis.  
Furthermore, extracts were tested for their ability to disperse mature biofilms. The 
survival of pathogenic organisms even after treatment with antimicrobial agents is enhanced if 
the cells exist in biofilms rather than as planktonic cells. Pronounced activity of the extracts 
was observed against the mature biofilm of A. hydrophila and V. parahaemolyticus. Response 
to treatment was also observed to be indicator-dependent. Aeromonas hydrophila causes 
septicaemia in fish and serious damage to the aquaculture industry (Defoirdt, 2016). Quorum 
sensing signals N-butanoyl-L-homoserine lactone (C4-HSL) and N-hexanoyl-L-homoserine 
lactone (C6-HSL) are utilized by A. hydrophila to establish virulence. Degradation of QS 
signals of A. hydrophila would yield an anti-virulence effect against the strain (Zhoa et al., 
2015). It is envisaged that the activity of tested extracts could be correlated to the production 
of quorum quenching enzymes such as acylases and lactonases. Streptomyces sp. make use of 
acylases PvdQ and AhlM, respectively, which are active against degradation of AHL chains 
longer than and shorter than 8 carbons (Safari et al., 2014). Tan et al. (2016) reported the anti-
biofilm activity demonstrated by Streptomyces A66 through the degradation of the QS factor 
N-AHSL (N-acylated homoserine lactone). Many Bacillus species are efficient producers of 
bioactive compounds and therefore, are dominant colonizers of seaweed surfaces. Bacillus spp. 
synthesize lactonases, such as AiiA, which hydrolyze the ester bond of the AHL molecules 
yielding N-acyl-homoserine (Tang et al., 2013). As QS is a density-dependent system, 
degradation of AHL reduces their concentration and this leads to the inactivation of QS and 
subsequently biofilm formation. Chu et al. (2014) reported the AHL-degrading Bacillus sp. 
QSI-1, which was able to increase the survival zebrafish Danio rerio infected with A. 
hydrophila YJ-1, by decreasing biofilm formation (77.3%) and protease production (83.9%).  
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Biofilm-inhibiting activity of the bacterial extracts observed in the current study 
without any antibacterial activity may have an impact in controlling biofilm-mediated 
infections. Interfering with biofilms is expected to overcome resistance because the effect is 
not lethal to the bacterium and would only restore sensitivity to antibiotics or allow clearance 
by the host immune system. Furthermore, utilization of seaweed-associated bacteria as 
potential probiotic microorganisms to control disease in aquaculture is encouraging, as they 
demonstrate potential to disrupt the QS systems of pathogens. Extensive trials are needed to 
establish whether these seaweed-associated bacteria would be effective in disease prevention 
and growth enhancement of aquaculture animals. A better understanding is needed on the exact 
mode of action of seaweed-associated bacteria. Hence, further research could focus more on 
molecular techniques to elucidate the possible underlying mechanisms whereby these isolates 
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QUORUM SENSING INHIBITORY POTENTIAL OF SEAWEED-ASSOCIATED 




Staphylococcus aureus and Enterococcus faecalis are amongst the most frequent causes of a 
wide range of hospital- and community-acquired infections. The emergence of drug-resistant 
Gram-positive organisms such as methicillin-resistant S. aureus (MRSA) and vancomycin-
resistant enterococci (VRE) presents serious challenges due to the limited choice of effective 
treatments. Since Gram-positive bacteria employ quorum sensing to express their virulence, it 
can be targeted for the development of anti-virulence agents that can suppress virulence without 
influencing cell growth. Since seaweed harbor microorganisms, which are capable of producing 
novel compounds they are a valuable source of potential anti-virulence compounds.  
The inhibitory effects of 60 seaweed-associated bacterial extracts on phospholipase 
production was assessed using the phospholipase plate assay. To identify quorum sensing 
inhibitors (QSIs) that target agr/fsr systems, an S. aureus agr reporter strain that carries 
luciferase and green fluorescence protein genes under the agr P3 promoter was utilized, while 
E. faecalis fsr system inhibition was assessed using gelatinase-activity. Inhibition of 
phospholipase was not detected with all extracts tested. When tested against luminescence and 
green protein fluorescence (GFP) reduction in the agr assay, crude extracts of MAB6-SW1 
(Rhodococcus fascians), MAB10B-SW1 (Bacillus sp), MAB24-SW1 (Bacillus velezensis), 
AB7-SW8 (Streptomyces sp.), AB1-SW9 (Microbacterium maritypicum) and AB4-SW10 
(Strepyomyces labedae) were capable of quorum sensing inhibition without causing cell death, 
with some isolates demonstrating ≥ 50% inhibition of GFP. When tested against Enterococcus 
virulence factor under the control of the fsr QS system (gelatinase production), AB2-SW8 
(Streptomyces spp.) demonstrated wide-spectrum QSI potential against both fsr and agr 
systems without causing cell death. Seaweed-associated bacteria serve as potential producers 
of diverse compounds with potential anti-virulence activity for the treatment of MDR Gram-
positive infectious diseases. These bacteria are potential candidates for identifying novel QSI 






One of the greatest achievements of modern medicine has been the discovery of antimicrobial 
agents for the treatment of infectious diseases. Traditional treatment of infectious diseases was 
previously based on compounds that aim to kill or inhibit bacterial growth (Giannakaki and 
Miyakis, 2012). A major concern with this approach is the frequently observed development 
of resistance to antimicrobial compounds. Infections caused by multidrug-resistant (MDR) 
Gram-positive bacteria represent a major public health concern, not just in terms of morbidity 
and mortality, but also in terms of increased expenditure on patient management and 
implementation of infection control measures (Gupta et al., 2016). 
Staphylococcus aureus and Enterococcus spp. are established pathogens in the hospital 
environment, and their frequent multidrug resistance complicates effective treatment of 
infections (Vazquez-Guillamet and Kollef, 2014). Methicillin-resistant S. aureus and 
vancomycin-resistant Enterococcus faecalis strains have emerged, with these clinical isolates 
being reported and isolated from infections, which have proved difficult to treat (Kalia, 2013). 
These organisms are now a serious epidemic in healthcare settings and are linked to increased 
rates of illness particularly in intensive care units and death (Painter et al., 2014). A global 
post-antibiotic era is currently faced with decreased efficiency of antibiotics thus the 
development of novel therapeutic approaches for the treatment of bacterial infections 
constitutes an urgent need in research (Defoirdt, 2016). 
The ability of these Gram-positive isolates to invade host tissue and cause infections is 
due to the expression of virulence factors such as toxins, adhesins and immune evasins (Painter 
et al., 2014). Expression of virulence factors is under regulatory control of quorum sensing 
(QS) systems. Several studies have demonstrated that QS is essential for the establishment of 
infections by Gram-positive organisms, in particular S. aureus and E. faecalis (Harris et al., 
2013; Nielsen et al., 2014; Painter et al., 2014). Therefore, there is considerable need for the 
discovery of anti-QS drugs to be utilized in therapeutic settings. In recent years anti-QS has 
focused on Gram-negative organisms (Padmavathi et al., 2014; Torres et al., 2016) and there 
are fewer reports on inhibition of QS as a mechanism to control Gram-positive organisms (Gray 
et al., 2013). This is due to the fact that the enzymes responsible for auto-inducer synthesis, 
such as ribosomes and peptidases, are commonly essential for the growth and survival of the 
bacterial cells (Desouky et al., 2013).   
Compounds able to override bacterial signaling are present in nature. Seaweed-
associated bacteria secrete biologically active, beneficial compounds that regulate the 
morphogenesis of marine organisms and help them survive under varied environmental 
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conditions such as QS inhibition through metabolite production by the host systems (Egan et 
al., 2013). The nutrient-rich seaweed surface constitutes a competitive environment that 
induces microorganisms to synthesize bioactives in order to ensure their dominant positions on 
the host, leading to the biosynthesis of structurally novel compounds (Singh et al., 2013). 
Mansson et al. (2011) investigated crude extracts and fractions from a marine Photobacterium, 
which led to the identification of two novel depsipeptides, solonamides A and B, solonamide 
B, which interfere with agr in S. aureus 8325-4 and USA300 community-acquired MRSA (CA-
MRSA) strain, respectively. Quorum sensing inhibitory action of ambuic acid was observed in 
S. aureus and other Gram-positive bacteria. The compound affected the biosynthesis of cyclic 
peptide (AIP) thus leading to discovery of ambuic acid as a broad spectrum anti-QS activity 
(Nakayama et al., 2013). Compounds with such abilities are termed anti-virulence drugs as 
opposed to antibacterial drugs (i.e., most traditional antibiotics). Anti-virulence drugs target 
key regulatory bacterial systems that govern the expression of virulence factors. An alternative 
to antibiotic action is attenuation of bacterial virulence such that the organism fails to establish 
successful infection (Lee et al, 2014). The observation that quorum sensing is linked to 
virulence factor production and biofilm formation suggests that many virulent organisms could 
potentially be rendered non-pathogenic by inhibition of their QS systems (Kalia, 2013). 
Research into QS, and inhibition thereof, may provide a means of treating many common and 
damaging chronic infections without the use of growth-inhibitory agents, such as antibiotics, 
preservatives, and disinfectants, that unavoidably select for resistant organisms (Quintana et 
al., 2015). This current study places emphasis on anti-QS ability of seaweed-associated 
bacterial extracts as therapeutic means to combat MDR Gram-positive infections. 
 
4.2 Materials and methods 
4.2.1  Bacterial isolates 
Ninety-six bacterial strains were previously isolated from ten South African intertidal seaweeds 
(Amphiroa bowerbankii Harvey, Cheilosporum cultratum Areschoug (Harvey), Codium 
duthieae (P. Silva), Codium spp., Gelidium pteridifolium (R.E, Norris, Hommersand & 
Fredericq), Gracilaria spp., Jania verrucosa (Lamourous), Laurencia brongiartii (J. Agarah), 
Ulva rigida (C. Agarah) collected along the coastline of Durban, South Africa. Based on 
preliminary antimicrobial and anti-biofilm results, 60 bacterial isolates were selected for 





4.2.2 Fermentation and ethyl acetate extraction  
Isolates were pre-cultured in 5 ml of International Streptomyces Project media 2 (ISP2; Shirling 
and Gottlieb 1966) broth for 2 d, and then inoculated in 250 ml of ISP2 broth and incubated 
with shaking for 7 d at 30 °C. Bacterial cells were pelleted at 9500 rpm for 10 min to collect 
supernatants. An equal volume (1:1) of ethyl acetate was added to each cell-free supernatant 
followed by agitation for 1 h at 30 °C. The ethyl acetate layer was collected and then subjected 
to a second extraction (1:1 volume ethyl acetate) with agitation of flasks for 4 h after which the 
ethyl acetate layer was collected. Ethyl acetate was evaporated in a rotary evaporator (Ilmvac, 
ROdist digital 230V 50/60Hz) and each crude extract obtained was weighed (Nithya et al., 
2011). Thereafter, crude extracts were dissolved in dimethyl sulfoxide (DMSO) to a final 
concentration of 50 mg/ml. 
 
4.2.3 Detection of anti-quorum sensing activity 
4.2.3.1 Phospholipase assay 
Phospholipase plate assay was conducted with some minor modifications (Kouker and Jaegar, 
1987). Olive oil (1%) and Rhodamine B (0.001% w/v) was used as a substrate. Rhodamine B 
was dissolved in distilled water and sterilized by filtration. Growth medium contained (per 
liter): 8 g nutrient broth; 4 g sodium chloride and 10 g agar. The medium was adjusted to a pH 
7.0 autoclaved and cooled to 60 °C, following which 31.25 ml of 1% olive oil and 10 ml 0.001% 
w/v of Rhodamine B solution were added with vigorous stirring and emulsified by mixing for 
1 min. The medium was allowed to stand for 10 min at 60 °C to reduce foaming.  
Eighteen-hour cultures of methicillin-resistant Staphylococcus aureus ATCC 43300 
(MRSA) were grown in trypticase soy agar (TSA) with the presence of extracts (0.5, 0.75 and 
1 mg/ml). Cells were pelleted by centrifugation at 10,000 rpm for 10 min and the cell-free 
supernatant harvested and filtered through a 0.2 µm filter, and then added to the 6 mm punched 
holes made in the phospholipid agar plate. Following an incubation period of 24 h, plates were 
exposed to UV irradiation and photographed. Orange halos were indicative of lytic activity of 
a quorum sensing inhibition (QSI) negative extract. Supernatants from QSI-positive cultures 
exhibited limited to no lytic effects and no orange halo (Kouker and Jaeger, 1987). 
 
4.2.3 Staphylococcus aureus agr inhibition assay   
 Staphylococcus aureus agr reporter strain 8325-4 (pSB20035) (kindly provided by Prof. Paul 
Williams, University of Nottingham) and S. aureus ATCC 12600T were cultured overnight in 
LB broth at 37 ˚C with gentle agitation (Desouky et al., 2013). An overnight culture of S. 
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aureus 8325-4 (pSB20035) and S. aureus ATCC 12600T were diluted 1:50 into 200 μl of fresh 
LB broth, containing 5 μl of the culture extract to be tested then the mixture was dispensed into 
flat clear bottom, white 96-well microtiter plate. Microplates were agitated at 120 rpm at 37 
˚C. S. aureus 8325-4 (pSB20035) and S. aureus ATCC 12600T were used as positive and 
negative controls, respectively (Fig. 4.1).  
 
Figure 4.1: Schematic representation of the Three-Step high throughput system for agr/fsr QS 
inhibitors. Step 1: Staphylococcus aureus 8325-4 (pSB2035) is incubated with extracts in 96-well 
microtitre plate its growth and luminescence are monitored. Step 2: Bacterial cells are harvested from 
the positive wells and fluorescence is measured after washing. Step 3: Enterococcus faecalis OG1RF is 
cultured with positive samples from step 2, and the gelatinase activity in the culture supernatant is 
measured by azocoll assay (Desouky et al., 2013). 
 
Growth readings and luminescence were taken after 7 h incubation using a microtitre 
plate reader (Promega Glomax Multi+ Detection System). The OD600 and luminescence were 
taken after 7 h incubation. If the OD was less than 50% of the positive control, the sample was 
judged to have growth inhibitory activity and removed from the QSI test. The induction level 
of luciferase was calculated by subtracting the luminescence of the negative control from the 
positive control S. aureus ATCC 12600T. Extracts that reduced the induction level to less than 
50% were considered to be QSI positive. Fluorescence was measured by transferring sample 
to 1.5 ml microtube and cells harvested by centrifugation at 13000 × g for 2 min. The 
supernatant was discarded and the cells washed with 200 μl of phosphate buffered saline (PBS). 
After repeating the washing twice, the cells were suspended in PBS and dispensed into each 
well of black walled microtitre plates. Then the fluorescence was measured using Promega 
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Glomax Multi+ Detection System at an excitation wavelength of 485 and emission wavelength 
of 535 nm. The induction level of GFP was calculated by subtracting the F485-F535 value of 
the negative control. The full induction level was calculated by subtracting the F485-F535 
value of the negative control from that of the positive control. The inhibitory effect was 
evaluated by dividing the induction level by the full induction level, and less than 50% was 
taken to represent significant inhibition. (Desouky et al., 2013). 
 
4.2.4 Enterococcus faecalis fsr inhibition assay 
Enterococcus faecalis fsr inhibition assay was conducted according to Desouky et al. (2013) 
with some minor modifications. Enterococcus faecalis OG1RF was cultured in Todd Hewitt 
Broth (THB) overnight at 37 ˚C with gentle agitation. Samples to be tested for fsr QSI were 
dispensed into 1.5 ml microtubes. An overnight culture of E. faecalis OG1RF was diluted 1:50 
in fresh THB and the culture was dispensed into 1.5 ml microtube containing 5 µl of sample. 
Tubes were incubated for 24 h at 37 ˚C with agitation at 120 rpm. Following incubation, 200 
µl of the culture was dispensed into each well of 96-well flat bottom microtiter plate and growth 
measured at 600 nm optical density (GloMax multi-detection systems-Promega). The rest of 
the culture in the microtube was centrifuged (Prism-microcentrifuge-Labnet) at 9,100 × g for 
5 min. Eight hundred microliters of azocoll solution was dispensed into a new 1.5 ml microtube 
and pre-incubated by shaking at 37 ˚C for 15 min (Desouky et al., 2013). Forty microliters of 
E. faecalis OG1RF culture supernatant was collected and added to azocoll suspension, and 
mixture was incubated with shaking (120 rpm) at 37˚C for 24 h. After 24 h, the azocoll 
suspension was centrifuged at 20,400 × g for 5 min. Two hundred microliters of the supernatant 
was dispensed into the wells of a 96-well microtitre plate, and the absorbance measured at 
OD560. The inhibitory effect was evaluated by dividing the induction level by the full induction 
level and less than 50% was be taken as significant inhibition. 
 
4.3 Results 
4.3.1 Screening of phospholipase activity 
To evaluate whether extracts could inhibit extracellular phospholipase production, a plate-
based assay was conducted using Rhodomine B as an indicator. Using MRSA ATCC 43300 
without treatment as a reference, the inhibitory effects of the seaweed-associated bacterial 
extracts on phospholipase production was observed. At all concentrations tested (0.5, 0.75 and 
1 mg/ml), orange halos which are indicative of phospholipase activity were observed. Although 
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concentration was varied the orange halos did not decrease with increasing concentration and 
could be clearly observed after 24 h incubation (Fig 4.2).  
     
Figure 4.2: Phospholipase plate assay demonstrating lipase activity in the presences of crude 
seaweed-associated bacterial extracts A) S. aureus ATCC 43300 control and MAB25A-SW1 
demonstrating presence of lytic activity B) presences of orange halos after treatment with 
MAB2-SW1 and MAB4-SW1. 
 
4.3.2 Screening inhibitors targeting agr and fsr QS systems 
To screen seaweed-associated bacterial extracts targeting the agr and fsr QS systems, a three-
step system was utilized. Prior to analysis, the growth inhibitory effect of extracts was assessed 
in order to ascertain that QS inhibition was not due to growth inhibitory effect. None of the 60 
extracts demonstrated a growth inhibitory effect. At the first and second steps, S. aureus 8325-
4 encoding luminescence and GFP genes under the QS control was used. A total of 60 seaweed-
associated bacterial extracts were tested, of which 27% (16/60) decreased the luciferase level 
to < 50% of the positive control (Table 4.1). Those extracts were taken further to validate the 
QS inhibitory potential by reflecting the promoter activity through GFP in the second step. 
Extracts from MAB6-SW1 (Rhodococcus fascians), MAB10B-SW1 (Bacillus spp.), MAB24-
SW1 (Bacillus velezensis), AB7-SW8 (Streptomyces sp.), AB1-SW9 (Microbacterium 
maritypicum) and AB4-SW10 (Streptomyces labedae) maintained their inhibitory activity (Fig 
4.2). The bacterial extracts were further subjected to the third step which tested the ability to 
inhibit the biosynthesis of gelatinase by E. faecalis OGIRF. Only the bacterial extract from 
AB2-SW8 (Streptomyces spp.) decreased induction of gelatinase to less than 50%. The results 











Table 4.1: Effect of seaweed-associated bacterial extracts targeting the agr and fsr regulatory 
systems. 
Step Screening Method # of 
positive 
samples 
% of positive 
samples 
1st Inhibition of agr system reflected by luciferase (<50%) 16 27 
2nd Inhibition of agr system reflected by GFP (<50%) 6 10 








Figure 4.3: Seaweed-associated bacteria (A) MAB6-SW1 - Rhodococcus fascians, (B) MAB10B-SW1 
- Bacillus spp., (C) MAB24-SW1 - B. velezensis, (D) AB7-SW8 - Streptomyces spp., (E) AB1-SW9 - 
Microbacterium maritypicum and (F) AB4-SW10 - Streptomyces labedae, which demonstrated 














Table 4.2: Quorum sensing inhibition activity of screened seaweed-associated bacterial 
extracts 
 -Results unavailable. *The expression of luciferase and GFP was controlled by the agr system in reporter strain 
S. aureus 8325-4 (pSB2035). #The expression of gelatinase was controlled by the fsr system in indicator strain 
E. faecalis OG1RF. 
 
4.4 Discussion 
The rise of mortality and morbidity rates due to previously treatable infectious has created a 
serious epidemic in the health care and food sectors. The ability of microorganisms such as S. 
aureus, P. aeruginosa and E. faecalis to evolve mechanisms of antimicrobial resistance and 
poor management of infections has been the main contributor (Bhardwaj et al., 2013). 
Therapeutic options are limited to the use of antibiotics, which, also contributes to antibiotic 
resistance. As treatment options run dry, there is an urgent need for discovery of alternative 
options (LaSarre and Federle, 2013). The discovery of QS systems and their role in virulence 
has now shifted the focus of research to anti-virulence compounds, which may be useful 
alternatives to antibiotics (Painter et al., 2014). 
 Research into QS inhibition has focused more on Gram-negative pathogens, and less 
on Gram-positive due to the fact that most pathogenic organisms are Gram-negative (Zhao et 
al., 2015; Padmavathi et al. 2014). This has led to an increase in drug resistant Gram-positive 
pathogens with limited treatment options (Kalia, 2013). Stapylococcus aureus causes of a wide 
range of nosocomial and community-acquired infections (Shojima and Nakayama, 2014). 
Stapylocooccal QS is encoded by the agr locus and is responsible for the production of δ-
 Expression level in the presence of extract 
Extract Luciferase* (agr) GFPa (agr) Gelatinase# (fsr) 
MAB2-SW1 44.20 95.42 75.13 
MAB6-SW1 62.93 48.86 116.91 
MAB10B-SW1 90.77 43.51 66.52 
MAB10C-SW1 41.06 65.25 103.07 
MAB24-SW1 33.55 14.63 77.25 
AB5-SW2 46.96 95.45 -- 
AB6-SW2 45.99 109.64 - 
AB12-SW2 43.23 79.44 107.75 
AB3-SW5 40.20 119.98 - 
AB6-SW5 42.39 143.78 70.23 
AB7-SW5 26.49 72.25 85.32 
AB8-SW5 38.14 83.82 65.31 
AB3-SW6 47.67 73.04 - 
AB1-SW8 49.73 84.62 78.94 
AB2-SW8 32.10 76.87 43.01 
AB7-SW8 41.04 42.86 61.01 
AB9-SW8 46.55 90.33 79.43 
AB1-SW9 28.53 48.28 130.89 
AB4-SW10 52.02 41.75 100.92 
142 
 
hemolysin, lipase, proteases and enterotoxins, which contribute to its virulence (Nakayama et 
al., 2013). Thus the inhibition of QS is seen as a viable option to decrease the pathogenicity of 
Gram-positive pathogens (Singh et al., 2016).  
The lack of phospholipase inhibition in this study could be linked to the low 
concentration of extract, which was utilized. However, upon further screening of seaweed-
associated bacterial extracts, 10% displayed QSI against the S. aureus reporter strain. This 
could suggest that the assay is not very sensitive or the presence of potential AIP-interfering 
molecules in the crude extracts. Inhibition of auto-inducer biosynthesis is regarded as the first 
preference as it is the starting point in QS signal circuit. Two enzymes, AgrB and SpsB are 
known to be involved in the biosynthesis of AIP (Singh et al., 2016). These are processing 
enzymes with protease activity and degradation is expected to block QS systems. However, 
enzymatic inhibition has a growth inhibitory effect, which is a contributory effect to the raise 
of MDR and therefore has to disregarded (Kalia, 2013; Singh et al., 2016). This explains the 
difficulty in obtaining natural QSI compounds and the low data hits which were obtained in 
this study. Blockage of AgrC-AgrA two component regulatory system and utilization of AIP 
antagonists would, therefore, be the preferred QSI method (Singh et al., 2016).  
To the best of our knowledge, there are no reports on seaweed-associated bacterial 
extracts, which inhibit Gram-positive QS, making this study amongst the first to report on QSI 
of Gram-posistive organisms. On screening of 60 seaweed-associated bacterial extracts, six 
appeared to have QSI activity against S. aureus reporter strain as reflected by GFP inhibition. 
These results reflect those of Desouky et al. (2013) who reported the screening of 906 soil and 
marine actinomycetes culture extracts. Extracts decreased the luciferase level in the agr 
reporter strain to < 10% of their negative control, the second screening of 20 samples subjected 
to GFP assay yielded only16 samples which inhibited the expression of GFP (Desouky et al., 
2013). Further screening of the 16 samples against gelatinase induction in E. faecalis identified 
only four culture extracts (608, 609, Y51, and Y67), which demonstrated QS inhibitory activity 
against the agr and fsr systems without growth inhibitory activity. Igarashi et al. (2015) 
identified avellanin C from Hamigera ingelheimensis as an inhibitor of QS in S. aureus. 
Avellanin C decreased luminescence emission from the reporter strain with an IC50 value of 
4.4 μM. Arthoamide from Arthrobacter sp. inhibited luminescence production of reporter 
strain S. aureus, which indicated inhibition of agr signaling pathway (Igarashi et al., 2015). 
Another compound polyhydroxyanthraquinone isolated from Penicillium restrictum inhibited 
QS signaling of all four groups of S. aureus (Daly et al. 2015). Quorum sensing inhibition of 
S. aureus could potentially decrease staphylococcal virulence by hindering the production of 
143 
 
certain virulence factors without hampering growth thus potentially avoiding selective 
pressures for drug-resistance (Chen and McClane, 2012). This makes it an interesting target in 
anti-virulence theraphy. 
 Quorum sensing inhibition targeting fsr system of E. faecalis has also received attention 
for its potential ability to decrease the pathogenicity of the strain (Singh and Nakayama, 2015). 
Enterococcus faecalis often causes opportunistic infections such as bacteremia, endocarditis, 
and urinary tract infections. Similar to S. aureus, virulence factors in enterococci are primarily 
mediated by QS (Thurlow et al., 2010). Gelatinase an extracellular metalloprotease that 
liquefies gelatine and collagen is considered a QS-mediated virulence factor in E. faecalis 
(Singh and Nakayama, 2015). In the current study, only the crude extract of AB2-SW8, 
identified as a Streptomyces sp., inhibited gelatinase production without any significant 
inhibition on growth suggesting QSI potential of the isolate. Furthermore, the extract also 
demonstrated QSI against the S. aureus reporter strain, which suggests broad-spectrum QSI 
activity against Gram-positive pathogens. Streptomyces sp. have been widely recognized as 
pharmaceutically important microorganism as they produce diverse range of secondary 
metabolites (Tan et al., 2016). Streptomyces sp. are known to inhibit QS of Gram-negative 
bacteria through the production of acylase, however, this enzyme has no effect on Gram-
positive QSI (LaSarrea and Federle, 2013). This suggests that other QS inhibitory compounds 
are present in the crude extract of AB2-SW8. Nakayama et al. (2007) reported QSI potential 
of siamycin isolated from Streptomyces sp. strain Y33-1, which inhibited the fsr QS system 
through inhibition of the receptor histidine kinase. Additionally, Nakayama et al. (2009) also 
isolated ambuic acid, which demonstrated broad-spectrum Gram-positive QSI. The compound 
inhibited the biosynthesis of the cyclic peptide quormones of S. aureus and the QS-mediated 
gelatinase production of E. faecalis.  
Pathogenic bacteria are often resistant to traditional antibiotics, forging the need to 
develop new strategies to control infectious diseases. Identification of seaweed-associated 
bacterial extracts demonstrating Gram-positive QS inhibitory activity may undoubtedly prove 
to be of paramount importance in the future of clinical as well as industrial treatments of 
bacterial infections. This study showed the potential of seaweed-associated bacteria as a source 
for compounds targeting the S. aureus agr and E. faecalis fsr systems as a basis for discovering 
broad-spectrum anti-virulence compounds that target communication by Gram-positive 
pathogens mediated by agr-type QS systems. Further studies on identification and 
characterization of specific molecules within the crude extracts and their role in QSI must still 
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DISCUSSION AND CONCLUSION 
 
The screening of marine microorganisms as a potential source of novel bioactive compounds 
is a promising strategy due to the unique physiochemical properties of the marine environment 
(Egan et al., 2013). In comparison to terrestrial microorganisms, they produce bioactive 
compounds with uncommon functional entities (Rocha-Martin et al., 2014). Seaweed-
associated bacteria offer competitive strategies against other epibiotic/biofilm/biofouling 
micro- and macro-organisms by synthesis of a variety of chemical interaction compounds; 
(Defoirdt, 2013). As such they represent a reservoir of novel compounds for the production of 
bioactive molecules of pharmaceutical interest. This study investigated the potential of 
seaweed-associated bacteria as a source of novel bioactive compounds with antimicrobial, anti-
biofilm and Gram-positive anti-QS activity.  
Majority of seaweed-associated bacterial isolates inhibited one or more of the resistant 
indicator organisms. The best activity was against the MRSA isolate, however, the inhibitory 
activity of extracts was more pronounced against A. salmonicida, the aquaculture indicator. 
These results are similar to the findings by Kanagasabhapathy et al. (2009) who reported 
secondary metabolites from seaweed-associated bacteria with pronounced antimicrobial 
activity against aquaculture indicators as compared to clinical indicators. Epiphytic bacteria 
isolated from Padina pavonica demonstrated broad-spectrum antibacterial activity against 
clinical and animal pathogens (A. salmonicidia, A. hydrophila, E. coli, S. aureus, V. 
proteolyticus) (Ismail et al., 2016). JanakiDevi et al. (2013) isolated seaweed-associated 
bacteria which demonstrated antibacterial activity against E. coli, K. pneumoniae, P. 
aeruginosa, Salmonella sp., Serratia sp., Shigella dysenteriae, V. cholerae, Micrococcus and 
Staphylococcus spp. Several antibacterial compounds (cosmomycin B, galtamycin B, 
maltophilins) identified from seaweed-associated bacteria displayed antimicrobial activity 
against S. aureus and E. coli (Brana et al., 2014).  
Isolate MAB24-SW1, identified as B. velezensis, which is closely related to B. 
amyloliquefaciens, exhibited the highest level of antimicrobial activity against both clinical 
and aquaculture indicators in this study. This activity was in part associated with the synthesis 
of a potential analogue of surfactin. Surfactin is synthesized by multifunctional non-ribosomal 
peptide sythetase (NRPS) (Płaza et al., 2015; Jasim et al., 2016). The presence of polyketide 
synthetase (PKS) and NRPS biosynthetic clusters appear to be widespread amongst Bacillus 
strains isolated from different shallow and deep water marine hosts (Blunt et al., 2015). 
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Nonribosomal peptide synthases are an important group of enzymes, which are responsible for 
the biosynthesis of well-known secondary metabolites like vancomycin, siderophores, 
cyanotoxins, biosurfactants, immunosuppressants, anticancer agents, anti-inflammatory agents 
etc. (Tambadou et al. 2015). Surfactin production is reported for B. subtilis isolates and it 
possesses several desirable industrial, pharmaceutical and physicochemical properties, 
including activity over a wide pH range (Mnif and Ghribi, 2015). Jasim et al. (2016) isolated 
a novel endophytic Bacillus sp., which demonstrated antibacterial activity due to the production 
of NRPS related surfactin. Furthermore, MAB24-SW1 (B. velezensis) also demonstrated 
biofilm inhibitory potential, which indicates that the crude extract contains a mixture of 
bioactive compounds, which could be working synergistically. Thus further work should be 
directed at exploring B. velezensis as a potential source of novel bioactive agents. 
An alternative way to control infection in aquaculture is by applying probiotics (Tan et 
al., 2016), which have QSI potential using seaweed-associated bacterial isolates administered 
by feeding. Quorum sensing-degrading bacteria could be considered a better alternative to 
replace application of antibiotics in aquaculture as biocontrol of bacterial fish disease and in 
reducing the pathogenicity of Vibrio species. The production of surfactin could be a desirable 
property should B. velezensis be employed as a probiotic in aquaculture applications. Chen et 
al. (2010) reported the use of recombinant AHL-lactonase from Bacillus sp. as a potential 
probiotic by injecting the isolate in carp infected with pathogenic A. hydrophila. They obtained 
a decrease in the fish mortality rates. Li et al. (2014) reported on the effect of probiotic mixture 
of B. subtilis and B. cereus in controlling infections caused by V. alginolyticus. Bacillus spp. 
to be good candidates as probiotics due to the wide spectrum of bioactive compounds they 
produce (Li et al., 2014). Furthermore, they are known to promote growth of beneficial bacteria 
in intestinal tract of humans and animals (Pandey et al., 2014). The identification of 
Streptomyces and Bacillus species in this study, further highlights the potential of isolated 
seaweed-associated bacteria as a source of probiotics. Studies have showed that feed-stock 
supplemented with Streptomyces protected fish and shrimp from pathogens (Defoirdt, 2016; 
Tan et al., 2016). Streptomyces produce broad-spectrum inhibitory compounds involved in the 
attenuation of biofilm formation, anti-QS activity and anti-virulence activity in Vibrio sp. (Tan 
et al., 2016). Streptomyces sp. identified in this study demonstrated anti-biofilm inhibitory 
activity these indicates that crude extracts contain bioactive with potential ant-virulence 
activity. 
In addition to antimicrobial screening, the effect of the extracts on biofilm formation 
and QS was evaluated. Seaweed-associated bacterial extracts at 5 mg/ml displayed the best 
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results in the initial adherence assay. Inhibition (≥ 50%) was noted in the following order: P. 
aeruginosa, Y. ruckeri, S. aureus, V. parahaemolyticus, and A. hydrophila. The extracts’ 
activity against P. aeruginosa, Y. ruckeri and V. parahaemolyticus, might be the result of QS 
inhibitory compounds that disrupt the QS-mediated virulence expression. Egan et al. (2002) 
demonstrated that seaweed associated P. tunicata blocked biofilm formation by the synthesis 
of pigmented substances that inhibited AHL-dependent transcriptional of Vibrio cholerae. 
Husain and Ahmad (2015) reported that 35 out of 88 actinomycetes inhibited the biofilm 
formation of V. harveyi, Vibrio vulnificus, and V. anguillarum without affecting their growth. 
Seaweed-associated bacterial extracts also inhibited the initial attachment of P. aeruginosa, 
which was promising as P. aeruginosa is amongst one of the most difficult pathogens to treat. 
Secondary metabolites speculated to contain QSI compounds from Diaphorobacter sp. and 
Delftia sp. significantly reduced P. aeruginosa PAO1 cell adhesion (Christiaen et al., 2014).  
This study also demonstrated the ability of extracts to disperse mature biofilm, with 
most extracts dispersing mature biofilm at 10 mg/ml. The order of dispersal (≥ 50% biofilm 
reduction) was as follows: V. parahaemolyticus, S. aureus, A. hydrophila, P. aeruginosa, E. 
tarda and Y. ruckeri. A higher number of extracts disperse mature biofilm of MRSA as 
compared to those active against MDR P. aeruginosa (13%). Extracts had an overall high 
inhibitory activity against aquaculture indicators demonstrating significant dispersal activity as 
compared to inhibition of initial adherence.  
Most of the isolates obtained in the study were identified as Bacillus and Streptomyces 
species. These results are comparable to those of by Burgess et al. (2003) who identified 
majority of Bacillus species from varying seaweed sources, i.e. B. pumilus, B. licheniformis 
and B. subtilis and observed QS-mediated inhibition, which resulted in decreased fouling. 
Bacillus species are known producers of the QQ enzyme lactonase, which targets and 
inactivates acylated homoserine lactones required for QS regulation in pathogenic bacteria 
(Naik et al., 2012). Marine Bacillus sp. S3 displayed QS inhibition when grown in the presence 
of the inducer strain P. aeruginosa (Dusane et al., 2011). Acylase enzymes produced by 
Streptomyces inactivates QS by degrading AHL signals (Hassan et al., 2016). Antimicrobial 
compounds from Streptomyces have been extensively studied from an antimicrobial 
perspective (Tan et al., 2016), however less is reported about their QS and biofilm inhibitory 
compounds (Tan et al., 2016). Behenic acid, borrelidin and 1H-pyyrole-2-carboxylic acid 
produced by Streptomyces coelicoflavus inhibited QS-mediated virulence factors of P. 
aeruginosa (Hassan et al., 2016). Piericidin A1 secreted by Streptomyces sp. demonstrated QSI 
activity against Chromobacterium violaceum (Ooka et al., 2013). Thus screening seaweed-
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associated bacterial these isolates is a promising lead to the discovery of novel QSI compounds 
for the treatment of infections. However, it must be noted that whilst some extracts had 
inhibitory activity, others increased biofilm formation. Further investigation into these isolates 
is required in order to investigate their modes of action. 
 The Gram-positive agr QS system plays an important role in promoting acute and 
aggressive infection in both animals and humans (Gray et al., 2013). Inhibition of agr in S. 
aureus has been reported to block ulcer formation and reduce abscess size (Gray et al., 2013; 
Singh et al., 2015). The potential anti-virulence activity of seaweed-associated bacterial 
extracts against Gram-positive QS systems was assessed using reporter strain S. aureus 8325–
4, which carries plasmid pSB2035 encoding luciferase and GFP genes under agrP3 promoter 
control (Desouky et al., 2013). Only 27% (16/60) of extracts performed strongly in this assay, 
when luminescence inhibition was assessed. Using the confirmatory GFP assay, six extracts 
displayed inhibitory activity. This could be due to metabolites that hamper S. aureus cellular 
metabolic activity, yielding a false-positive result as Photorhadbus luciferase activity depends 
on a bacterially generated flavinmononucleotide, FMNH2. Hence, the GFP assay directly 
reflects the promoter activity of agrP3 was employed (Desouky et al., 2013). It was, therefore, 
unsurprising that very few positive QSI results were obtained when compared to the luciferase 
assay. Despite the intense effort to discover QSI compounds against Gram-positive organisms, 
few natural compounds have been reported (Desouky et al., 2013, Singh and Nakayama, 2015; 
Singh et al., 2016). This is due to the peptide-based autoinducer utilized by Gram-positive, 
organisms. Enzymatic (QQ enzymes) activity is non-specific thus enzymes essential for the 
growth and survival of the bacterial cells are affected (LaSarre and Federle, 2013). This might 
explain the low Gram-positive QS inhibitory potential of the extracts in this study. Compounds 
WS9326A and WS9326B isolated from actinomycetes strains inhibited hemolysis production 
in S. aureus strains 8325–4 (type-I AIP) (Desouky et al., 2015). Several authors have suggested 
enzymatic degradation of Gram-negative AHL QS signals as a strategy employed by several 
organisms, including several Bacillus, Streptomyces and Rhodococcus species (Reuter et al., 
2015; Tan et al., 2016). However, these enzymes are not effective in QS-mediated systems of 
Gram-positive organisms (Gray et al., 2013). This suggests that seaweed-associated bacteria 
(Streptomyces, Bacillus, Rhodococcus) observed in this study produce other bioactive 
compounds apart from AHL-degrading enzymes with effect against Gram-positive QS-
mediated virulence factors  
To obtain an extract, which had wide spectrum of activity, the gelatinase assay was 
utilized for E. faecalis OGIRF exposed to extracts. Extract AB2-SW8 (Streptomyces sp.) 
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displayed inhibition of gelatinase with no effect on cell growth. This suggests that the observed 
effect may have been due to the inhibition of fsr QS-mediated gelatinase induction. Quorum 
sensing mediated virulence factors in E. faecalis include proteases, gelatinase (GelE) which 
aids in digesting host extracellular matrix proteins and serine protease (SprE), that enable E. 
faecalis to invade host tissues (Gray et al., 2013). The methanolic extract from plant Salvadora 
persica demonstrated gelatinase inhibition by targeting gelE expression in E. faecalis (Rezaei 
et al., 2011). There are a limited number of natural products that have been explored as Gram-
positive QS inhibitors (Singh et al., 2016). Given the urgent need to treat MDR Gram-positive 
infections, seaweed-associated bacterial extracts are potential reservoirs of bioactive 
compounds as they represent a source for natural QS inhibitory compounds. An overall 
assessment of the QSI assays suggests that while selected extracts demonstrated limited activity 
against Gram-positive organisms, they displayed potential as QS inhibitory compounds against 
Gram-negative organisms. This assumption is based on the activity observed in anti-biofilm 
assays, as QS is important in biofilm formation (Satheesh et al., 2016). 
In conclusion, marine substrata are colonized by a variety of marine microorganisms, 
which are capable of producing novel compounds due to their diverse and often extreme 
environmental conditions and interactions with their associated marine eukaryotic host 
organisms (Tang and Zhang, 2014). This study demonstrated that seaweed-associated bacterial 
isolates synthesize bioactive compounds with antimicrobial, anti-biofilm and anti-virulence 
activity. Identifying seaweed-associated bacterial as sources of compounds for anti-virulence 
therapy and as weapon to combat MDR in clinical and aquaculture environments is of 
paramount importance. The rate of discovery of these anti-QS compounds is still in its early 
stages, especially anti-QS activity against Gram-positive pathogens. Thus the discovery of 
potential QSI compounds in this study must be explored further as a weapon to combat MDR 
pathogens. Future studies willl target isolation and purification of compounds in crude extracts 
of seaweed-associated bacterial isolates and structure elucidation coupled with determination 
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A1 Colony characteristics of seaweed-associated bacteria 
Table A1.1: Colony characteristics of isolates associated with seaweed 1 
Isolate Aerial/pigmentation description Sporulation: 
Yes (Y)/No (N) 
Substrate description 
MAB2-SW1 Rough, white, powdery Y Brownish colour 
MAB3-SW1 Cream with smooth whitish borders N Transparent, pale yellow 
MAB4-SW1 Glossy rhizoid white N Translucent yellow 
MAB4B-SW1 Creamy white  Y Yellow 
MAB5-SW1 Cream with rough wrinkled texture Y Dark yellow 
MAB7-SW1 Smooth bright yellow N Mustard  
MAB8-SW1 White N Cream 
MAB9A-SW1 White, rough Y Light yellow 
MAB9B-SW1 Peachy-orange, mucoid N Peach 
MAB10A-SW1 Creamy white  N Yellow 
MAB10B-SW1 Whitish cream glossy surface N Cream 
MAB10C-SW1 Glossy cream white N Mustard  
MAB11-SW1 Glistening cream: opaque N Dark brown, yellow 
MAB12-SW1 Glossy white with smooth borders, 
translucent 
N Yellow 
MAB13-SW1 Green with grey spores Y Yellow 
MAB14-SW1 Radial colonies, green centre with white 
rings 
Y Dark mustard, yellow 
MAB16-SW1 Glossy cream, whitish border N Translucent yellow 
MAB17-SW1 Glossy cream white N Translucent white 
MAB18-SW1 Glistening cream, opaque N Yellow 
MAB19A-SW1 Glistening yellow, smooth surface N Transparent, pale yellow 
MAB19B-SW1 Green with white surface Y Translucent yellow, brown 
MAB20-SW1 Creamy white, mucoid Y Light yellow 
MAB21-SW1 Cream N Translucent 
MAB22-SW1 Green powdery Y Yellow 
MAB23-SW1 Cream smooth surface, butyrous N Dark brown, yellow 
MAB24-SW1 Cream; wrinkled butyrous surface N Cream 
MAB25A-SW1 Glistening, smooth cream: transparent N Translucent 
MAB25B-SW1 Glossy cream, whitish N Cloudy yellow 
MAB26-SW1 Cream, white borders N Dark yellow 
MAB27-SW1 Cream N Translucent yellow 
MAB28-SW1 Pink with white borders N Pale Yellow 
MAB33-SW1 Cream smooth surface, butyrous N Cloudy white 
MAB34A-SW1 Creamy white, mucoid. Y Light yellow 
MAB34B-SW1 Creamy white, mucoid. N Light yellow 
MAB35-SW1 Cream, butyrous, wavy edges Y Light yellow 
MAB36-SW1 Cream rhizoid smooth surface Y Yellow 
MAB37-SW1 Glossy cream with white borders N Translucent white 
MAB38-SW1 Glossy cream with white borders N Cloudy yellow 
MAB39A-SW1 Green, brown and black, raised Y Dark mustard, yellow 
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MAB39B-SW1 White, butyrous N Cream 
MAB39C-SW1 White powdery with rough green surface Y Mustard  
 
Table A1.2: Characteristics of isolates associated with seaweed 2 
Isolate Aerial/pigmentation description Sporulation 
Yes (Y)/No (N) 
Substrate description 
AB1-SW2 Cream with pink and purple, powdery Y Pale yellow, pink 
AB3-SW2 Semi-transparent, cream and some brown, 
mucoid 
Y Cream 
AB4-SW2 White, raised Y Light orange 
AB5-SW2 Light yellow, smooth N Cream 
AB6-SW2 Milky white, mucoid N Pale yellow, olive green 
AB7-SW2 Very bright pink, glossy and butyrous N Light, pinky orange 
AB8-SW2 Light pink, white, dry, soft Y Light pink, mustard 
AB9-SW2 Radial colonies, green centre then grey and 
white rings 
Y Dark olive green 
AB9B-SW2 Bright pink, butyrous N Light, pinky orange 
AB10-SW2 Light pink, white, powdery Y Yellow 
AB11-SW2 Dark brown with white borders Y Dark mustardy yellow 
AB12-SW2 Semi-transparent, creamy white N Cream 
AB27-SW2 Cream, butyrous - turning pink N Light Yellow 
 
Table A1.3: Characteristics of isolates associated with seaweed 5 
Isolate Aerial/pigmentation description Sporulation: 
Yes (Y)/No (N) 
Substrate description 
AB1-SW5 White with yellow centres, rough Y Greeny yellow, brown 
AB2-SW5 White and grey, mucoid and powdery Y Dark brown, yellow 
AB2B-SW5 Creamy brown with fine green spores Y Brown 
AB3-SW5 White, grey, powdery N Wrinkled, mustardy yellow 
AB4-SW5 White with dark patches, powdery Y Wrinkled, light yellow 
AB6-SW5 White, creamy butyrous N Light yellow 
AB7-SW5 Milky white, light yellow, transparent, 
mucoid 
N Transparent, pale yellow 
AB8-SW5 Grey circles Y Brown 
 
Table A1.4: Characteristics of isolates associated with seaweed 6 
Isolate Aerial/pigmentation description Sporulation 
Yes (Y)/No (N) 
Substrate description 
AB1-SW6 Yellow Y Light yellow 
AB2-SW6 Translucent yellow and grey Y Yellow 
AB3-SW6 White, pearly, translucent N Cream 
AB4-SW6 Grey and white Y Cream 
AB5-SW6 Milky white, blurred edges, butyrous, 
pearly 
N Cream 
AB6-SW6 Milky white, butyrous, very shiny Y Cream 
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Table A1.5: Characteristics of isolates associated with seaweed 7 
Isolate Aerial/pigmentation description Sporulation 
Yes (Y)/No (N) 
Substrate description 
AB1-SW7 Transparent, some white and grey, powdery Y Light yellow 
AB2-SW7 Clear, grey and white, powdery Y Light yellow 
 
Table A1.6: Characteristics of isolates associated with seaweed 8 
Isolate Aerial/pigmentation description Sporulation 
Yes (Y)/No (N) 
Substrate description 
AB1-SW8 White, matt U Cream 
AB2-SW8 Olive green with white spores Y Dark Yellow 
AB3-SW8 White, mucoid N Light yellow 
AB4-SW8 Mostly white, some beige, powdery Y Yellow 
AB5-SW8 Darkish brown, white edges, wrinkled Y Dark tan, wrinkled 
AB6-SW8 White, powdery Y Light yellow 
AB6B-SW8 White, translucent N Cream 
AB7-SW8 White, powdery Y Wrinkled, mustardy yellow 
AB8-SW8 Almost transparent, white Y Yellow, wrinkled 
AB9-SW8 Beige, white surface and edges  Y Yellow and pale yellow 
AB10-SW8 Dark grey, powdery Y White and brown, wrinkled 
AB11-SW8 Dark beige, white pigmentation, mucoid N Dark mustardy yellow 
AB12-SW8 Glistening slight transparent cream Y Dark mustardy yellow 
AB13-SW8 White N Cream 
AB14-SW8 Cream with white borders Y Cream 
AB15-SW8 Cream with white Y Light yellow 
 
Table A1.7: Characteristics of isolates associated with seaweed 9 
Isolate Aerial/pigmentation description Sporulation 
Yes (Y)/No (N) 
Substrate description 
AB1-SW9 Opaque white, milky and smooth N Pale yellow 
AB2-SW9 Opaque, cream, small colonies N Pale yellow 
AB3-SW9 Opaque, cream, butyrous N Pale yellow 
AB4-SW9 Yellow, mucoid N Yellow 
AB5-SW9 Yellow, mucoid N Dark yellow 
 
Table A1.8: Characteristics of isolates associated with seaweed 10 
Isolate Aerial/pigmentation description Sporulation: Yes 
(Y)/No (N) 
Substrate description 
AB1-SW10 Grey-beige, rough Y Olive green 
AB2-SW10 White, rough Y Light brown-mustard 
AB3-SW10 Light yellow with yellow and white 
interspersed. Sandy texture. 
Y Yellow 




A2 Antimicrobial potential of seaweed-associated bacteria 













S. griseus ATCC 
15468 
3 7 2 0 0 
MAB2-SW1 0 0 0 0 0 
MAB3-SW1 0 0 0 0 0 
MAB4-SW1 8 0 0 0 0 
MAB4-SW1B 0 0 0 0 0 
MAB5-SW1 0 0 0 0 0 
MAB6-SW1 0 0 0 0 0 
MAB7-SW1 7 0 0 17 0 
MAB8-SW1 0 0 0 0 0 
MAB9A-SW1 0 0 0 0 0 
MAB9B-SW1 0 0 0 0 0 
MAB10A-SW1 0 TGI 0 0 0 
MAB10B-SW1 13 0 0 0 12 
MAB10C-SW1 0 0 0 0 6 
MAB11-SW1 11 0 0 6 8 
MAB12-SW1 0 0 0 0 10 
MAB13-SW1 0 0 0 0 0 
MAB14-SW1 0 0 0 0 0 
MAB16-SW1 0 0 0 0 7 
MAB17-SW1 0 0 0 0 8 
MAB18-SW1 0 0 0 0 0 
MAB19A-SW1 GI 0 0 0 0 
MAB19B-SW1 0 0 0 0 0 
MAB20-SW1 0 6 0 0 0 
MAB21-SW1 0 0 0 0 0 
MAB22-SW1 0 0 0 0 12 
MAB23-SW1 0 0 0 0 0 
MAB24-SW1 0 TGI 0 0 TGI 
MAB25A-SW1 TGI 0 0 TGI 11 
MAB25B-SW1 0 0 0 0 5 
MAB26-SW1 0 0 0 0 0 
MAB27-SW1 TGI 0 0 TGI 14 
MAB28-SW1 0 0 0 0 0 
MAB33-SW1 0 0 0 0 0 
MAB34A-SW1 0 0 0 0 2 
MAB34B-SW1 0 0 0 0 2 
MAB35-SW1 0 0 0 0 0 
MAB36-SW1 5 0 0 0 0 




MAB38-SW1 0 0 0 0 0 
MAB39A-SW1 0 0 0 0 9 
MAB39B-SW1 0 0 0 0 0 
MAB39C-SW1 0 0 0 0 0 
AB1-SW2 0 0 0 8 0 
AB3-SW2 0 0 0 0 5 
AB4-SW2 0 0 0 0 0 
AB5-SW2 0 0 0 0 10 
AB6-SW2 0 0 0 0 4 
AB7-SW2 0 0 0 0 0 
AB8-SW2 0 0 0 0 0 
AB9-SW2 0 0 0 0 6 
AB9B-SW2 0 0 0 0 0 
AB10-SW2 0 7 0 0 0 
AB11-SW2 0 0 0 0 9 
AB12-SW2 0 10 0 0 5 
AB1-SW5 0 0 0 0 0 
AB2-SW5 0 0 0 0 0 
AB2B-SW5 0 0 0 0 0 
AB3-SW5 0 0 0 0 0 
AB4-SW5 0 0 0 0 0 
AB5-SW5 0 0 0 0 0 
AB6-SW5 0 0 0 0 0 
AB7-SW5 6 0 0 0 0 
AB8-SW5 0 8 0 0 0 
AB1-SW6 0 0 0 0 0 
AB2-SW6 0 0 0 0 0 
AB3-SW6 0 0 0 0 0 
AB4-SW6 0 0 0 0 0 
AB5-SW6 0 0 6 0 0 
AB6-SW6 GI GI 0 0 0 
AB1-SW7 0 0 0 4 0 
AB2-SW7 0 0 0 0 0 
AB1-SW8 0 0 0 0 10 
AB2-SW8 9 0 0 0 0 
AB3-SW8 0 0 0 0 0 
AB4-SW8 0 0 0 0 0 
AB5-SW8 0 0 0 0 0 
AB6-SW8 0 0 0 0 0 
AB6B-SW8 0 0 0 0 0 
AB7-SW8 0 0 12 0 0 
AB8-SW8 0 0 0 0 0 
AB9-SW8 0 6 0 0 0 
AB10-SW8 0 0 0 0 0 
AB11-SW8 0 0 0 0 4 
AB12-SW8 0 0 0 0 10 




AB14-SW8 0 0 0 0 0 
AB15-SW8 0 0 0 0 0 
AB1-SW9 0 0 0 0 12 
AB2-SW9 0 0 0 0 6 
AB3-SW9 0 0 0 0 0 
AB4-SW9 0 0 0 0 0 
AB5-SW9 0 0 0 0 0 
AB1-SW10 0 13 0 0 0 
AB2-SW10 0 0 0 6 10 
AB3-SW10 0 0 0 0 0 
AB4-SW10 0 0 0 0 0 
 * SW1= Gracilaria spp., SW2 – Codium spp., SW5 - Amphiroa bowerbankii (Harvey), SW6 - Laurencia 
brongniartii (J. Agarah), SW8 - Gelidium pteridifolium (R Norris, Hommersand and Fredericq), SW9 - Ulva 
rigida (C. Agarah), SW10 - Codium duthieae (P. Silva). 
# Grading: - = no activity; + = weak activity (zone of inhibition of 1-4 mm); ++ = moderate activity (zone of 
inhibition of 5-8 mm); +++ = strong activity (zone of inhibition 9-15 mm); ++++ = highly active (zone of 






































S. griseus ATCC 
15468 0 6 4 10 5 TGI 
MAB2-SW1 0 TGI 0 0 0 0 
MAB3-SW1 0 TGI 7 0 0 0 
MAB4-SW1 0 TGI TGI 0 0 0 
MAB4B-SW1 0 TGI 0 0 0 0 
MAB5-SW1 0 0 0 0 0 0 
MAB6-SW1 0 0 0 0 0 0 
MAB7-SW1 0 TGI TGI 0 0 0 
MAB8-SW1 0 TGI 0 0 0 0 
MAB9A-SW1 0 20 0 0 0 0 
MAB9B-SW1 0 0 0 0 0 0 
MAB10A-SW1 0 0 0 0 0 0 
MAB10B-SW1 0 TGI 0 0 0 0 
MAB10C-SW1 0 TGI 10 0 6 0 
MAB11-SW1 0 TGI 0 0 0 0 
MAB12-SW1 0 TGI 4 0 0 0 
MAB13-SW1 0 TGI 0 0 0 0 
MAB14-SW1 0 0 0 0 0 0 
MAB16-SW1 0 0 0 0 11 0 
MAB17-SW1 7 TGI 4 0 9 TGI 
MAB18-SW1 0 4 0 0 6 0 
MAB19A-SW1 0 0 0 0 0 0 
MAB 19B-SW1 0 TGI 10 0 0 TGI 
MAB20-SW1 0 TGI 5 0 0 0 
MAB21-SW1 0 0 0 0 0 0 
MAB22-SW1 0 TGI 2 0 0 0 
MAB23-SW1 0 0 TGI 0 0 0 
MAB24-SW1 3 TGI 5 0 0 0 
MAB25A-SW1 0 TGI 6 14 0 15 
MAB25B-SW1 0 0 0 0 0 0 
MAB26-SW1 0 TGI 5 0 0 0 
MAB27-SW1 0 TGI 4 0 0 0 
MAB28-SW1 0 TGI 0 0 0 0 
MAB33-SW1 0 0 0 0 0 0 
MAB34A-SW1 6 TGI 2 0 6 0 
MAB34B-SW1 0 TGI 2 0 0 0 
MAB35-SW1 0 0 0 0 0 0 
MAB36-SW1 0 0 0 0 0 0 
MAB37-SW1 0 TGI 9 0 9 16 
MAB38-SW1 0 TGI 0 0 0 0 
MAB39A-SW1 0 TGI 0 0 0 0 
MAB 39B-SW1 0 TGI 0 0 0 0 
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MAB39C-SW1 0 0 4 TGI 2 0 
AB1-SW2 0 TGI 21 0 0 0 
AB3-SW2 0 TGI 5 0 0 0 
AB4-SW2 0 0 0 0 0 0 
AB5-SW2 0 0 0 0 0 0 
AB6-SW2 0 TGI 15 0 0 0 
AB7-SW2 0 TGI 7 0 0 0 
AB8-SW2 0 0 0 0 0 0 
AB9-SW2 0 0 0 0 0 0 
AB9B-SW2 0 TGI 2 0 0 0 
AB10-SW2 0 TGI 2 0 0 0 
AB11-SW2 0 TGI 12 0 0 0 
AB12-SW2 0 0 0 0 0 0 
AB1-SW5 0 TGI 0 0 0 0 
AB2-SW5 2 0 TGI 0 0 0 
AB2B-SW5 0 TGI 0 0 0 0 
AB3-SW5 0 TGI TGI 0 3 TGI 
AB4-SW5 0 TGI 0 0 0 0 
AB6-SW5 0 TGI TGI 4 0 0 
AB7-SW5 0 0 0 0 0 0 
AB8-SW5 0 TGI 11 0 0 0 
AB1-SW6 0 0 0 0 0 0 
AB2-SW6 0 0 0 0 0 0 
AB3-SW6 0 0 0 0 0 0 
AB4-SW6 0 0 0 0 0 0 
AB5-SW6 0 TGI 0 0 0 0 
AB6-SW6 0 TGI 6 0 0 0 
AB1-SW7 0 TGI 0 0 0 0 
AB2-SW7 0 0 8 TGI 0 0 
AB1-SW8 0 TGI TGI 0 0 0 
AB2-SW8 0 TGI 6 0 0 0 
AB3-SW8 0 0 0 0 0 0 
AB4-SW8 0 0 0 0 0 0 
AB5-SW8 0 TGI 9 0 0 0 
AB6-SW8 0 TGI TGI 0 11 0 
AB6B-SW8 0 TGI 2 0 0 2 
AB7-SW8 0 TGI 5 0 2 6 
AB8-SW8 0 TGI 10 0 12 0 
AB9-SW8 0 TGI TGI 0 TGI 0 
AB10-SW8 0 TGI 21 0 0 0 
AB11-SW8 TGI TGI TGI TGI TGI TGI 
AB12-SW8 0 TGI 14 0 0 4 
AB13-SW8 0 0 0 6 TGI TGI 
AB14-SW8 0 0 0 0 0 0 
AB15-SW8 0 TGI 3 0 0 0 
AB1-SW9 0 TGI TGI 0 0 0 
AB2-SW9 0 TGI 4 0 0 0 
AB3-SW9 0 TGI 0 0 0 0 
AB4-SW9 0 0 0 0 0 0 
AB5-SW9 0 TGI 0 0 0 0 
AB1-SW10 0 TGI 9 0 0 7 
AB2-SW10 0 TGI 2 0 0 0 
AB3-SW10 0 TGI 6 0 0 0 
AB4-SW10 0 TGI 10 0 0 0 
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* SW1= unidentified red seaweed, SW2 – Codium spp., SW5 - Amphiroa bowerbankii (Harvey), SW6 - Laurencia 
brongniartii (J. Agarah), SW8 - Gelidium pteridifolium (R Norris, Hommersand and Fredericq), SW9 - Ulva 
rigida (C. Agarah), SW10 - Codium duthieae (P. Silva). 
# Grading: - = no activity; + = weak activity (zone of inhibition of 1-4 mm); ++ = moderate activity (zone of 
inhibition of 5-8 mm); +++ = strong activity (zone of inhibition 9-15 mm); ++++ = highly active (zone of 




























A3 Anti-quorum sensing potential of Seaweed-associated bacteria 
Table A3.1: The quorum sensing inhibition activity of seaweed associated bacterial extracts 
monitored by luciferase reporter assay  
Extract  Induction Full induction Inhibition 
S. aureus 8325-4  2460.3  774.493  
S. aureus 12600 1685.807    
MAB-SW1 2028.16 342.353  44.20 
MAB4-SW1 2183.533 497.726  64.26 
MAB6-SW1 2173.217 487.410  62.93 
MAB10A-SW1 2329.263 643.456  83.08 
MAB10C-SW1 2003.863 318.056  41.06 
MAB21-SW1 2123.573 437.766  56.52 
MAB34A-SW1 2338.87 653.063  84.32 
MAB35-SW1 2086.183 400.376  51.69 
AB4-SW2 2235.217 549.410  70.93 
AB9B-SW2 2160.897 475.090  61.34 
AB27-SW2 2349.543 663.736  85.69 
AB2-SW5 2269.87 584.063  75.41 
AB4-SW5 2453.907 768.100  99.17 
AB1-SW6 2147.553 461.746  59.61 
S. aureus 8325-4  2074.547  1169.173  
S .aureus 12600 905.3737    
AB3-SW6 1462.757 557.383  47.67 
AB5-SW6 1585.457 680.083  58.16 
AB1-SW7 1675.803 770.429  65.89 
AB2-SW7 1545.803 640.429  54.77 
AB6B-SW8 1932.52 1027.146  87.85 
AB8-SW8 1622.46 717.086  61.33 
AB11-SW8 1502.123 596.749  51.04 
AB14-SW8 1623.463 718.089  61.41 
AB3-SW9 1733.79 828.416  70.85 
AB5-SW9 1669.46 764.086  65.35 
AB4-SW9 1674.14 768.766  65.75 
AB2-SW10 1699.14 793.766  67.89 
AB3-SW10 1640.147 734.773  62.84 
AB4-SW10 1928.18 1022.806  87.48 
 
Extract  Induction Full induction Inhibition 
S. aureus 8324-5 2748.37  517.793  
S. aureus 12600 2230.577    
MAB7-SW1 2700.583 470.006  90.77 
MAB10B-SW1 2663.933 433.356  83.69 
MAB11-SW1 2537.213 306.636  59.21 
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MAB12-SW1 2627.26 396.683  76.61 
MAB16-SW1 2557.217 326.640  63.08 
MAB17-SW1 2738.843 508.266  98.16 
MAB2-SW1 2573.817 343.240  66.28 
MAB22-SW1 2690.813 460.236  88.88 
MAB24-SW1 2404.317 173.740  33.55 
MAB25A-SW1 2555.077 324.500  62.66 
MAB27-SW1 2572.743 342.166  66.08 
MAB37-SW1 2756.43 525.853  101.55 
AB1-SW2 2550.077 319.500  61.70 
AB5-SW2 2473.757 243.180  46.96 
AB6-SW2 2468.743 238.167  45.99 
AB10-SW2 2765.777 535.200  103.36 
AB11-SW2 2636.757 406.180  78.44 
AB12-SW2 2454.47 223.893  43.23 
AB3-SW5 2438.75 208.173  40.20 
AB6-SW5 2450.073 219.496  42.39 
AB7-SW5 2367.743 137.166  26.49 
AB8-SW5 2428.073 197.496  38.14 
AB6-SW6 2555.743 325.166  62.79 
AB1-SW8 2488.117 257.540  49.73 
AB2-SW8 2396.813 166.236  32.10 
AB7-SW8 2443.107 212.530  41.04 
AB9-SW8 2471.65 241.073  46.55 
AB12-SW8 2606.983 376.406  72.69 
AB1-SW9 2378.317 147.740  28.53 
AB1-SW10 2661.94 431.363  83.30 
AB4-SW10 2499.973 269.396  52.02 













Table A3.2: The quorum sensing activity of seaweed-associated bacterial extracts evaluated 
by green fluorescence protein of reporter strain S. aureus. 
Extract Average Induction Full induction Inhibition 
S. aureus 8324-5 4283.103  4012.825  
S. aureus 12600 270.278    
MAB2-SW1 4099.647 3829.369  95.428 
MAB4-SW1 4323.997 4053.719  101.01 
MAB6-SW1 2231.097 1960.819  48.86 
MAB0A-SW1 3744.013 3473.735  86.56 
MAB10C-SW1 2888.9 2618.622  65.25 
MAB21-SW1 4351.907 4081.629  101.71 
MAB34A-SW1 4721.413 4451.135  110.92 
MAB35-SW1 4393.307 4123.029  102.74 
AB4-SW2 4615.47 4345.192  108.28 
AB9B-SW2 3980.827 3710.549  92.46 
AB27-SW2 3596.917 3326.639  82.90 
AB2-SW5 3816.68 3546.402  88.37 
AB4-SW5 4321.637 4051.359  100.96 
AB1-SW6 3966.81 3696.532  92.11 
S. aureus 8325-4  4934.537  4662.765  
S. aureus 12600 271.772    
AB3-SW6 3677.723 3405.951  73.04 
AB5-SW6 3501.03 3229.258  69.25 
AB1-SW7 5084.89 4813.118  103.22 
AB2-SW7 4503.043 4231.271  90.74 
AB6B-SW8 3309.993 3038.221  65.15 
AB8-SW8 4185.687 3913.915  83.93 
AB11-SW8 4592.83 4321.058  92.67 
AB14-SW8 4486.52 4214.748  90.39 
AB3-SW9 4946.53 4674.758  100.25 
AB5-SW9 4101.86 3830.088  82.14 
AB4-SW9 4323.59 4051.818  86.89 
AB2-SW10 5439.34 5167.568  110.82 
AB3-SW10 4253.373 3981.601  85.39 












Extract Average Induction Full induction Inhibition 
S. aureus 8324-5 3670.843  893.3063  
S. aureus 12600 2777.537    
MAB7-SW1 3722.32 944.783  105.76 
MAB10B-SW1 3166.267 388.7297  43.51 
MAB11-SW1 3480.997 703.4597  78.74 
MAB12-SW1 3739.66 962.123  107.70 
MAB16-SW1 3792.963 1015.426  113.67 
MAB17-SW1 3527.59 750.053  83.96 
MAB20-SW1 3559.083 781.5463  87.48 
MAB22-SW1 3472.863 695.3263  77.83 
MAB24-SW1 2908.243 130.7063  14.63 
MAB25A-SW1 3918.663 1141.126  127.74 
MAB27-SW1 3415.487 637.9497  71.41 
MAB37-SW1 3535.07 757.533  84.80 
AB1-SW2 3375.36 597.823  66.92 
AB5-SW2 3630.27 852.733  95.45 
AB6-SW2 3757.023 979.4863  109.64 
AB10-SW2 3335.807 558.2697  62.49 
AB11-SW2 3590.38 812.843  90.99 
AB12-SW2 3487.247 709.7097  79.44 
AB3-SW5 3849.36 1071.823  119.98 
AB6-SW5 4061.993 1284.456  143.78 
AB7-SW5 3423.013 645.4763  72.25 
AB8-SW5 3526.32 748.783  83.82 
AB6-SW6 3581.487 803.9497  89.99 
AB1-SW8 3533.507 755.9697  84.62 
AB2-SW8 3464.253 686.7163  76.87 
AB7-SW8 3160.427 382.8897  42.86 
AB9-SW8 3584.54 807.003  90.33 
AB12-SW8 3943.69 1166.153  130.54 
AB1-SW9 3208.887 431.3497  48.28 
AB1-SW10 3431.19 653.653  73.17 
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Table A3.3: The quorum sensing inhibition activity of seaweed-associated bacterial extracts 





     
Negative control 0.084 0.100   
E. faecalis OGIRF 0.184    
MAB2-SW1 0.159  0.075 75.13 
MAB6-SW1 0.172  0.087 116.91 
MAB10C-SW1 0.187  0.103 103.07 
MAB10B-SW1 0.150  0.066 66.52 
MAB11-SW1 0.169  0.085 85.72 
MAB24-SW1 0.161  0.077 77.25 
MAB35-SW1 0.177  0.092 92.83 
MAB34A-SW1 0.180  0.095 95.82 
AB6-SW2 0.190  0.106 106.75 
AB12-SW2 0.191  0.107 107.45 
AB3-SW5 0.141  0.057 57.32 
AB6-SW5 0.154  0.070 70.23 
AB7-SW5 0.169  0.085 85.32 
AB8-SW5 0.149  0.065 65.31 
AB5-SW6 0.160  0.076 76.45 
AB1-SW8 0.163  0.079 78.94 
AB2-SW8 0.127  0.043 43.01 
 AB5-SW8 0.160  0.076 76.53 
AB7-SW8 0.145  0.061 61.01 
AB9-SW8 0.163  0.079 79.43 
AB11-SW8 0.183  0.099 99.39 
AB1-SW9 0.214  0.130 130.89 
AB3-SW10 0.202  0.118 118.48 
AB4-SW10 0.185  0.100 100.92 
   *The induction of gelatinase was controlled by the fsr system of E. faecalis OGIRF. 
 
